000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1292|2594|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|||1292||1292|2594 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4|Vistor hf|Janssen-Cilag AB|||||| 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|SEK|6170|9213|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|||6170||6170|9213 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|42458|54728|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|||42458||42458|54728 000055|B03XA0103|NeoRecormon|sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|114398|144293|lyfsjukr|||00|1|0|60|Icepharma hf|Roche|||114398||114398|144293 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|63619|81073|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|||63619||63619|81073 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9666|13958|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||9666||9666|13958 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|1460|2822|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|||1460||1460|2822 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|3369|5412|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|||3369||3369|5412 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|28761|37992|lyfalmen|||00|28|0|42|Icepharma hf|Eli Lilly Nederland -|||28761||28761|37992 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|37404|48753|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|||37404||37404|48753 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|18817|25612|lyfalmen|V0813|25145|00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||18817||18817|25612 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|SEK|6170|9213|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|||6170||6170|9213 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|5504|7880|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|||5504||5504|7880 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7072|13642|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7072||7072|13642 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|16395|22279|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|||16395||16395|22279 000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1795|3276|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||1795||1795|3276 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|18836|25636|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|||18836||18836|25636 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5003|7163|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|||5003||5003|7163 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|37363|48702|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|||37363||37363|48702 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5281|8007|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|||5281||5281|8007 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2175||2175|3114 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2965|4864|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|||||2965|4864 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|26059|34628|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|||26059||26059|34628 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1823|3314|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|||1823||1823|3314 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4836|7403|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4836||4836|7403 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|3837|6047|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|||3837||3837|6047 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5179|7869|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|||5179||5179|7869 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|13921|19199|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|||13921||13921|19199 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4263|6625|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||4263|6625 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2590||2590|3708 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3527|5627|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3527||3527|5627 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|2|Vistor hf|McNeil Denmark ApS|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1|Vistor hf|McNeil Denmark ApS|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|153816|193368|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|||153816||153816|193368 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|12971|18334|lyfalmen|||00|60|0|30|Sofus Consulting AB|Procter & Gamble-|||12971||12971|18334 000957|H01AC0101|Genotropin|sts|0| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|31723|41363|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||31723||31723|41363 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|5884|8424|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|||5884||5884|8424 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1596|3006|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1596||1596|3006 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11016|15790|lyfalmen|||00|30|0|240|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11016||11016|15790 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|22195|29818|lyfalmen|||00|100|0|800|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||22195||22195|29818 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2141|3746|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|||2141||2141|3746 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|10956|15708|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|||10956||10956|15708 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|376291|470350|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|||376291||376291|470350 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|4339|6729|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|||4339||4339|6729 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|2740|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|||1400||1400|2740 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|30218|39489|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|||30218||30218|39489 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|||00|98|0|65|Actavis Group hf|Actavis hf|||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|||00|98|0|131|Actavis Group hf|Actavis hf|||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|75|Actavis Group hf|Actavis hf|||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3035|00|98|0|261|Actavis Group hf|Actavis hf|||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6203|9258|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6203||6203|9258 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4107|6414|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|||4107||4107|6414 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||2456||2456|4173 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24922|32895|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|||24922||24922|32895 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|SKY|0|0|1|100|CHF|13679|19215|lyfalmen|V0011|17349|00|25|0|5|Icepharma hf|SkyPharma PLC|||13679||13679|19215 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33775|43917|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|||33775||33775|43917 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22919|30402|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|||22919||22919|30402 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|6437|9216|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|||6437||6437|9216 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|10279|14665|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|||10279||10279|14665 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Vistor hf|Bayer A/S|||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1206|1727|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|||1206||1206|1727 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|3933|6178|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|||3933||3933|6178 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|959|2142|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|||959||959|2142 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|70846|90071|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||70846||70846|90071 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4094|6396|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|||4094||4094|6396 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5475|8270|lyfalmen|V0793|8270|00|60|0|24|Actavis Group hf|Actavis hf|||5475||5475|8270 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8376|12207|lyfalmen|V0456|12100|43|100|0|33|Vistor hf|LEO Pharma A/S|||8376||8376|12207 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3594|5718|lyfalmen|V0084|5633|00|28|0|19|Vistor hf|AstraZeneca A/S DK|||3594||3594|5718 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7106|10484|lyfalmen|V0086|10291|00|56|0|37|Vistor hf|AstraZeneca A/S DK|||7106||7106|10484 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1265|2557|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|||1265||1265|2557 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4736|7267|lyfalmen|V0085|7166|00|28|0|37|Vistor hf|AstraZeneca A/S DK|||4736||4736|7267 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|4338|6727|lyfalmen|||00|100|0|27|Icepharma hf|Schering Oy|||4338||4338|6727 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|19901|26644|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|||19901||19901|26644 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5789|8696|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|||5789||5789|8696 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|17799|24027|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|||17799||17799|24027 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|29126|38129|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|||29126||29126|38129 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12558|17820|lyfalmen|V0087|17506|00|100|0|67|Vistor hf|AstraZeneca A/S DK|||12558||12558|17820 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7554|11092|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|||7554||7554|11092 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|3634|5772|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|||3634||3634|5772 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|16881|23202|lyfalmen|V0089|22868|00|100|0|133|Vistor hf|AstraZeneca A/S DK|||16881||16881|23202 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3866|6087|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|||3866||3866|6087 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|6320|9417|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|||6320||6320|9417 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|6623|9828|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|||6623||6623|9828 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3855|6072|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|||3855||3855|6072 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|19494|26455|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|||19494||19494|26455 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|92525|117061|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|||92525||92525|117061 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|46477|59731|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|||46477||46477|59731 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|26641|35036|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|||26641||26641|35036 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2485|4213|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||||2485|4213 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1532|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|||510||510|1532 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2485|4213|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|||2485||2485|4213 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3662|lyfalmen|V0984|3662|00|100|0|100|Actavis Group hf|Actavis hf|||2079||2079|3662 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|184304|231326|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|||184304||184304|231326 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|2675|4629|vetorma|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2675|4629 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1276|2572|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|||1276||1276|2572 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|27224|35761|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|||27224||27224|35761 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|59498|76260|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|||59498||59498|76260 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|15018|14192|lyfalmen|V0193|14192|00|98|0|196|Icepharma hf|M.S.D.|||9839||9839|14192 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|12508|17757|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|||12508||12508|17757 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|259194|324564|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|||259194||259194|324564 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|18433|25134|lyfalmen|V1710|25133|00|100|0|25|Vistor hf|U.C.B|||18433||18433|25134 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|41992|54465|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||41992||41992|54465 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|7996|11691|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|||7996||7996|11691 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|11929|17029|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|||11929||11929|17029 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17458|23603|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|||17458||17458|23603 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26008|34247|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|||26008||26008|34247 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|29392|38461|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|||29392||29392|38461 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|43638|56197|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|||43638||43638|56197 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|57258|73154|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|||57258||57258|73154 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|70488|89625|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|||70488||70488|89625 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|186846|234491|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|||186846||186846|234491 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7332|10790|lyfalmen|V0990|10740|00|120|0|30|Vistor hf|AstraZeneca A/S DK|||7332||7332|10790 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|86201|109188|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|||86201||86201|109188 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6700|9933|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|||6700||6700|9933 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|128253|161542|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|||128253||128253|161542 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|SEK|63804|81621|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|||63804||63804|81621 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|137113|172573|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|||137113||137113|172573 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|205307|257475|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|||205307||205307|257475 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|102727|129763|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|||102727||102727|129763 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|3873|6096|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|||3873||3873|6096 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3325|5353|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3325||3325|5353 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|13341|18795|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|||13341||13341|18795 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|5955|8922|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|||5955||5955|8922 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|19909|26972|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|||||19909|26972 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|821|1955|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|||821||821|1955 003910|B03XA0102|Eprex|stl|6000|ae/spr|0,6|ml|6|spr||B03XA01|01.01.2002|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|65489|83401|lyfsjukr|||51|4|0|36|Vistor hf|Janssen-Cilag AB|||65489||65489|83401 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1170|2428|lyfalmen|V0931|2428|00|28|0|28|Actavis Group hf|Actavis hf|||1170||1170|2428 003932|B03XA0102|Eprex|stl|8000|ae/spr|0,8|ml|6|spr||B03XA01|01.01.2002|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|81874|103801|lyfsjukr|||51|5|0|48|Vistor hf|Janssen-Cilag AB|||81874||81874|103801 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|599|1653|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|||599||599|1653 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4068|6361|lyfalmen|V0933|6361|00|98|0|98|Actavis Group hf|Actavis hf|||4068||4068|6361 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|88502|112052|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|||88502||88502|112052 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2526|4268|lyfalmen|V0608|1937|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|||2526||2526|4268 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|31211|40725|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|||31211||31211|40725 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7455|10957|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|||7455||7455|10957 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2|Vistor hf|Janssen-Cilag AB|||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|3665|5814|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3665||3665|5814 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|558|1598|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||558||558|1598 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|998|2195|lyfalmen|||10|30|0|15|Icepharma hf|Valeant Pharmaceuticals B.V.|||998||998|2195 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|5825|8745|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5825||5825|8745 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5347|8097|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5347||5347|8097 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|7443|10941|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7443||7443|10941 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|706|1798|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|||706||706|1798 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|5583|8417|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|||5583||5583|8417 004338|B03XA0102|Eprex|stl|1000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|11358|16008|lyfsjukr|||51|3|0|6|Vistor hf|Janssen-Cilag AB|||11358||11358|16008 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|22903|30382|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||22903||22903|30382 004364|B03XA0102|Eprex|stl|2000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|22733|30170|lyfsjukr|||51|3|0|12|Vistor hf|Janssen-Cilag AB|||22733||22733|30170 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|2039|3607|lyfalmen|V1901|3553|00|30|0|30|Vistor hf|Schering-Plough|||2039||2039|3607 004372|B03XA0102|Eprex|stl|4000|ae/spr|0,4|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|44983|57871|lyfsjukr|||51|2|0|24|Vistor hf|Janssen-Cilag AB|||44983||44983|57871 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7449|10949|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7449||7449|10949 004375|B03XA0102|Eprex|stl|3000|ae/spr|0,3|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|34016|44217|lyfsjukr|||51|2|0|18|Vistor hf|Janssen-Cilag AB|||34016||34016|44217 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4785|7334|lyfalmen|||00|100|0|100|Vistor hf|Schering-Plough|||||4785|7334 004383|B03XA0102|Eprex|stl|10000|ae/spr|1|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|90448|114475|lyfsjukr|||51|6|0|60|Vistor hf|Janssen-Cilag AB|||90448||90448|114475 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4302|8366|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||4302||4302|8366 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3058|4990|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |||3058||3058|4990 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|584|1633|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|||584||584|1633 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3007|4921|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3007||3007|4921 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4079|6376|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |||4079||4079|6376 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|30936|40383|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|||30936||30936|40383 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|5761|8658|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |||5761||5761|8658 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|7669|11248|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |||7669||7669|11248 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1771|3244|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1771||1771|3244 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|51560|66060|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|||51560||51560|66060 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|61873|78899|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|||61873||61873|78899 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|41249|53223|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|||41249||41249|53223 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|6701|9934|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |||6701||6701|9934 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|34884|45298|lyfsjukr|||00|1|0|4|MedFarm ehf|E. Merck AB|||34884||34884|45298 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1810|3297|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|||1810||1810|3297 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2296|3956|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2296||2296|3956 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4492|6936|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||4492||4492|6936 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1269|2562|lyfalmen|V0923|2562|00|28|0|28|Actavis Group hf|Actavis hf|||1269||1269|2562 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team||||||1572 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|40254|51984|lyfsjukr|||00|5|0|7|Vistor hf|Biovitrum AB (publ)|||40254||40254|51984 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5|Actavis Group hf|Actavis hf|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|154973|194809|lyfsjukr|||00|19|0|28|Vistor hf|Biovitrum AB (publ)|||154973||154973|194809 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|174422|219023|lyfsjukr|||00|5|0|20|MedFarm ehf|E. Merck AB|||174422||174422|219023 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8943|12976|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||8943||8943|12976 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|10254|14634|lyfsjukr|||00|1000|0|3|Actavis Group hf|Actavis Group hf|||10254||10254|14634 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|19099|25646|lyfsjukr|||00|2000|0|7|Actavis Group hf|Actavis Group hf|||19099||19099|25646 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8291|12092|lyfalmen|V0714|7364|0|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||8291|12092 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10861|15579|lyfalmen|V0715|9747|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||10861|15579 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|611|1670|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|||611||611|1670 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|64979|82766|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|||64979||64979|82766 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5101|7303|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5101||5101|7303 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|362|1332|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|||362||362|1332 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|618|1679|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|||618||618|1679 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1169|2427|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|||1169||1169|2427 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1545|2937|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1545||1545|2937 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2183|3803|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||||2183|3803 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|9665|9585|lyfalmen|V0437|8588|00|90|0|90|Vistor hf|Yamanouchi Europe|||6444||6444|9585 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|||10|30|0|4|Actavis Group hf|Actavis hf|||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis hf|||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|21995|29569|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|||21995||21995|29569 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|39840|51786|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|||39840||39840|51786 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|2628|4407|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|||2628||2628|4407 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Napp|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1060|2279|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|||1060||1060|2279 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|53143|68348|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|||||53143|68348 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|35818|46778|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|||35818||35818|46778 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1399|2739|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|||1399||1399|2739 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|27864|17102|lyfalmen|V0815|15476|00|28|0|42|Icepharma hf|Eli Lilly Nederland -|||11983||11983|17102 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|4998|7623|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|||4998||4998|7623 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|35438|46305|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|||35438||35438|46305 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|965|2150|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||965||965|2150 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|13861|19442|lyfalmen|V0718|19442|00|12|0|84|Icepharma hf|M.S.D.|||13861||13861|19442 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|6446|9588|lyfalmen|||00|30|0|30|Vistor hf|Boehringer Ingelheim International|||6446||6446|9588 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|6788|10052|lyfalmen|V0985|9912|00|30|0|30|Vistor hf|Boehringer Ingelheim International|||6788||6788|10052 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|3954|6206|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|||3954||3954|6206 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1504|2881|lyfalmen|||00|30|0|6|Icepharma hf|Servier|||1504||1504|2881 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2622|4399|lyfalmen|||00|60|0|11|Icepharma hf|Servier|||2622||2622|4399 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|6962|10288|lyfalmen|||00|180|0|34|Icepharma hf|Servier|||6962||6962|10288 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|3826|6032|lyfalmen|||00|90|0|17|Icepharma hf|Servier|||3826||3826|6032 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Actavis Group hf|Actavis hf|||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|5792|8700|lyfalmen|||00|180|0|90|Icepharma hf|Servier|||5792||5792|8700 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|2241|3882|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|||2241||2241|3882 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|4162|5959|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|||4162||4162|5959 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|63560|81000|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|||63560||63560|81000 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|32629|42491|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|||32629||32629|42491 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|32629|42491|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|||32629||32629|42491 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6858|10147|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||6858||6858|10147 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|3050|4979|lyfalmen|V0939|4897|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||3050||3050|4979 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|15577|26957|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||15577||15577|26957 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6044|9042|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||6044||6044|9042 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|70865|90094|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|||70865||70865|90094 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|10707|15370|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||10707||10707|15370 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|5332|8076|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|||5332||5332|8076 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|2959|4856|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||2959||2959|4856 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|2809|4652|lyfalmen|||59|8|0|2|Icepharma hf|Roche|||2809||2809|4652 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|832|1969|lyfalmen|||00|1|0|1|Icepharma hf|Eli Lilly Nederland -|||832||832|1969 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|9682|13979|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||9682||9682|13979 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|20337|27505|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|||20337||20337|27505 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3464|5541|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||3464||3464|5541 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6517|9684|lyfalmen|V1039|9508|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||6517||6517|9684 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|9416|11598|lyfalmen|V1110|9318|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||7927||7927|11598 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|13241|18670|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|||13241||13241|18670 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4417|6834|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4417||4417|6834 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|13303|16408|lyfalmen|V1111|13111|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||11472||11472|16408 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|80208|101726|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|||80208||80208|101726 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|5924|8880|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||5924||5924|8880 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|30172|39432|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|||30172||30172|39432 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|116625|147066|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|||116625||116625|147066 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|5796|8706|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||5796||5796|8706 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|160529|201726|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|||160529||160529|201726 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|81331|103125|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|||81331||81331|103125 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|972|2159|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||972||972|2159 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|7927|11598|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||7927||7927|11598 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|34822|45221|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer HealthCare AG|||34822||34822|45221 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|59871|76407|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer HealthCare AG|||59871||59871|76407 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2241|3882|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|||2241||2241|3882 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|8300|15981|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||8300||8300|15981 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8812|12799|lyfalmen|V0391|12568|00|60|0|0|Vistor hf|LEO Pharma A/S|||8812||8812|12799 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|13083|18473|lyfalmen|V2001|18147|00|120|0|0|Vistor hf|LEO Pharma A/S|||13083||13083|18473 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|33002|43272|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|||33002||33002|43272 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma|||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|14621|20388|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|||14621||14621|20388 006903|L03AX1301|Copaxone|sts|20|mg/hgl|28|hgl|1|pakki|+ leysir|L03AX13|01.01.2001|30.11.2008|R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|||lyfsjukr|||00|28|0|28|Vistor hf|Teva Pharmaceuticals Limited|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|16475|22696|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|||16475||16475|22696 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3559|5670|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||3559||3559|5670 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|679|1762|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|||679||679|1762 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|28928|38200|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|||28928||28928|38200 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|22786|43575|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||22786||22786|43575 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11322|16205|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||11322||11322|16205 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1694|3139|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|||1694||1694|3139 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5332|8076|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||5332||5332|8076 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|16967|23309|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||16967||16967|23309 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5482|8280|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|||5482||5482|8280 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7079|10447|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||7079||7079|10447 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|24775|33030|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||24775||24775|33030 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|141181|177638|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||141181||141181|177638 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|249391|312359|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||249391||249391|312359 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1985|3534|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|||1985||1985|3534 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2493|4224|lyfalmen|||00|3|0|30|Vistor hf|Allergan|||2493||2493|4224 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|140702|177041|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||140702||140702|177041 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|216542|271462|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||216542||216542|271462 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|188261|236252|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||188261||188261|236252 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|122845|154810|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||122845||122845|154810 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|309491|387184|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||309491||309491|387184 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3333|5363|lyfalmen|V0988|5274|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3333||3333|5363 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|6714|9613|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||6714||6714|9613 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|113724|143454|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||113724||113724|143454 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|24231|32035|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|||24231||24231|32035 007494|QP52AA0101|Droncit, vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer Animal Health GmbH||||||3208 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6480|9634|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6480||6480|9634 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|4668|7175|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|||4668||4668|7175 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2841|4696|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||2841||2841|4696 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|4668|7175|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|||4668||4668|7175 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|8567|12266|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|||8567||8567|12266 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|20256|27404|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||20256||20256|27404 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|9097|13185|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|||9097||9097|13185 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9039|13107|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||9039||9039|13107 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2382|3410|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|||2382||2382|3410 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2164|3777|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||2164||2164|3777 007657|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|1|hgl||QH02AB06|01.05.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|1773|3499|vetalmen|||58|50|0|0|Icepharma hf|Intervet International B.V.|||1773||1773|3499 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7214|10630|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7214||7214|10630 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|21908|29460|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||21908||21908|29460 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|3831|6039|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|||3831||3831|6039 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0|Icepharma hf|Baxter|||||| 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2499|4232|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2499||2499|4232 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1256|2545|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1256||1256|2545 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|150077|188713|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|||150077||150077|188713 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Astellas Pharma A/S|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|20961|27964|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|||20961||20961|27964 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|37815|48947|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|||37815||37815|48947 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|624|1687|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||624||624|1687 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3336|5367|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|||3336||3336|5367 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|22845|30310|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||22845||22845|30310 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|28557|37421|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|||28557||28557|37421 008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|393|1374|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||393||393|1374 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|6350|9458|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|||6350||6350|9458 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|87075|110276|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|||87075||87075|110276 008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1244|2529|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1244||1244|2529 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|175057|219813|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|||175057||175057|219813 008123|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|1|hgl||J07AH07|01.05.2002|31.12.2008|R|K|3|0|0|0|0|WAB|0|0|0|100|USD|4031|6311|lyfalmen|||00|0|0|0|Icepharma hf|Wyeth AB|||4031||4031|6311 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|126944|159913|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|||126944||126944|159913 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|186854|234501|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|||186854||186854|234501 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|218133|273443|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|||218133||218133|273443 008182|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|10|hgl||J07AH07|01.05.2002|31.12.2008|R|K|3|0|0|0|0|WAB|0|0|0|100|USD|40319|52381|lyfalmen|||00|5|0|0|Icepharma hf|Wyeth AB|||40319||40318|52381 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1914|3438|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||1914||1914|3438 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1094|2325|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|||1094||1094|2325 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|250|1180|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||250||250|1180 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|30085|39323|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||30085||30085|39323 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|23491|31114|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||23491||23491|31114 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|411|1398|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||411||411|1398 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29440|38520|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|||29440||29440|38520 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7334|10793|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||7334||7334|10793 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1109|2345|lyfalmen|V0733|2345|00|20|0|7|Actavis Group hf|Actavis hf|||1109||1109|2345 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2324|3994|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||2324||2324|3994 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1225|2503|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1225||1225|2503 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7398|10880|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||7398||7398|10880 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4340|6730|lyfalmen|V0734|6730|00|100|0|33|Actavis Group hf|Actavis hf|||4340||4340|6730 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6660|9878|lyfalmen|V0736|8592|00|100|0|50|Actavis Group hf|Actavis hf|||6660||6660|9878 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|8769|12740|lyfalmen|V0738|12740|00|100|0|67|Actavis Group hf|Actavis hf|||8769||8769|12740 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|194917|244539|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|||194917||194917|244539 008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|393|1374|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||393||393|1374 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|734|1836|lyfalmen|V0431|1836|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |||734||734|1836 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|620|1682|lyfalmen|V0430|1682|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |||620||620|1682 008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1244|2529|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1244||1244|2529 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|4844|8383|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||4844||4844|8383 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|10276|19745|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||10276||10276|19745 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4260|6621|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|||4260||4260|6621 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.|||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2721|4533|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|||2721||2721|4533 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|123732|155914|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|||123732||123732|155914 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|128977|162444|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|||128977||128977|162444 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2481|4293|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2481||2481|4293 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|2897|4772|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|||2897||2897|4772 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2841|4696|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||2841||2841|4696 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2154|3763|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2154||2154|3763 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|5696|8570|lyfalmen|V1350|8415|00|4|0|8|Icepharma hf|Lilly ICOS Limited|||||5696|8570 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|950|2130|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|||950||950|2130 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|11220|16066|lyfalmen|V1351|15761|00|8|0|16|Icepharma hf|Lilly ICOS Limited|||||11220|16066 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|4888|7474|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||4888||4888|7474 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|15173|21075|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|||15173||15173|21075 009137|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|26656|35054|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|||26656||26656|35054 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|6916|10226|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|||6916||6916|10226 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|13129|18531|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|||13129||13129|18531 009275|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|10993|15554|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|||10993||10993|15554 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|57370|73293|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||57370||57370|73293 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0|Icepharma hf|Fresenius Kabi||||||1618 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5229|7936|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|||5229||5229|7936 009286|M05BA0303|Pamidronatdinatrium Mayne 6 mg/ml|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|14411|19809|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|||14411||14411|19809 009297|M05BA0304|Pamidronatdinatrium Mayne 9 mg/ml|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|18934|25440|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|||18934||18934|25440 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1282|2580|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|||1282||1282|2580 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1378|2710|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|||1378||1378|2710 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1623|3043|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|||1623||1623|3043 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1868|3375|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|||1868||1868|3375 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|||||| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|229168|287182|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||229168||229168|287182 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5808|8722|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|||5808||5808|8722 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|8902|12921|lyfalmen|||00|55|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8902||8902|12921 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GSC|0|0|0|100|DKK|66198|84284|lyfsjukr|||00|30|0|30|Swedish Orphan International AB|Gilead Science International (S) |||66198||66198|84284 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9038|13105|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||9038||9038|13105 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|38893|50289|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|||38893||38893|50289 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|792|1915|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||792||792|1915 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6195|9247|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|||6195||6195|9247 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6082|9094|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||6082||6082|9094 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7208|10622|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||7208||7208|10622 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|517|1542|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|||517||517|1542 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6562|9745|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||6562||6562|9745 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7234|10657|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||7234||7234|10657 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|5565|8392|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|||5565||5565|8392 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2194|3818|lyfalmen|V1151|2754|00|30|0|15|Vistor hf|N.V. Organon|||2194||2194|3818 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|3894|6125|lyfalmen|V1152|3949|00|30|0|30|Vistor hf|N.V. Organon|||3894||3894|6125 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|8316|12126|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|||8316||8316|12126 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|177212|222496|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|||177212||177212|222496 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|4261|6623|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|||4261||4261|6623 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1135|2381|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||1135||1135|2381 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|43780|56691|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|||43780||43780|56691 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|26269|34890|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|||26269||26269|34890 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|228505|286356|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|||228505||228505|286356 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|394989|493629|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||394989||394989|493629 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|165420|207815|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|||165420||165420|207815 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|7719|11052|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|||7719||7719|11052 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|12087|17233|lyfalmen|V1153|11903|00|96|0|96|Vistor hf|N.V. Organon|||12087||12087|17233 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|18311|24982|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|||18311||18311|24982 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8083|11809|lyfalmen|||00|30|0|15|Lundbeck Export A/S|H. Lundbeck A/S|||8083||8083|11809 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|13202|18621|lyfalmen|||00|50|0|25|Lundbeck Export A/S|H. Lundbeck A/S|||13202||13202|18621 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|23769|31777|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||23769||23769|31777 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3657|5803|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||3657||3657|5803 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|8423|12271|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||8423||8423|12271 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|11814|16873|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||11814||11814|16873 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|69714|132966|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||69714||69714|132966 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|11473|16151|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||11473||11473|16151 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7868|11265|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|||7868||7868|11265 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1254|2542|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|||1254||1254|2542 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|4562|7031|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||4562||4562|7031 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6078|8702|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|||6078||6078|8702 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|11146|15744|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|||11146||11146|15744 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4242|6073|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||4242||4242|6073 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2431|3481|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2431||2431|3481 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|6932|10247|lyfalmen|||00|9|0|90|Vistor hf|Allergan|||6932||6932|10247 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|11146|15744|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|||11146||11146|15744 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6119|8761|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|||6119||6119|8761 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4079|5840|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||4079||4079|5840 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|11830|16894|lyfalmen|V1080|16894|00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||11830||11830|16894 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2264|3241|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2264||2264|3241 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|403751|504537|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|||403751||403751|504537 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|403751|504537|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|||403751||403751|504537 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|590331|736830|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||590331||590331|736830 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|785668|980024|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||785668||785668|980024 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1785|3263|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|||1785||1785|3263 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|30|IKR|6037|9033|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||6037||6037|9033 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|30|IKR|3384|5433|lyfalmen|||10|56|0|56|Actavis Group hf|Actavis hf|||3384||3384|5433 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|44236|56941|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|||44236||44236|56941 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2544|3642|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|||2544||2544|3642 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|2678|4475|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|||2678||2678|4475 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20937|28252|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||20937||20937|28252 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20937|28252|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||20937||20937|28252 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35040|45810|lyfalmen|V1702|45809|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||35040||35040|45810 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35040|45810|lyfalmen|V1703|45809|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||35040||35040|45810 011078|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|1|plpoki|án PVC (Ecobag)|B05AA07|01.05.2002|28.02.2009|R|A|2|0|0|0|1|BRA|0|0|0|100|XEU|||lyfsjukr|||00|500|0|0|Actavis Group hf|Braun|||||| 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|15811|21870|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|||15811||15811|21870 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5562|8388|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||5562||5562|8388 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5562|8388|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|||5562||5562|8388 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|22665|30403|lyfalmen|||00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|||22665||22665|30403 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|11607|16592|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|||11607||11607|16592 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|6141|lyfalmen|V0197|5712|00|98|0|98|Actavis Group hf|Actavis hf|||3906||3906|6141 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7311|10762|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|||7311||7311|10762 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|10985|15748|lyfalmen|||00|12|0|6|Vistor hf|Bayer AG-|||10985||10985|15748 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6044|9042|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|||6044||6044|9042 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7100|10165|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|||7100||7100|10165 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2279|3263|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2279||2279|3263 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5562|8388|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|||5562||5562|8388 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7896|11556|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|||7896||7896|11556 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1561|3080|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1561||1561|3080 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|4557|6524|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4557||4557|6524 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1249|2535|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|||1249||1249|2535 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|100233|126658|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|||100233||100233|126658 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|9725|14038|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|||9725||9725|14038 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2003|3559|lyfalmen|V0935|3559|00|28|0|56|Actavis Group hf|Actavis hf|||2003||2003|3559 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|7008|10351|lyfalmen|V0937|10351|00|98|0|196|Actavis Group hf|Actavis hf|||7008||7008|10351 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3731|5342|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|||3731||3731|5342 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3389|4852|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|||3389||3389|4852 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4217|6563|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4217||4217|6563 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|14517|20259|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||14517||14517|20259 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|42603|54908|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|||42603||42603|54908 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10002|14414|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10002||10002|14414 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1180|2442|lyfalmen|||00|20|0|36|Vistor hf|Meda AB|||1180||1180|2442 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|5676|8543|lyfalmen|||00|4|0|4|Icepharma hf|Lilly ICOS Limited|||5676||5676|8543 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A|||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5481|9485|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||5481||5481|9485 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|760|1872|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |||760||760|1872 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9357|13538|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|||9357||9357|13538 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|25758|44576|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||25758||25758|44576 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|SEK|483851|604262|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||483851||483851|604262 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|3917|6156|lyfalmen|||00|4|0|2|Vistor hf|Bayer AG-|||3917||3917|6156 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4334|6722|lyfalmen|||00|4|0|4|Vistor hf|Bayer AG-|||4334||4334|6722 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A|||||| 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|12767|18080|lyfalmen|||00|12|0|12|Vistor hf|Bayer AG-|||12767||12767|18080 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|5373|8132|lyfalmen|||00|4|0|8|Vistor hf|Bayer AG-|||5373||5373|8132 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|15535|21526|lyfalmen|||00|12|0|24|Vistor hf|Bayer AG-|||15535||15535|21526 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|3746|5924|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|||3746||3746|5924 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|5670|8535|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|||5670||5670|8535 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|5825|8745|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|||5825||5825|8745 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6388|12339|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||6388||6388|12339 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9507|13742|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|||9507||9507|13742 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1657|3270|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1657||1657|3270 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|1224|2501|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|||1224||1224|2501 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|20961|27964|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|||20961||20961|27964 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|8297|11879|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|||8297||8297|11879 013259|B02BD0402|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|SEK|31985|41689|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|||31985||31985|41689 013270|B02BD0402|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|SEK|63974|81515|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|||63974||63974|81515 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4196|8164|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4196||4196|8164 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|10084|19380|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||10084||10084|19380 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1058|2088|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1058||1058|2088 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|170208|213776|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|||170208||170208|213776 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|28368|37186|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|||28368||28368|37186 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|113471|143139|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|||113471||113471|143139 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|55259|70665|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|||55259||55259|70665 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|19275|26182|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|||19275||19275|26182 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|175265|220072|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|||175265||175265|220072 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf||||||1367 013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|6567|9752|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||6567||6567|9752 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1173|2432|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|||1173||1173|2432 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|432|1427|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|||432||432|1427 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|43220|55676|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||43220||43220|55676 013720|A10AD0118|Mixtard 30|stl|100|ae/ml|10|ml|1|hgl||A10AD01|01.10.1985|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2934|4822|lyfalmen|||50|10|0|25|Vistor hf|Novo-Nordisk|||2934||2934|4822 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|4435|6859|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4435||4435|6859 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|15251|21172|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||15251||15251|21172 013804|A10AC0105|Insulatard Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AC01|01.07.1993|31.01.2009|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4875|7456|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||4875||4875|7456 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1215||1215|2489 013879|A10AD0120|Mixtard 40 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5842|8767|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5842||5841|8767 013890|A10AD0119|Mixtard 50 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5999|8980|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5999||5998|8980 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|6567|9752|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||6567||6567|9752 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5102|7764|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|||5102||5102|7764 013913|A10AD0121|Mixtard 30 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5523|8334|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5523||5522|8334 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2499|4232|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|||2499||2499|4232 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4701|7220|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||4701||4701|7220 013958|A10AB0103|Actrapid Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AB01|01.02.2004|31.01.2009|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4836|7403|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|||4836||4836|7403 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|207978|260800|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||207978||207978|260800 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|367732|459694|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||367732||367732|459694 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2478|4203|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|||2478||2478|4203 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|11865|16639|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|||11865||11865|16639 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|22152|29764|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|||22152||22152|29764 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|56865|72982|lyfalmen|||AC|3|0|38|Icepharma hf|Eli Lilly Nederland -|||56865||56865|72982 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33945|44129|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|||33945||33945|44129 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1198|2466|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|||1198||1198|2466 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20910|27900|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|||20910||20910|27900 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0|Vistor hf|Janssen-Cilag AB|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23025|30534|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|||23025||23025|30534 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30133|39383|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|||30133||30133|39383 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20910|27900|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|||20910||20910|27900 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|14407|20122|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|||14407||14407|20122 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|78143|99156|lyfsjukr|||0|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|||||78143|99156 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|5384|10427|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5384||5384|10427 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|276398|345983|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|||276398||276398|345983 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2277|3930|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |||2277||2277|3930 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4043|6327|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||4043||4043|6327 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|13684|19222|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||13684||13684|19222 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|71247|90570|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|||71247||71247|90570 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|110292|139181|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|||110292||110292|139181 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|21586|29060|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|||21586||21586|29060 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|64757|82807|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|||64757||64757|82807 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|43173|55935|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|||43173||43173|55935 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24|Icepharma hf|Pharma Nord ApS|||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|601|1656|lyfalmen|||00|10|0|18|Vistor hf|Meda AB|||601||601|1656 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72|Icepharma hf|Pharma Nord ApS|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|8912|12934|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||8912||8912|12934 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||2563||2563|4318 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4586|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|||2760||2760|4586 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1030|2238|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|||1030||1030|2238 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|10004|14416|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||10004||10004|14416 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|326543|408414|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|||326543||326543|408414 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|86793|109925|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|||86793||86793|109925 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5791|8699|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|||5791||5791|8699 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|12761|18072|lyfalmen|V1732|18072|00|100|0|11|Vistor hf|Orion Corporation|||12761||12761|18072 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5791|8699|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|||5791||5791|8699 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|19218|26111|lyfalmen|V1731|26110|00|100|0|33|Vistor hf|Orion Corporation|||19218||19218|26111 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|31273|41120|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|||31273||31273|41120 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|75542|95917|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||75542||75542|95917 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|75542|95917|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||75542||75542|95917 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|75542|95917|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||75542||75542|95917 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5791|8699|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|||5791||5791|8699 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|12627|17906|lyfalmen|V1730|17906|00|100|0|22|Vistor hf|Orion Corporation|||12627||12627|17906 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|75542|95917|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||75542||75542|95917 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|26230|34841|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|||26230||26230|34841 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|45620|58982|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|||45620||45620|58982 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|937|2112|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||937||937|2112 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3011|5211|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3011||3011|5211 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4231|7322|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||4231||4231|7322 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2686|4648|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||2686||2686|4648 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3368|5828|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||3368||3368|5828 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4292|6665|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|||4292||4292|6665 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3774|6531|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||3774||3774|6531 015912|D11AX1401|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AX14|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|1898|3416|lyfalmen|||0|10|0|0|Vistor hf|Astellas Pharma A/S|||||1898|3416 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2132|3734|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|||2132||2132|3734 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1364|2691|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|||1364||1364|2691 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3011|5211|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3011||3011|5211 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|100|GBP|1312|2621|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1312||1312|2621 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|14637|20408|lyfalmen|||00|90|0|180|Icepharma hf|Servier|||14637||14637|20408 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|4610|7096|lyfalmen|||00|6|0|6|Vistor hf|Laboratorios Almirall S.A.|||4610||4610|7096 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|4923|7521|lyfalmen|||00|30|0|60|Icepharma hf|Servier|||4923||4923|7521 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|6527|9698|lyfalmen|||00|9|0|9|Vistor hf|Laboratorios Almirall S.A.|||6527||6527|9698 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11562|16531|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||11562||11562|16531 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1013|2215|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|||1013||1013|2215 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|17322|23751|lyfalmen|||00|100|0|200|Vistor hf|AstraZeneca A/S DK|||17322||17322|23751 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1074|2298|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|||1074||1074|2298 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|2380|4070|lyfalmen|||00|3|0|3|Vistor hf|Laboratorios Almirall S.A.|||2380||2380|4070 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS|||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|7062|10424|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|||7062||7062|10424 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|6915|10224|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|||6915||6915|10224 016228|A10BD0301|Avandamet|filmhtfl|501|mg|56|stk|1|þpakki|500+1mg|A10BD03|01.03.2004|31.12.2008|R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|2566|4323|lyfalmen|||00|56|0|28|GlaxoSmithKline ehf|SmithKline Beecham PLC|||2566||2566|4323 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|3950|6201|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|||3950||3950|6201 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3106|5055|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3106||3106|5055 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6598|9794|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6598||6598|9794 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|4301|6677|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|||4301||4301|6677 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10044|14471|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10044||10044|14471 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2086|3671|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2086||2086|3671 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14731|20525|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14731||14731|20525 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10548|15155|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|||10548||10548|15155 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|3895|6126|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|||3895||3895|6126 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|4382|6274|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4382||4382|6274 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|5548|7943|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5548||5548|7943 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|16112|21927|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16112||16112|21927 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|132849|167265|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||132849||132849|167265 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|8057|11536|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8057||8057|11536 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3103|5051|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3103||3103|5051 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|7450|10667|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7450||7450|10667 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|25256|33311|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||25256||25256|33311 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|212095|265926|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||212095||212095|265926 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Vistor hf|McNeil Denmark ApS|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Vistor hf|McNeil Denmark ApS|||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|74384|94476|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||74384||74384|94476 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|17608|24107|lyfalmen|V1701|23669|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||17608||17608|24107 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS||||||6634 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35215|46028|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||35215||35215|46028 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2233|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|227048|284542|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|||227048||227048|284542 016671|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|2|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|28|0|7|Lyfjaver ehf|Lyfjaver ehf|||3911||| 016680|N07BA0112|Nicorette Orange|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 016682|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||5412||| 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|198492|248990|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|||198492||198492|248990 016688|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|10|mg|56|stk|1|glas||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|||20990||| 016693|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|56|0|42|Lyfjaver ehf|Lyfjaver ehf|||16502||| 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2563|4318|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|||2563||2563|4318 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|7763|11375|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||7763||7763|11375 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|66164|84242|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|||66164||66164|84242 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3524|5623|lyfalmen|V0789|5623|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|||3524||3524|5623 016739|N07BA0112|Nicorette Orange|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 016761|N07BA0112|Nicorette Orange|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|6425|9559|lyfalmen|V0713|9559|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|||6425||6425|9559 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|60975|78099|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|||60975||60975|78099 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|90129|114396|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|||90129||90129|114396 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|29330|38701|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|||29330||29330|38701 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|49125|63346|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|||49125||49125|63346 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|18791|25580|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|||18791||18791|25580 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|28184|37274|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|||28184||28184|37274 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|2269|3920|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|||2269||2269|3920 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|4403|6815|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|||4403||4403|6815 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|8574|12476|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|||8574||8574|12476 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|8638|12563|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|||8638||8638|12563 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GSC|0|0|0|100|XEU|38139|49351|lyfsjukr|||00|30|0|30|Swedish Orphan International AB|Gilead Science International (S) |||38139||38139|49351 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|15133|21026|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|||15133||15133|21026 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3289|5304|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |||3289||3289|5304 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17814|34104|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17814||17814|34104 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30821|40240|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|||30821||30821|40240 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1451|2809|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1451||1451|2809 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1468|2833|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|||1468||1468|2833 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|273012|341767|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|||273012||273012|341767 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|6572|9759|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|||6572||6572|9759 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|151193|190103|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|||151193||151193|190103 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|43042|55455|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||43042||43042|55455 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31856|41528|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|||31856||31856|41528 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1366|2694|lyfalmen|V0221|2694|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|||1366||1366|2694 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|142668|179489|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|||142668||142668|179489 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|48035|61989|lyfalmen|||00|28|0|0|Icepharma hf|Roche|||48035||48035|61989 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|143376|180688|lyfalmen|||00|84|0|0|Icepharma hf|Roche|||143376||143376|180688 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5821|8740|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |||5821||5821|8740 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|4807|7364|lyfalmen|V0714|7364|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||4807||4807|7364 017305|N03AX1202|Gabapentin NM Pharma|hylki|400|mg|100|stk|1|glas||N03AX12|01.10.2007|31.01.2009|R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|100|0|22|Actavis Group PTC ehf|Merck NM AB|||7470||| 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|10872|15594|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |||10872||10872|15594 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2558|4312|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|||2558||2558|4312 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|10828|15348|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|||10828||10828|15348 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|2678|4475|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|||2678||2678|4475 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|6860|10150|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |||6860||6860|10150 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|6357|12280|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||6357||6357|12280 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|33174|43487|lyfalmen|V1371|43487|00|84|0|84|Vistor hf|Janssen-Cilag AB|||33174||33174|43487 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|10781|15471|lyfalmen|V1370|15460|00|28|0|14|Vistor hf|Janssen-Cilag AB|||10781||10781|15471 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10639|15278|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10639||10639|15278 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|41450|53790|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|||41450||41450|53790 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10639|15278|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10639||10639|15278 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2704|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|||1373||1373|2704 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|5596|8434|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||5596||5596|8434 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2565|4321|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|||2565||2565|4321 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3788|5981|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3788||3788|5981 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|55031|70381|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|||55031||55031|70381 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|11862|16938|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|||11862||11862|16938 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|8331|12146|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|||8331||8331|12146 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3027|4948|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|||3027||3027|4948 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3306|5327|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|||3306||3306|5327 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|9784|14118|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|||9784||9784|14118 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|15218|20814|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||15218||15218|20814 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|75250|95554|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|||75250||75250|95554 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3185|5163|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3185||3185|5163 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|30652|40029|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|||30652||30652|40029 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|7852|11496|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|||7852||7852|11496 018617|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|87947|111362|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|||87947||87947|111362 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|12983|18031|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|||12983||12983|18031 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1385|2720|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|||1385||1385|2720 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|21346|28761|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|||21346||21346|28761 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2772|4602|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|||2772||2772|4602 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1054|2271|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |||1054||1054|2271 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6284|9368|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|||6284||6284|9368 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|17191|23588|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|||17191||17191|23588 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|35468|46343|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||35468||35468|46343 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|125950|158675|lyfsjukr|||00|28|0|0|Vistor hf|Teva Pharmaceuticals Limited|||||125950|158675 018803|C10AA0502|Lipitor (Lyfjaver)|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|||lyfalmen|||00|100|0|200|Lyfjaver ehf|Lyfjaver ehf|||22673||| 018814|C10AA0502|Lipitor (Lyfjaver)|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|||lyfalmen|||00|100|0|400|Lyfjaver ehf|Lyfjaver ehf|||26641||| 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|45503|58364|lyfalmen|V0375|58364|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|||45124||45124|58364 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|49395|62970|lyfalmen|V0376|62970|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|||48823||48823|62970 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|13861|19442|lyfalmen|V0718|19442|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||13861||13861|19442 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|2955|4850|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|||2955||2955|4850 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|9141|13245|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|||9141||9141|13245 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|52211|66870|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||52211||52211|66870 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|565|1607|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|||565||565|1607 018979|C10AA0502|Lipitor (Lyfjaver)|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|||lyfalmen|||00|100|0|100|Lyfjaver ehf|Lyfjaver ehf|||15692||| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1069|2109|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1069||1069|2109 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|12270|17461|lyfalmen|V1052|13023|00|5|0|62|Vistor hf|Janssen-Cilag AB|||12270||12270|17461 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|13951|19554|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|||13951||13951|19554 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|13951|19554|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|||13951||13951|19554 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|13675|18560|lyfalmen|V1372|18559|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|||13153||13153|18560 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|7959|11641|lyfalmen|V1051|9546|00|5|0|42|Vistor hf|Janssen-Cilag AB|||7959||7959|11641 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||20662||20662|27592 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|6975|10306|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|||6975||6975|10306 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4302|6678|lyfalmen|V1050|5362|00|5|0|21|Vistor hf|Janssen-Cilag AB|||4302||4302|6678 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||23122||23122|30654 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|13754|19309|lyfalmen|V1053|15486|00|5|0|83|Vistor hf|Janssen-Cilag AB|||13754||13754|19309 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|54005|69104|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||54005||54005|69104 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|704694|879212|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|||704694||704694|879212 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|||||| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6482|9637|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||6482||6482|9637 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|56353|72027|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|||56353||56353|72027 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6482|9637|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||6482||6482|9637 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|15949|22041|lyfalmen|||00|140|0|0|Icepharma hf|Eli Lilly Nederland -|||15949||15949|22041 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|568|1611|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|||568||568|1611 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3426|5490|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||3426||3426|5490 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|8561|12458|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||8561||8561|12458 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|4884|7468|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||4884||4884|7468 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|16305|22485|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||16305||16305|22485 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|||||| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3426|5490|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||3426||3426|5490 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|11965|17077|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||11965||11965|17077 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|5739|8217|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|||5739||5739|8217 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|||||| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|4884|7468|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||4884||4884|7468 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|||||| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|16305|22485|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||16305||16305|22485 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|594|1646|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|||594||594|1646 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|28591|37463|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|||28591||28591|37463 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|206197|258583|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|||206197||206197|258583 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|||||| 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|872|2024|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|||872||872|2024 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|207886|260686|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|||207886||207886|260686 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|11868|16946|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|||11868||11868|16946 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|11868|16946|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|||11868||11868|16946 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|56636|72697|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|||56636||56636|72697 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|11868|16946|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|||11868||11868|16946 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|11868|16946|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|||11868||11868|16946 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|11868|16946|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|||11868||11868|16946 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|744599|928893|lyfsjukr|||02|6|0|9|Vistor hf|Biovitrum AB (publ)|||744599||744599|928893 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|345|1309|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||345||345|1309 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|59165|75528|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||59165||59165|75528 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1305|2611|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|||1305||1305|2611 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0|Artasan ehf|Novartis Healthcare A/S-A|||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|||||| 020180|C03CC0101|Edecrin|sts|0| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|19615|26288|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||19615||19615|26288 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4226|6575|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|||4226||4226|6575 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|23068|30905|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||23068||23068|30905 020261|A10BD0301|Avandamet|filmhtfl|1002|mg|56|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005|31.12.2008|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|4899|7489|lyfalmen|||00|56|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4899||4899|7489 020272|A10BD0301|Avandamet|filmhtfl|1004|mg|56|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005|31.12.2008|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|8798|12780|lyfalmen|||00|56|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8798||8798|12780 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2274|3926|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|||2274||2274|3926 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|SEK|783|1903|lyfalmen|||00|7|0|3|Icepharma hf|Wyeth AB|||783||783|1903 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|9291|13449|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|||9291||9291|13449 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|65982|84333|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||65982||65982|84333 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|3629|5765|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3629||3629|5765 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|100|DKK|3437|5505|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||3437||3437|5505 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|10491|15077|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10491||10491|15077 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|23352|31258|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||23352||23352|31258 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|688|1774|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||688||688|1774 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6556|9737|lyfalmen|||00|28|0|28|Icepharma hf|Servier|||6556||6556|9737 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2005|3561|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2005||2005|3561 020472|C09CA0103|Cozaar (Lyfjaver)|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.09.2004|31.12.2008|R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|||lyfalmen|||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||12208||| 020483|C09DA0103|Cozaar Comp (Lyfjaver)|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.08.2004|31.12.2008|R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|||lyfalmen|||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||12226||| 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4034|6315|lyfalmen|V0709|5613|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|||4034||4034|6315 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|5879|8818|lyfalmen|V0710|8698|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|||5879||5879|8818 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|11719|16744|lyfalmen|V0711|14745|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|||11719||11719|16744 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|2989|4897|lyfalmen|V0939|4897|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||2989||2989|4897 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|19232|26129|lyfalmen|||00|84|0|84|Icepharma hf|Servier|||19232||19232|26129 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki|+stjaka|G03CA03|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|1904|3424|lyfalmen|V0418|3424|05|15|0|15|D.A.C. ehf|D.A.C. ehf|||||1904|3424 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.|||||| 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004|31.01.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|4561|5287|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|||3277||3277|5287 020700|L04AA2101|Raptiva|sts|100|mg/ml|125|mg|4|hgl|+ leysir|L04AA21|01.05.2005||R|K|4|0|1|0|1|SEE|0|0|0|100|SEK|149341|187797|lyfsjukr|||00|500|0|50|Gróco ehf|Serono Europe|||149341||149341|187797 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0|Icepharma hf|Medimpex UK Limited|||||| 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7295|10740|lyfalmen|V0990|10740|00|120|0|30|D.A.C. ehf|D.A.C. ehf|||||7295|10740 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2106|3645|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2106||2106|3645 020774|L04AB0101|Enbrel|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|SEK|197375|247599|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|||197375||197375|247599 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996||R|A|3|0|0|B|0|WLN|0|1|0|100|SEK|2336|4010|lyfalmen|||00|28|0|10|Icepharma hf|Wyeth Lederle Nordiska|||||2336|4010 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2609|4381|lyfalmen|V0429|4381|00|3|0|5|D.A.C. ehf|D.A.C. ehf|||2609||2609|4381 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006||R|K|3|0|0|E|0|BIP|0|0|0|100|SEK|5210|7911|lyfalmen|||00|100|0|0|Vistor hf|BioPhausia AB|||5210||5210|7911 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|5719|8601|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|||5719||5719|8601 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2005|3561|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|||2005||2005|3561 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|714|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3267|5274|lyfalmen|V0988|5274|06|2|0|0|D.A.C. ehf|D.A.C. ehf|||3267||3267|5274 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|8558|10975|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|||7468||7468|10975 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|11322|14745|lyfalmen|V0711|14745|00|60|0|20|D.A.C. ehf|D.A.C. ehf|||10246||10246|14745 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2233|lyfalmen|V0466|2233|00|12|0|12|D.A.C. ehf|D.A.C. ehf|||1026||1026|2233 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1436|lyfalmen|V0609|1436|00|30|0|15|Actavis Group hf|Actavis hf|||439||439|1436 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|964|2149|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|||964||964|2149 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1612|3028|lyfalmen|V0987|3028|23|200|0|50|D.A.C. ehf|D.A.C. ehf|||1612||1612|3028 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|3675|3267|lyfalmen|V0931|2428|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||1788||1788|3267 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|5734|4913|lyfalmen|V0935|3559|00|28|0|56|D.A.C. ehf|D.A.C. ehf|||3001||3001|4913 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|14226|19896|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|||14226||14226|19896 021278|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2009||R|K|3|0|0|*|0|DAC|0|0|0|100|DKK|2581|4343|lyfalmen|V1989|4343|0|2|0|25|D.A.C. ehf|D.A.C. ehf|||||2581|4343 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|6685|9912|lyfalmen|V0985|9912|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||||6685|9912 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|17515|23991|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|||17515||17515|23991 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4661|7166|lyfalmen|V0085|7166|00|28|0|37|D.A.C. ehf|D.A.C. ehf|||4661||4661|7166 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A|||||| 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|XEU|17161|19803|lyfalmen|V0560|19803|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||14151||14151|19803 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1302|2607|lyfalmen|V0965|2607|24|120|0|38|D.A.C. ehf|D.A.C. ehf|||1302||1302|2607 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|11507|16456|lyfalmen|V0729|16456|00|100|0|20|D.A.C. ehf|D.A.C. ehf|||||11507|16456 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6|Vistor hf|Boehringer Ingelheim|||||| 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|10367|14909|lyfalmen|V0728|14909|00|84|0|28|D.A.C. ehf|D.A.C. ehf|||10367||10367|14909 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|21404|28833|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|||21404||21404|28833 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2636|3774|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|||2636||2636|3774 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|2701|4506|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|||2701||2701|4506 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|4422|6841|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|||4422||4422|6841 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4400|6811|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|||4400||4400|6811 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|13904|19495|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|||13904||13904|19495 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11323|16206|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||11323||11323|16206 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|8199|11967|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|||8199||8199|11967 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|26416|34755|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||26416||26416|34755 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|23670|31654|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|||23670||23670|31654 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|34522|44847|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|||34522||34522|44847 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|23035|30864|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||23035||23035|30864 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3559|5670|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||3559||3559|5670 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|16247|22095|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|||16247||16247|22095 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|4343|6218|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4343||4343|6218 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|3927|6170|lyfalmen|V1951|6062|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||3927||3927|6170 021829|H01BA0203|Minirin (D.A.C.)|töflur|0,2|mg|30|stk|1|plglas||H01BA02|01.08.2006||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|8457|12317|lyfalmen|||00|30|0|15|D.A.C. ehf|D.A.C. ehf|||8457||8457|12317 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4661|7166|lyfalmen|V0085|7166|00|28|0|37|D.A.C. ehf|D.A.C. ehf|||4661||4661|7166 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|24205|32003|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|||24205||24205|32003 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5272|7995|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||5272||5272|7995 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|18441|25144|lyfalmen|||00|98|0|98|Icepharma hf|Eli Lilly Nederland -|||18441||18441|25144 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|85948|108873|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||85948||85948|108873 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|673|1328|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||673||673|1328 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45|Actavis Group hf|Actavis Group hf|||||| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|27637|36593|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|||27637||27637|36593 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|32310|42411|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|||32310||32310|42411 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|34152|44704|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|||34152||34152|44704 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|297279|371980|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||297279||297279|371980 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|353903|442477|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||353903||353903|442477 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1489|lyfalmen|V0917|1489|00|20|0|20|Actavis Group hf|Actavis hf|||478||478|1489 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|9718|16817|vetorma|||00|24|0|0|Vistor hf|Bayer Animal Health GmbH|||9718||9718|16817 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|22526|30230|lyfalmen|||02|1|0|0|Vistor hf|Allergan|||22526||22526|30230 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2149|3719|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2149||2149|3719 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|2760|4586|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2760||2760|4586 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1791 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|6443|4312|lyfalmen|V0308|3043|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2558||2558|4312 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|9994|6359|lyfalmen|V0310|4428|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4067||4067|6359 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2035|3522|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2035||2035|3522 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|704|1796|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||704||704|1796 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2047|3618|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2047||2047|3618 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1318|2281|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1318||1318|2281 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4434|6858|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4434||4434|6858 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2400|3506|lyfalmen|V0919|3506|00|100|0|100|Actavis Group hf|Actavis hf|||1964||1964|3506 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|2556|lyfalmen|V0918|2556|00|60|0|60|Actavis Group hf|Actavis hf|||1264||1264|2556 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|1388|2724|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|||1388||1388|2724 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|3719|5887|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|||3719||3719|5887 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|14599|20361|lyfalmen|V0192|16731|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||14599||14599|20361 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|213195|267295|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|||213195||213195|267295 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy||||||2624 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|||67|30|0|10|Actavis Group hf|Actavis hf|||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|||67|30|0|20|Actavis Group hf|Actavis hf|||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|23035|30864|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||23035||23035|30864 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|3729|5901|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|||3729||3729|5901 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5361|8116|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|||5361||5361|8116 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GSI|0|0|0|100|DKK|113944|143728|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|||113944||113944|143728 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|28491|37656|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|||28491||28491|37656 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|38061|49571|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|||38061||38061|49571 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|19274|26181|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||19274||19274|26181 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5415|8189|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|||5415||5415|8189 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|19470|26425|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||19470||19470|26425 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|19763|26472|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|||19763||19763|26472 023329|N03AX1204|Gabapentin Merck NM|hylki|300|mg|100|stk|1|glas||N03AX12|01.05.2004|31.01.2009|R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||5471||| 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|6563|9747|lyfalmen|V0715|9747|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|||6563||6563|9747 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|0|100|XEU|15650|21669|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|||15650||15650|21669 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|8146|11663|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|||8146||8146|11663 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|32065|41788|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|||32065||32065|41788 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|24268|32081|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|||24268||24268|32081 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|57772|73794|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|||57772||57772|73794 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|38570|49887|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|||38570||38570|49887 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|7782|11142|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|||7782||7782|11142 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|115470|145628|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|||115470||115470|145628 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|19456|26090|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|||19456||19456|26090 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|15862|21616|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|||15862||15862|21616 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|11348|16240|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|||11348||11348|16240 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|38913|50314|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|||38913||38913|50314 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|77825|98760|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|||77825||77825|98760 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|7944|11621|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|||7944||7944|11621 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|184678|231792|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|||184678||184678|231792 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|155651|195653|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|||155651||155651|195653 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|15887|21964|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|||15887||15887|21964 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|11916|17011|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|||11916||11916|17011 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|132137|166378|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |||132137||132137|166378 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|22301|29950|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||22301||22301|29950 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|3867|6088|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|||3867||3867|6088 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3420|5481|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|||3420||3420|5481 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|61007|77821|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|||61007||61007|77821 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8938|12970|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||8938||8938|12970 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|104368|131806|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|||104368||104368|131806 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3618|5750|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|||3618||3618|5750 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|SEK|84131|106608|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|||84129||84129|106608 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|5443|7793|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|||5443||5443|7793 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3714|5880|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|||3714||3714|5880 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|18729|25503|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|||18729||18729|25503 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1942|2780|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||1942||1942|2780 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7955|11636|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7955||7955|11636 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|13910|19503|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||13910||13910|19503 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|62432|79913|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|||62432||62432|79913 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|23035|30864|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||23035||23035|30864 024478|V04CL0024|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7252|10682|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||7252||7252|10682 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|347|1311|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|||347||347|1311 024482|V04CL0025|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7252|10682|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||7252||7252|10682 024504|V04CL0011|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12219|17398|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12219||12219|17398 024510|V04CL0012|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12219|17398|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12219||12219|17398 024526|V04CL0014|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12239|17423|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12239||12239|17423 024530|N05AH0304|Zyprexa (D.A.C.)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.08.2005|31.01.2009|R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|||lyfalmen|||00|56|0|42|D.A.C. ehf|D.A.C. ehf|||22041||| 024532|V04CL0015|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12219|17398|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12219||12219|17398 024559|V04CL0016|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12219|17398|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12219||12219|17398 024565|V04CL0017|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12364|17578|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12364||12364|17578 024576|V04CL0018|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12219|17398|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12219||12219|17398 024583|V04CL0019|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7252|10682|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||7252||7252|10682 024589|V04CL0020|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12219|17398|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12219||12219|17398 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|69023|88119|lyfalmen|||00|100|0|125|Vistor hf|Novartis Europharm Ltd|||69023||69023|88119 024600|V04CL0021|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12364|17578|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||12364||12364|17578 024603|V04CL0009|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1489|2861|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||1489||1489|2861 024622|V04CL0013|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7252|10682|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||7252||7252|10682 024644|V04CL0023|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7252|10682|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||7252||7252|10682 024670|V04CL0022|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7252|10682|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||7252||7252|10682 024681|V04CL0010|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1489|2861|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||1489||1489|2861 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|961|2145|lyfalmen|V0143|2086|70|30|0|30|D.A.C. ehf|D.A.C. ehf|||961||961|2145 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|5458|8247|lyfalmen|||00|4|0|0|Icepharma hf|M.S.D.|||5458||5458|8247 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|870|2021|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||870||870|2021 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2489|4218|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2489||2489|4218 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1703|3151|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|||1703||1703|3151 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3240|5237|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|||3240||3240|5237 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|959|2142|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|||959||959|2142 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|16132|22269|lyfalmen|||00|12|0|0|Icepharma hf|M.S.D.|||16132||16132|22269 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|94860|119968|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||94860||94860|119968 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|93780|118624|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||93780||93780|118624 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9138|17578|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||9138||9138|17578 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|16928|23260|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|||16928||16928|23260 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|20589|27818|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||20589||20589|27818 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6006|8991|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|||6006||6006|8991 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|6387|9508|lyfalmen|V1039|9508|00|28|0|56|D.A.C. ehf|D.A.C. ehf|||6387||6387|9508 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|27322|36201|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|||27322||27322|36201 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|1785|3263|lyfalmen|V1090|3263|06|5|0|17|D.A.C. ehf|D.A.C. ehf|||1785||1785|3263 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|5004|7631|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||5004||5004|7631 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|14291|19977|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||14291||14291|19977 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2557|4127|lyfalmen|V0989|4127|06|5|0|0|D.A.C. ehf|D.A.C. ehf|||2422||2422|4127 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|14587|20346|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|||14587||14587|20346 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|21097|28451|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|||21097||21097|28451 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3426|5490|lyfalmen|V0966|5490|23|200|0|100|D.A.C. ehf|D.A.C. ehf|||3426||3426|5490 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|52851|67984|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|||52851||52851|67984 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4990|7144|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|||4990||4990|7144 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|23035|30864|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||23035||23035|30864 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|791|1914|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||791||791|1914 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3332|5766|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||3332||3332|5766 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|816|1948|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|||816||816|1948 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1454|2814|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||1454||1454|2814 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|7540|13048|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||7540||7540|13048 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1632|3055|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|||1632||1632|3055 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|339|1300|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|||339||339|1300 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2575|4335|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|||2575||2575|4335 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|6530|9702|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||6530||6530|9702 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1659|3092|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||1659||1659|3092 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|6638|9848|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||6638||6638|9848 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|8886|12899|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||8886||8886|12899 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|11737|16768|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||11737||11737|16768 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|840|1980|lyfalmen|V0431|1836|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|||840||840|1980 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|801|1927|lyfalmen|V0430|1682|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|||801||801|1927 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|117436|148075|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|||117436||117436|148075 027938|C07AA0701|Sotacor|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1992|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|50|Vistor hf|Bristol-Myers Squibb|||1427||| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|22603|30326|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||22603||22603|30326 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|22603|30326|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||22603||22603|30326 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2413|4115|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2413||2413|4115 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|20256|27404|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||20256||20256|27404 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|7751|11359|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||7751||7751|11359 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1172|2431|lyfalmen|V0712|2431|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||1172||1172|2431 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1669|3105|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|||1669||1669|3105 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3133|5092|lyfalmen|V0351|3898|10|60|0|30|Vistor hf|Ferrosan A/S|||3133||3133|5092 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|861|2009|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||861||861|2009 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|7584|14618|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||7584||7584|14618 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|847|1990|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|||847||847|1990 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|11324|16208|lyfalmen|||00|10|0|5|Icepharma hf|Roche as|||11324||11324|16208 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|1941|3474|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|||1941||1941|3474 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|960|2143|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||960|2143 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|896|2056|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|||896||896|2056 029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|427|1420|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||427||427|1420 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|6622|9827|lyfalmen|V0297|9827|00|7|0|0|D.A.C. ehf|D.A.C. ehf|||6622||6622|9827 029334|J05AG0302|Stocrin (Lyfjaver)|töflur|600|mg|30|stk|1|glas||J05AG03|01.09.2005|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|XEU|53513|68490|lyfsjukr|||00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|||53513||53512|68490 029343|L03AB0802|Betaferon (Lyfjaver)|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.09.2005|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|163112|204942|lyfsjukr|||00|15|0|30|Lyfjaver ehf|Lyfjaver ehf|||163112||163112|204942 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7981|5537|lyfalmen|||00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|||3461||3461|5537 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7223|8671|lyfalmen|||00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|||5770||5770|8671 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|11351|11679|lyfalmen|V0367|3035|00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|||7987||7987|11679 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|15962|22058|lyfalmen|||00|98|0|523|Lyfjaver ehf|Lyfjaver ehf|||15962||15962|22058 029769|D07AB0101|Emovat|krem|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995|31.12.2008|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|2127|3727|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2127||2127|3727 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|17905|24159|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|||||17905|24159 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|20529|27744|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||20529||20529|27744 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|427|1420|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||427||427|1420 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1681|3122|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1681||1681|3122 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyflausa|||00|60|0|25|Icepharma hf|Navamedic ASA|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9943|14334|lyfalmen|V1400|14135|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|||9943||9943|14334 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3376|5422|lyfalmen|V1401|5420|00|100|0|8|Vistor hf|Novartis Healthcare A/S-|||||3376|5422 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0|Strandmöllen A/S|Strandmöllen A/S|||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0|Strandmöllen A/S|Strandmöllen A/S|||||| 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|782|1902|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|||782||782|1902 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1140|2387|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|||1140||1140|2387 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|796|1921|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|||796||796|1921 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3013|4929|lyfalmen|||17|10|0|25|Icepharma hf|Eli Lilly Nederland -|||3013||3013|4929 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4313|6693|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|||4313||4313|6693 031555|J06BA0105|Gammanorm (D.A.C.)|stl|165|mg/ml|10|ml|1|lykja||J06BA01|01.03.2009||R|K|3|0|0|0|1|DAC|0|0|0|100|DKK|12741|17730|lyfsjukr|||0|10|0|0|D.A.C. ehf|D.A.C. ehf|||||12741|17730 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1830|3324|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|||1830||1830|3324 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5993|8973|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||5993||5993|8973 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|35288|45801|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|||35288||35288|45801 031971|C07AA0704|Sotalol Merck NM|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1597|3008|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||1597||1597|3008 031997|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA07|01.03.2000|31.12.2008|R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1145||| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|9201|13174|lyfsjukr|||0|4|0|0|Strandmöllen A/S|Strandmöllen A/S|||||9201|13174 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|13449|18612|lyfsjukr|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|||||13449|18612 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|46534|59802|lyfsjukr|||0|50|0|0|Strandmöllen A/S|Strandmöllen A/S|||||46534|59802 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|23471|31406|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||23471||23471|31406 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|3633|6287|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||3633||3633|6287 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|121895|153627|lyfsjukr|||0|6|0|0|Gróco ehf|Serono Nordic|||||121895|153627 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|12920|22359|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||12920||12920|22359 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|454|1456|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|||454||454|1456 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1214|2488|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1214||1214|2488 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2371|4679|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2371|4679 034066|V07AB09|Sterilt Vatten Braun|leysir|0| |5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|100|0|0|Actavis Group hf|Braun||||||0 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|714|1809|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||714||714|1809 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|1867|3374|lyfalmen|||00|300|0|10|Vistor hf|Astra|||1867||1867|3374 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1752|3218|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|||1752||1752|3218 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3005|4918|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|||3005||3005|4918 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|8473|12131|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|||8473||8473|12131 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|16601|22853|lyfalmen|||10|300|0|100|Vistor hf|Ferring|||16601||16601|22853 035333|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.05.2006|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|103293|130467|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|||103293||103293|130467 035342|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.05.2006|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|77319|98130|lyfsjukr|||00|15|0|0|Lyfjaver ehf|Lyfjaver ehf|||77319||77319|98130 035351|L01BB0502|Fludara (Lyfjaver)|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.05.2006|31.12.2008|R|A|3|0|1|0|1|LVR|0|0|0|100|SEK|157994|198570|lyfsjukr|||00|250|0|0|Lyfjaver ehf|Lyfjaver ehf|||157994||157994|198570 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|V0705|5347|00|56|0|19|Actavis Group hf|Actavis hf|||3321||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|V0706|8873|00|56|0|37|Actavis Group hf|Actavis hf|||5919||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|115145|145223|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||115145||115145|145223 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43131|55566|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||43131||43131|55566 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|845|1987|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||845||845|1987 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|450|1451|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||450||450|1451 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|5036|7674|lyfalmen|||00|60|0|60|Vistor hf|Meda AS|||5036||5036|7674 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|209237|262368|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||209237||209237|262368 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|401624|501889|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||401624||401624|501889 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|802723|1001258|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||802723||802723|1001258 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|713|1808|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|||713||713|1808 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1139|2386|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|||1139||1139|2386 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|AstraZeneca A/S DK|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2248|3891|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|||2248||2248|3891 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|682|1766|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|||682||682|1766 037176|M01AB0507|Vostar|sþ-tfl|50|mg|30|stk|1|glas||M01AB05|01.04.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|30|0|15|Actavis Group hf|Actavis hf||361|361|361|| 037192|M01AB0507|Vostar|sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.04.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis hf|||890||| 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6028|9021|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6028||6028|9021 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12056|17195|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||12056||12056|17195 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|23646|31624|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||23646||23646|31624 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|46452|60018|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||46452||46452|60018 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2703|4508|lyfalmen|||00|100|0|17|Icepharma hf|Roche|||2703||2703|4508 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1069|2291|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|||1069||1069|2291 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|643|1713|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|||643||643|1713 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S||||||2050 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S||||||3375 037861|C03AA0301|Aquazið|töflur|25|mg|100|stk|1|glas||C03AA03|01.05.1983|31.12.2008|R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf||812|812|812|| 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|1731|3189|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|||1731||1731|3189 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1554|lyfalmen|V0917|1489|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||526||526|1554 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2727|lyfalmen|V0918|2556|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1390||1390|2727 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3772|lyfalmen|V0919|3506|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2160||2160|3772 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|996|2192|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|||996||996|2192 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|203926|255755|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|||203926||203926|255755 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|9526|13768|lyfalmen|||00|90|0|90|Icepharma hf|Servier|||9526||9526|13768 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4196|6535|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |||4196||4196|6535 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2836|4689|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2836||2836|4689 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|35594|46182|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|||35594||35594|46182 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|61936|78978|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|||61936||61936|78978 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5525|8338|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|||5525||5525|8338 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1406|2748|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1406||1406|2748 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2157|3768|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2157||2157|3768 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|334|478|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||334||334|478 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|767|1098|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||767||767|1098 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1361|1949|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|||1361||1361|1949 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3575|5692|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|||3575||3575|5692 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon||||||1579 041005|L04AB0102|Enbrel (Lyjaver)|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.05.2006|31.12.2008|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|95412|120655|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|||95412||95412|120655 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|7813|11443|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||7813||7813|11443 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2630|4409|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|||2630||2630|4409 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4189|7249|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||4189||4189|7249 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|161520|203277|lyfalmen|||02|100|0|0|Icepharma hf|Schering AG|||161520||161520|203277 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4|Vistor hf|McNeil Denmark ApS|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1210|2482|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|||1210||1210|2482 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|9073|12990|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|||9073||9073|12990 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3473|4972|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3473||3473|4972 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4380|6271|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4380||4380|6271 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4139|5926|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||4139||4139|5926 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6276|8986|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||6276||6276|8986 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|7204|10314|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||7204||7204|10314 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7880|11282|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|||7880||7880|11282 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4184|5990|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4184||4184|5990 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3070|4395|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3070||3070|4395 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2647|3790|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|||2647||2647|3790 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|9248|13241|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|||9248||9248|13241 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|3744|5360|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||3744||3744|5360 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2088|2989|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||2088||2088|2989 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6902|9882|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|||6902||6902|9882 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2341|3352|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||2341||2341|3352 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|737|1841|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||737||737|1841 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|14091|19728|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|||14091||14091|19728 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3253|4657|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3253||3253|4657 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0|Icepharma hf|Fresenius Kabi|||||| 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|299|1246|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||299||299|1246 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|2832|4055|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||2832||2832|4055 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3350|5386|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3350||3350|5386 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5206|7454|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||5206||5206|7454 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|537|1569|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||537||537|1569 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1149|2400|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|||1149||1149|2400 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 044114|J01DH0202|Meronem (Lyfjaver)|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.02.2008|31.12.2008|R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|28835|37766|lyfsjukr|||00|5000|0|2|Lyfjaver ehf|Lyfjaver ehf|||28835||28834|37766 044124|J01DH0202|Meronem (Lyfjaver)|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.02.2008|31.12.2008|R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|55229|70628|lyfsjukr|||00|10|0|5|Lyfjaver ehf|Lyfjaver ehf|||55229||55229|70628 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|12180|17349|lyfalmen|V0011|17349|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|||12180||12180|17349 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006|28.02.2009|R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|||lyfalmen|||00|4|0|8|D.A.C. ehf|D.A.C. ehf|||5959||| 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|36091|46801|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||36091||36091|46801 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1185|2448|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1185||1185|2448 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7044|10399|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||7044||7044|10399 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf|||||| 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|||||| 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf|||||| 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|||||| 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf|||||| 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf|||||| 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf|||||| 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|||||| 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|||||| 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|||||| 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|||||| 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|||||| 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|||||| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|20151|38556|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||20151||20151|38556 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|5076|7729|lyfalmen|V1088|7729|02|10|0|1|Icepharma hf|Vian SA|||5076||5076|7729 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|8305|12111|lyfalmen|V1089|12111|02|20|0|2|Icepharma hf|Vian SA|||8305||8305|12111 047042|L04AB0101|Enbrel|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|SEK|102526|129512|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|||102526||102526|129512 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|807|1936|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||807||807|1936 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1053|2269|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|||1053||1053|2269 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|||47555||47555|61073 047560|L04AB0101|Enbrel|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|SEK|204072|255937|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|||204072||204072|255937 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|8214|11987|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|||8214||8214|11987 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4191|6000|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|||4191||4191|6000 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6615|9471|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|||6615||6615|9471 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|VAL|0|0|0|100|DKK|2104|3696|lyfalmen|||00|100|0|0|Icepharma hf|Valeant Pharmaceuticals B.V.|||2104||2104|3696 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|16471|22691|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|||16471||16471|22691 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|3725|5895|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|||3725||3725|5895 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1710|3161|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|||1710||1710|3161 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|61869|79212|lyfalmen|||00|150|0|38|Icepharma hf|Roche|||61869||61869|79212 048520|N04BD0104|Selegilin Merck NM|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2358|4040|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||2358||2358|4040 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|7774|11390|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|||7774||7774|11390 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|459|1463|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|||459||459|1463 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|18201|24845|lyfalmen|||00|3|0|0|Icepharma hf|Roche Registration Limited|||18201||18201|24845 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2606|4377|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|||2606||2606|4377 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Vistor hf|Janssen-Cilag AB|||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3420|5481|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||3420||3420|5481 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|10066|14500|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|||10066||10066|14500 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|7602|11157|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||7602||7602|11157 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|954|2018|lyfalmen|||00|98|0|65|PortFarma ehf|PortFarma|||868||868|2018 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|||00|98|0|131|PortFarma ehf|PortFarma|||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|3097|lyfalmen|V0367|3097|00|100|0|267|PortFarma ehf|PortFarma |||1663||1663|3097 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4259|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|||2519||2519|4259 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|1926|3454|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|||1926||1926|3454 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|4783|7331|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|||4783||4783|7331 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|17550|24035|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|||17550||17550|24035 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|14339|20037|lyfalmen|V0718|19442|00|12|0|84|D.A.C. ehf|D.A.C. ehf|||||14339|20037 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|75043|95614|lyfalmen|||00|300|0|38|Icepharma hf|Roche|||75043||75043|95614 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|7602|10884|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|||7602||7602|10884 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|521914|632156|lyfsjukr|||00|112|0|0|Vistor hf|Bayer HealthCare AG|||506256||506256|632156 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3577|5695|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3577||3577|5695 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12756|18066|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12756||12756|18066 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2963|4861|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2963||2963|4861 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8937|12968|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8937||8937|12968 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|455|1458|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|||455||455|1458 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1624|3044|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|||1624||1624|3044 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0|D.A.C. ehf|D.A.C. ehf|||||| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|8642|12568|lyfalmen|V0391|12568|00|60|0|0|D.A.C. ehf|D.A.C. ehf|||8642||8642|12568 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2157|3768|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|||2157||2157|3768 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|440|1437|lyfalmen|||72|25|0|10|Vistor hf|BioPhausia AB|||440||440|1437 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|944|2121|lyfalmen|V1910|2121|00|30|0|30|Actavis Group PTC ehf|Mylan AB|||944||944|2121 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|2845|4701|lyfalmen|V1911|4701|00|100|0|100|Actavis Group PTC ehf|Mylan AB|||2845||2845|4701 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1454|2814|lyfalmen|V1912|2814|00|30|0|45|Actavis Group PTC ehf|Mylan AB|||1454||1454|2814 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4205|6547|lyfalmen|V1913|6547|00|100|0|150|Actavis Group PTC ehf|Mylan AB|||4205||4205|6547 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|1668|3104|lyfalmen|||72|100|0|40|Vistor hf|BioPhausia AB|||1668||1668|3104 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|33383|43429|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|||33383||33383|43429 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|3532|5633|lyfalmen|V0084|5633|00|28|0|19|D.A.C. ehf|D.A.C. ehf|||3532||3532|5633 051732|C08CA0104|Amlódipín PortFarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|1909|3043|lyfalmen|V0308|3043|00|100|0|0|PortFarma ehf|PortFarma |||1623||1623|3043 051750|C08CA0104|Amlódipín PortFarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|3111|4428|lyfalmen|V0310|4428|00|100|0|0|PortFarma ehf|PortFarma |||2644||2644|4428 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|367629|459566|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||367629||367629|459566 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|740712|924054|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||740712||740712|924054 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|749184|934602|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||749184||749184|934602 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2|D.A.C. ehf|D.A.C. ehf|||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|31619|41233|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|||31619||31619|41233 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38964|50378|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|||38964||38964|50378 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31305|40842|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|||31305||31305|40842 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|42215|54425|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|||42215||42215|54425 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36223|46965|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|||36223||36223|46965 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30093|39333|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|||30093||30093|39333 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40800|52664|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|||40800||40800|52664 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37959|49126|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|||37959||37959|49126 052944|C01DA1402|Monit-L|forðahlk|30|mg|100|stk|1|glas||C01DA14|01.01.1994|31.12.2008|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1770|3242|lyfalmen|||10|100|0|75|Actavis Group hf|Actavis hf|||1770||1770|3242 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2358|4040|lyfalmen|V0903|4040|00|100|0|100|Actavis Group PTC ehf|Mylan AB|||2358||2358|4040 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2341|4017|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|||2341||2341|4017 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|72938|92675|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|||72938||72938|92675 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|5398|8166|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5398||5398|8166 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|32221|42300|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|||32221||32221|42300 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|9983|14388|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|||9983||9983|14388 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|30825|40562|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|||30825||30825|40562 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|4789|7339|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|||4789||4789|7339 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|106573|134551|lyfsjukr|||43|120|0|0|Vistor hf|Janssen-Cilag International N.V.|||106573||106573|134551 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|502|1522|lyfalmen|V0902|1522|00|20|0|20|Actavis Group PTC ehf|Mylan AB|||502||502|1522 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|13792|19356|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|||13792||13792|19356 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1104|2339|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1104||1104|2339 054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1311|2619|lyfalmen|V0451|2583|08|100|0|5|Vistor hf|Astellas Pharma A/S|||1311||1311|2619 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|763|1876|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|||763||763|1876 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2497|4229|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||2497||2497|4229 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|1|Vistor hf|AstraZeneca A/S DK|||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A|||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|68961|87724|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|||68961||68961|87724 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|2|Vistor hf|AstraZeneca A/S DK|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCB|0|0|1|100|SEK|1170|2428|lyfalmen|||00|200|0|5|Vistor hf|U.C.B|||1170||1170|2428 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|12298|23597|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||12298||12298|23597 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|7436|12868|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||7436||7436|12868 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|658|1733|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|||658||658|1733 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|11250|16107|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11250||11250|16107 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|5908|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||3734||3734|5908 055434|P03AC0401|Nix|krem|50|mg/g|30|g|1|túpa||P03AC04|01.01.1996|31.12.2008|R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|1526|2911|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1526||1526|2911 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4359|6756|lyfalmen|V0337|6756|00|100|0|100|Actavis Group hf|Actavis hf|||4359||4359|6756 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|6185|9234|lyfalmen|V0338|9234|00|100|0|200|Actavis Group hf|Actavis hf|||6185||6185|9234 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|11516|lyfalmen|V0339|11516|00|100|0|400|Actavis Group hf|Actavis hf|||7867||7867|11516 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1072|2295|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|||1072||1072|2295 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|25237|33288|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||25237||25237|33288 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|286415|358454|lyfsjukr|||00|15|0|30|Meda AB|Elan Pharma International|||286415||286415|358454 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|64211|81810|lyfsjukr|||00|30|0|30|PortFarma ehf|PortFarma |||64211||64211|81810 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|17972|24243|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|||17972||17972|24243 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|9550|13673|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|||9550||9550|13673 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6218|8903|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|||6218||6218|8903 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|5141|7361|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|||5141||5141|7361 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|23938|31670|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|||23938||23938|31670 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|4674|7183|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||4674||4674|7183 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|16631|22891|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||16631||16631|22891 057978|N07BA0301|Champix|filmhtfl|0| |25|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|4843|7413|lyfalmen|||00|25|0|10|Vistor hf|Pfizer Limited|||4843||4843|7413 057987|N07BA0301|Champix|filmhtfl|1|mg|28|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|5411|8183|lyfalmen|||00|28|0|14|Vistor hf|Pfizer Limited|||5411||5411|8183 057996|N07BA0301|Champix|filmhtfl|1|mg|56|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|10876|15600|lyfalmen|||00|56|0|28|Vistor hf|Pfizer Limited|||10876||10876|15600 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|19486|26445|lyfalmen|||0|112|0|56|Vistor hf|Pfizer Limited|||||19486|26445 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|412|1399|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|||412||412|1399 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|19444|26393|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||19444||19444|26393 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|814|1945|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|||814||814|1945 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|109409|138082|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||109409||109409|138082 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1359|2685|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|||1359||1359|2685 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2143|3749|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|||2143||2143|3749 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3819|6023|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3819||3819|6023 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1359|2685|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|||1359||1359|2685 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|100225|126965|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||100225||100225|126965 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|29155|38483|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||29155||29155|38483 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|110526|139472|lyfsjukr|||00|30|0|0|PortFarma ehf|PortFarma |||110526||110526|139472 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|6985|10001|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|||6985||6985|10001 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|726|1826|lyfalmen|V0290|1589|00|98|0|33|Actavis Group PTC ehf|Merck NM AB|||726||726|1826 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|15839|21587|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|||15839||15839|21587 060087|L04AC0101|Zenapax|irþ|5|mg/ml|5|ml|3|hgl||L04AC01|01.04.2005|31.12.2008|R|K|3|0|0|0|1|RRL|0|0|0|100|DKK|184933|232109|lyfsjukr|||00|15|0|0|Icepharma hf|Roche Registration Limited|||184933||184933|232109 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|377786|472529|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||377786||377786|472529 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|191322|240381|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||191322||191322|240381 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|95662|121284|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||95662||95662|121284 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|7354|10820|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|||7354||7354|10820 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf||||||1836 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf||||||1836 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2654|5227|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||2654|5227 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1391|2745|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||1391|2745 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|8214|15818|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Animal Health|||||8214|15818 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7371|10843|lyfalmen|||00|84|0|84|Vistor hf|N.V. Organon|||||7371|10843 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1769 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|SEK|172664|216834|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||172664||172664|216834 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8|Actavis Group hf|Actavis hf|||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|6366|9115|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|||6366||6366|9115 061961|J01XX0901|Cubicin|irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|16726|22691|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|||16726||16726|22691 061970|J01XX0901|Cubicin|irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|23675|31343|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|||23675||23675|31343 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|489|1504|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||489||489|1504 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|4432|6855|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4432||4432|6855 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|6631|9839|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6631||6631|9839 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|SEK|7363|10542|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|||7363||7363|10542 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|SEK|834|1194|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|||834||834|1194 062711|J01EE0103|Primazol|töflur|480|mg|30|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|694|1782|lyfalmen|||00|30|0|8|Actavis Group hf|Actavis hf|||694||694|1782 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1028|2235|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1028||1028|2235 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|1974|3519|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|||1974||1974|3519 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|17385|30086|vetorma|||16|1000|0|0|Vistor hf|Bayer Animal Health GmbH|||17385||17385|30086 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|SEK|1915|3439|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|||1915||1915|3439 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|14671|20450|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||14671||14671|20450 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|4958|7569|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|||4958||4958|7569 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2001|3556|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|||2001||2001|3556 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team||||||2725 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1999|3553|lyfalmen|V1901|3553|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||1999||1999|3553 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|10603|15068|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|||10603||10603|15068 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2448|4236|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2448||2448|4236 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1028|2235|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1028||1028|2235 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2093|3681|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2093||2093|3681 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1047921|1306529|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|||||1047921|1306529 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|419168|523732|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|||||419168|523732 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2263|3911|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2263||2263|3911 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4191685|5220515|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|||||4191685|5220515 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2095843|2611192|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|||||2095843|2611192 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|843|1984|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||843||843|1984 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2346|4024|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|||2346||2346|4024 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|12622|17899|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||12622||12622|17899 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||5486||5486|7855 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|6|0|6|Vistor hf|Bayer A/S|||||| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|1|0|5|Vistor hf|Bayer A/S|||||| 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2634|4415|lyfalmen|V1989|4343|06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2634||2634|4415 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2060|3636|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|||2060||2060|3636 066142|N05BA0204|Klordiazepoxið Actavis|töflur|10|mg|50|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|345|1309|lyfalmen|||00|50|0|17|Actavis Group hf|Actavis hf|||345||345|1309 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|6955|10279|lyfalmen|||00|60|0|8|Vistor hf|Boehringer Ingelheim International |||6955||6955|10279 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|31992|41698|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|||31992||31992|41698 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A|||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A|||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A|||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|20210|38668|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||20210||20210|38668 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|813|1944|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|||813||813|1944 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|751|1581|lyfalmen|V0908|1581|00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||546||546|1581 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|2158|3769|lyfalmen|V0144|3769|70|30|0|15|D.A.C. ehf|D.A.C. ehf|||2158||2158|3769 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|621|1683|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|||621||621|1683 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|6860|10150|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |||6860||6860|10150 067579|N05BB0101|Atarax|töflur|25|mg|25|stk|1|þpakki||N05BB01|01.04.1995|31.01.2009|R|A|5|0|0|0|0|UCB|0|0|1|100|SEK|381|1357|lyfalmen|||00|25|0|8|Vistor hf|U.C.B|||381||381|1357 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCB|0|0|0|100|SEK|1170|2428|lyfalmen|||00|100|0|33|Vistor hf|U.C.B|||1170||1170|2428 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|730|1831|lyfalmen|V0901|1831|00|50|0|50|D.A.C. ehf|D.A.C. ehf|||730||730|1831 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7143|10534|lyfalmen|V0552|10534|10|30|0|8|Actavis Group hf|Actavis hf|||7143||7143|10534 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|26738|35474|lyfalmen|V0557|35474|10|30|0|30|Actavis Group hf|Actavis hf|||26738||26738|35474 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|5893|11396|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||5893||5893|11396 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|1966|3508|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|||1966||1966|3508 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|5799|8710|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|||5799||5799|8710 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vatten Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vatten Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|3033|4956|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|||3033||3033|4956 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1516|2898|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|||1516||1516|2898 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||44276||44276|56991 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|SEK|30914|40355|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|||30914||30914|40355 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|6832|9782|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||6832||6832|9782 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4860|6958|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||4860||4860|6958 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8535|12220|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||8535||8535|12220 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5431|7776|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||5431||5431|7776 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|4705|9134|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||4705||4705|9134 070623|C03AA0301|Aquazið|töflur|12,5|mg|100|stk|1|glas||C03AA03|01.03.1984||R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|748|1855|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||748||748|1855 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|14830|20648|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|||14830||14830|20648 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|4982|9661|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||4982||4982|9661 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|52604|67359|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|||52604||52604|67359 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|263020|329327|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|||263020||263020|329327 071670|J01CF0101|Diclocil|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.07.1991|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|||lyfalmen|||10|30|0|4|Vistor hf|Bristol-Myers Squibb|||2043||| 071712|J01CF0101|Diclocil|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.07.1991|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|||lyfalmen|||10|30|0|8|Vistor hf|Bristol-Myers Squibb|||2501||| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|7514|14484|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||7514||7514|14484 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13149|18555|lyfalmen|||00|15|0|5|Icepharma hf|Roche as|||13149||13149|18555 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|529|757|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|||529||529|757 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|175265|220072|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|||175265||175265|220072 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1619|2318|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|||1619||1619|2318 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|14372|20078|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|||14372||14372|20078 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|14372|20078|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|||14372||14372|20078 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1260|2550|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|||1260||1260|2550 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|3113|5065|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|||3113||3113|5065 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1578|2982|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|||1578||1578|2982 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|294|1239|lyfalmen|||00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||294||294|1239 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|793|1917|lyfalmen|||00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||793||793|1917 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1149|2400|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1149||1149|2400 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|498|1516|lyfalmen|V0856|1110|00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||498||498|1516 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|863|2012|lyfalmen|||00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||863||863|2012 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1714|3166|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1714||1714|3166 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|3463|5540|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||3463||3463|5540 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|10084|14525|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||10084||10084|14525 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4418|6836|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4418||4418|6836 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|14596|20357|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||14596||14596|20357 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4418|6836|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4418||4418|6836 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|14596|20357|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||14596||14596|20357 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6150|9186|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|||6150||6150|9186 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|221|1140|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|||221||221|1140 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|449|1450|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|||449||449|1450 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|19968|34556|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||19968||19968|34556 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2101|3692|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|||2101||2101|3692 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6150|9186|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|||6150||6150|9186 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1291|2280|lyfalmen|V1910|2121|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||1061||1061|2280 075028|C09AA0901|Monopril|töflur|10|mg|98|stk|1|þpakki||C09AA09|01.04.1995|31.12.2008|R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|9828|14177|lyfalmen|||00|98|0|65|Vistor hf|Bristol-Myers Squibb|||9828||9828|14177 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1342|2662|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|||1342||1342|2662 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1825|3054|lyfalmen|V1912|2814|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|||1631||1631|3054 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2303|3966|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|||2303||2303|3966 075101|C09AA0901|Monopril|töflur|20|mg|98|stk|1|þpakki||C09AA09|01.04.1995|31.12.2008|R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|14983|20839|lyfalmen|||00|98|0|131|Vistor hf|Bristol-Myers Squibb|||14983||14983|20839 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|||1536||1536|2925 075382|V01AA0503|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075408|V01AA0504|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075424|V01AA0501|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075440|V01AA0502|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075465|V04CL0006|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075481|V04CL0004|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075507|V04CL0005|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075523|V04CL0002|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075549|V04CL0008|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075564|V04CL0003|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075580|V04CL0007|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075606|V04CL0001|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075663|V01AA0302|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075689|V01AA1103|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075705|V01AA1102|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075721|V01AA1101|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 075724|B02BD0402|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|SEK|127946|161160|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|||127946||127946|161160 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2006|3958|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2006||2006|3958 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|25979|34529|lyfalmen|||00|98|0|0|Icepharma hf|M.S.D.|||25979||25979|34529 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2471|4194|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|||2471||2471|4194 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|PortFarma ehf|PortFarma |||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|PortFarma ehf|PortFarma |||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|PortFarma ehf|PortFarma |||2358||2358|4040 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|6878|11903|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||6878||6878|11903 077215|A03000001|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A03|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|SEK|6199|9253|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|||6199||6199|9253 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|628|1693|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||628||628|1693 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|955|1444|lyfalmen|V0609|1436|10|30|0|15|D.A.C. ehf|D.A.C. ehf|||445||445|1444 078121|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HON|0|0|0|100|SEK|20012|26782|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Nordic AB (V)|||20012||20012|26782 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|420|1410|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|||420||420|1410 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|640|1709|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|||640||640|1709 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|1226|2504|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||1226||1226|2504 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|2631|4411|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||2631||2631|4411 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|4961|7103|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||4961||4961|7103 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|14616|20064|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|||14616||14616|20064 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|16231|22075|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|||16231||16231|22075 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|127428|160515|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|||127428||127428|160515 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|8562|5712|lyfalmen|V0197|5712|00|98|0|98|Icepharma hf|M.S.D.|||3590||3590|5712 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|1900|2720|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||1900||1900|2720 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3280|4696|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||3280||3280|4696 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|5894|8439|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||5894||5894|8439 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3222|5213|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|||3222||3222|5213 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|6631|9494|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|||6631||6631|9494 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|19240|26139|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|||19240||19240|26139 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|10378|14788|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|||10378||10378|14788 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|1992|2852|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|||1992||1992|2852 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|2|Vistor hf|Janssen-Cilag AB|||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2160|3772|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|||2160||2160|3772 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|5477|8273|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5477||5477|8273 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|2953|4848|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2953||2953|4848 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|29278|50667|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||29278||29278|50667 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|23105|30633|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||23105||23105|30633 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|45900|59013|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||45900||45900|59013 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|25420|33833|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|||25420||25420|33833 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|5582|8415|lyfalmen|V1350|8415|00|4|0|8|D.A.C. ehf|D.A.C. ehf|||||5582|8415 081513|M01AE0102|Ibufen|töflur|200|mg|100|stk|1|glas||M01AE01|01.01.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|336|1296|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||336||336|1296 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Ísaga ehf|AGA AB|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Ísaga ehf|AGA AB|||||| 081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|1325|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||357||357|1325 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0|Ísaga ehf|AGA AB|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0|Ísaga ehf|AGA AB|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0|Ísaga ehf|AGA AB|||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|||||| 081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|6856|10144|lyfalmen|||00|28|0|56|Vistor hf|Bristol-Myers Squibb|||6856||6856|10144 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1987|2845|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|||1987||1987|2845 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|18442|25145|lyfalmen|V0813|25145|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||18442||18442|25145 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4825|7388|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|||4825||4825|7388 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8421|12268|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||8421||8421|12268 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0|Ísaga ehf|AGA AB|||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|2808|4651|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2808||2808|4651 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|555|1594|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|||555||555|1594 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|4587|7065|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4587||4587|7065 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|867|2017|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|||867||867|2017 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1386|2721|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|||1386||1386|2721 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4355|6750|lyfalmen|||00|100|0|6|Vistor hf|AstraZeneca A/S DK|||4355||4355|6750 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4786|7335|lyfalmen|||00|40|0|12|Vistor hf|AstraZeneca A/S DK|||4786||4786|7335 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|12593|17863|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|||12593||12593|17863 082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|28539|37716|lyfalmen|||00|112|0|19|Vistor hf|Novartis Healthcare A/S-|||28539||28539|37716 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|15169|21070|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|||15169||15169|21070 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13152|18559|lyfalmen|V1372|18559|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|||13152||13152|18559 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6085|9098|lyfalmen|||00|40|0|25|Vistor hf|AstraZeneca A/S DK|||6085||6085|9098 083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|27352|36238|lyfalmen|||00|112|0|37|Vistor hf|Novartis Healthcare A/S-|||27352||27352|36238 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|41712|54116|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|||41712||41712|54116 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|84746|107694|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|||84746||84746|107694 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|73497|93371|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|||73497||73497|93371 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|28539|37716|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|||28539||28539|37716 083964|L02AE0101|Suprefact|nefúði|0,1|mg/sk|10|g|4|stk|+ sk-dæla|L02AE01|01.10.1987||R|A|2.5|0|1|0|1|SNO|0|0|0|100|NOK|36627|47468|lyfsjukr|||23|40|0|33|Vistor hf|Sanofi-aventis Norge AS|||36627||36627|47468 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|7395|10588|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|||7395||7395|10588 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|257|1189|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|||257||257|1189 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|496|1513|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|||496||496|1513 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|60775|77532|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||60775||60775|77532 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|79250|100534|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||79250||79250|100534 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|94488|119505|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||94488||94488|119505 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|20383|27244|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||20383||20383|27244 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|30502|39842|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||30502||30502|39842 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|40574|52382|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||40574||40574|52382 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|892|2051|lyfalmen|||00|10|0|0|Vistor hf|Eisai Ltd|||892||892|2051 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|10308|14829|lyfalmen|||00|60|0|0|Vistor hf|Eisai Ltd|||10308||10308|14829 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|34366|44971|lyfalmen|||00|100|0|0|Vistor hf|Eisai Ltd|||34366||34366|44971 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|18658|25414|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18658||18658|25414 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|6411|9540|lyfalmen|V1800|9540|0|98|0|49|Actavis Group hf|Actavis Group hf|||||6411|9540 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|30|IKR|2540|4287|lyfalmen|||0|56|0|56|Actavis Group hf|Actavis Group hf|||||2540|4287 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|30|IKR|4530|6988|lyfalmen|||0|98|0|98|Actavis Group hf|Actavis Group hf|||||4530|6988 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5306|lyfalmen|||0|28|0|56|Actavis Group hf|Actavis Group hf|||||3291|5306 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|2909|2542|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||1254||1254|2542 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|28539|37716|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|||28539||28539|37716 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|691|1778|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||691||691|1778 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|12527|17464|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12527||12527|17464 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|19421|26364|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|||19421||19421|26364 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|34553|45203|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|||34553||34553|45203 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4483|5175|lyfalmen|V1911|4701|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||3194||3194|5175 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5391|7248|lyfalmen|V1913|6547|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|||4722||4722|7248 086199|J01DD0202|Fortum|sts|500|mg/hgl|5|hgl|1|pakki||J01DD02|01.08.2002|31.12.2008|R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|5703|8165|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5703||5703|8165 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|7650|10953|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7650||7650|10953 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|12633|17596|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||12633||12633|17596 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|60738|77486|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||60738||60738|77486 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|70878|90111|lyfsjukr|||00|28|0|0|Vistor hf|Novartis Healthcare A/S-|||70878||70878|90111 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3093|5038|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|||3093||3093|5038 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|153768|193309|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|||153768||153768|193309 087270|C07AB0309|Atenolol Actavis|töflur|50|mg|100|stk|1|glas||C07AB03|01.10.1985|31.12.2008|R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|67|Actavis Group hf|Actavis hf||610|610|610|| 087296|C07AB0309|Atenolol Actavis|töflur|100|mg|100|stk|1|glas||C07AB03|01.10.1985|28.02.2009|R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|133|Actavis Group hf|Actavis hf|||||| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|241|1167|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|||241||241|1167 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|212|1128|lyfalmen|V0886|1119|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||212||212|1128 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2507|4242|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||2507||2507|4242 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||01|500|0|0|Vistor hf|Nordic Drugs AB|||||| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EME|0|0|0|100|SEK|693|1781|lyfalmen|||00|5|0|28|MedFarm ehf|E. Merck AB|||693||693|1781 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|||||| 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|||||| 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|||||| 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|||||| 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|||||| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|14151|19803|lyfalmen|V0560|19803|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||14151||14151|19803 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Vistor hf|Nordic Drugs AB|||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|||||| 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|23390|30988|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|||23390||23390|30988 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|38098|49300|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|||38098||38098|49300 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|77983|98956|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|||77983||77983|98956 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1203|2473|lyfalmen|||00|120|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||1203||1203|2473 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1457|2818|lyfalmen|||14|20|0|20|Vistor haf|Meda AB|||1457||1457|2818 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|7224|10644|lyfalmen|||14|100|0|100|Vistor haf|Meda AB|||7224||7224|10644 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|440|1437|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|||440||440|1437 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|14305|16100|lyfalmen|V1111|13111|00|98|0|196|D.A.C. ehf|D.A.C. ehf|||11245||11245|16100 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|148555|186818|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||148555|186818 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|47095|50450|lyfalmen|V0561|50450|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||38767||38767|50450 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1157|2410|lyfalmen|V0408|1993|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||1157||1157|2410 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|153768|193309|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|||153768||153768|193309 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|1985|3534|lyfalmen|V0352|1798|00|100|0|25|Vistor hf|Ferrosan A/S|||1985||1985|3534 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|38901|50299|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|||38901||38901|50299 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|194502|244022|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|||194502||194502|244022 090451|L04AB0102|Enbrel (Lyjaver)|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.06.2007|31.12.2008|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|186155|233630|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|||186155||186155|233630 090460|L04AB0102|Enbrel (Lyjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|76169|96698|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|||76169||76169|96698 090469|L04AB0102|Enbrel (Lyjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|158827|199607|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|||158827||158827|199607 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1664|3099|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|||1664||1664|3099 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|361|1330|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|||361||361|1330 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|V0351|3898|10|60|0|30|Actavis Group hf|Actavis hf|||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|125134|157659|lyfsjukr|||00|28|0|0|Lyfjaver ehf|Lyfjaver ehf|||125134||125134|157659 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1632|2151|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |||966||966|2151 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2937|2921|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |||1533||1533|2921 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|125151|157680|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|||125151||125151|157680 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|161159|202510|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|||161159||161159|202510 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6956|13421|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||6956||6956|13421 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|6816|10090|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||6816||6816|10090 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|9797|14135|lyfalmen|V1400|14135|00|100|0|33|D.A.C. ehf|D.A.C. ehf|||||9797|14135 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|25195|33553|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||||25195|33553 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|25195|33553|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||||25195|33553 093215|L01XC0602|Erbitux (Lyfjaver)|irl|2|mg/ml|50|ml|1|hgl|lausn|L01XC06|01.06.2007|31.12.2008|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|40675|52508|lyfsjukr|||00|50|0|0|Lyfjaver ehf|Lyfjaver ehf|||40675||40675|52508 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|4766|7308|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4766||4766|7308 093496|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|5960|8928|lyfalmen|||00|60|0|32|Icepharma hf|Schering Oy|||5960||5960|8928 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|25158|43537|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||25158||25158|43537 093625|B03AA0702|Ferlen-R|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|100|0|50|Actavis Group hf|Actavis hf|||||| 093641|QN05CM9202|Xylapan, vet.|stl|20|mg/ml|50|ml|1|hgl||QN05CM92|01.04.1992|31.12.2008|R|A|3|0|0|0|0|VEQ|1|0|0|100|CHF|5124|9932|vetalmen|||00|50|0|0|Icepharma hf|Vétoquinol AG|||5124||5124|9932 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|SEK|15587|21273|lyfsjukr|||00|5|0|0|Icepharma hf|Wyeth AB|||15587||15587|21273 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16852|23166|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |||16852||16852|23166 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|55559|71356|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |||55559||55559|71356 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2032|3598|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|||2032||2032|3598 093824|N06AB0403|Cipramil (D.A.C.)|filmhtfl|20|mg|28|stk|1|þpakki||N06AB04|01.03.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3024|4944|lyfalmen|V0923|2562|0|28|0|28|D.A.C. ehf|D.A.C. ehf|||||3024|4944 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4065|6357|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|||4065||4065|6357 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2493|4224|lyfalmen|V0385|4224|23|84|0|84|D.A.C. ehf|D.A.C. ehf|||2493||2493|4224 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1695|3345|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||1695||1695|3345 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|12377|17594|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|||12377||12377|17594 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|17729|24258|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|||17729||17729|24258 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|79775|101505|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|||79775||79775|101505 094933|A03000001|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A03|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|SEK|43350|56156|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|||43350||43350|56156 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3145|5108|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|||3145||3145|5108 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|14093|19731|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||14093||14093|19731 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|33941|44442|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||33941||33941|44442 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|14093|19731|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||14093||14093|19731 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|30756|40476|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||30756||30756|40476 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|14093|19731|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||14093||14093|19731 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|54152|69604|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||54152||54152|69604 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3463|6768|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3463||3463|6768 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4570|8876|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4570||4570|8876 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|8322|16023|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8322||8322|16023 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2187|3131|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|||2187||2187|3131 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|13001|18054|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|||13001||13001|18054 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|130008|163727|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|||130008||130008|163727 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1276|2572|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||1276||1276|2572 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|15289|21220|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||15289||15289|21220 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|751|1746|lyfalmen|V1500|1746|07|5|0|0|D.A.C. ehf|D.A.C. ehf|||667||667|1746 096488|L04AX00401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX004|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|922343|1150185|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||922343|1150185 096497|L04AX00401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX004|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|846860|1056208|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||846860|1056208 096506|L04AX00401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX004|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|891155|1111355|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||891155|1111355 096515|L04AX00401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX004|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|978561|1220176|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||978561|1220176 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|15289|21220|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||15289||15289|21220 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1462|2824|lyfalmen|||00|30|0|18|Icepharma hf|Servier|||1462||1462|2824 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|30578|40255|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||30578||30578|40255 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|84316|106841|lyfsjukr|||00|1|0|0|Vistor hf|Pfizer Limited|||84316||84316|106841 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|3264|3598|lyfalmen|V0426|3598|00|20|0|5|D.A.C. ehf|D.A.C. ehf|||2032||2032|3598 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1056|2273|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|||1056||1056|2273 097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|58693|75258|lyfalmen|V0563|75126|00|100|0|100|D.A.C. ehf|D.A.C. ehf|||||58693|75258 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||13690||13690|18912 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1586|2993|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1586||1586|2993 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8291|8766|lyfalmen|V0714|7364|10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5840||5840|8766 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10861|11484|lyfalmen|V0715|9747|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7843||7843|11484 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3813|3591|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |||2027||2027|3591 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1410|2754|lyfalmen|V1151|2754|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|||1410||1410|2754 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|6247|9318|lyfalmen|V1110|9318|00|98|0|98|Actavis Group hf|Actavis hf|||6247||6247|9318 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|9042|13111|lyfalmen|V1111|13111|00|98|0|196|Actavis Group hf|Actavis hf|||9042||9042|13111 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|15426|21390|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||15426||15426|21390 098486|G03GA002|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|10949|15699|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||10949|15699 098504|G03GA002|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|101564|128632|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||101564|128632 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2450|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||1186||1186|2450 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|19241|26140|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||19241||19241|26140 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|680|1763|lyfalmen|V1500|1746|07|5|0|0|Vistor hf|LEO Pharma A/S|||680||680|1763 099476|N05AH0404|Quetiapin Merck NM|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|4871|7451|lyfalmen|V0725|7451|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|||4871||4871|7451 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|11123|15935|lyfalmen|V0726|15935|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|||11123||11123|15935 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|17999|24594|lyfalmen|V0727|24594|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|||17999||17999|24594 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|542|1576|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|||542||542|1576 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|||||| 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|||||| 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|||||| 099861|H01AC0104|Saizen|sts|0| |3,33|mg|10|hgl|+ leysir|H01AC01|01.07.1992|31.12.2008|R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|143350|180338|lyfsjukr|||02|33|0|50|Gróco ehf|Serono Nordic|||143350||143350|180338 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|40796|52659|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|||40796||40796|52659 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|60390|77053|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|||60390||60390|77053 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|44174|56864|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|||44174||44174|56864 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|98082|123980|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|||98082||98082|123980 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12478|17720|lyfalmen|||00|28|0|7|Icepharma hf|Lilly ICOS Limited|||||12478|17720 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12478|17720|lyfalmen|||00|28|0|14|Icepharma hf|Lilly ICOS Limited|||||12478|17720 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|11796|16848|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|||11796||11796|16848 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|1939|3472|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1939||1939|3472 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|16299|22477|lyfalmen|||0|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||16299|22477 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|27475|36391|lyfalmen|||0|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||27475|36391 101386|R06AX1301|Clarityn|mixtúra|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|3|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10|Vistor hf|Schering-Plough|||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|35387|46242|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|||35387||35387|46242 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|117958|149043|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|||117958||117958|149043 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|1761|3230|lyfalmen|||00|28|0|19|Vistor hf|Bayer HealthCare AG|||1761||1761|3230 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|5525|8338|lyfalmen|||00|98|0|65|Vistor hf|Bayer HealthCare AG|||5525||5525|8338 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2291|3949|lyfalmen|V1152|3949|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||2291||2291|3949 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|8152|11903|lyfalmen|V1153|11903|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|||8152||8152|11903 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|8362|8592|lyfalmen|V0736|8592|00|100|0|50|D.A.C. ehf|D.A.C. ehf|||5712||5712|8592 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|10457|20090|vetalmen|||0|250|0|0|Vistor hf|Boehringer Ingelheim|||||10457|20090 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1283|2581|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|||1283||1283|2581 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2628|4407|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|||2628||2628|4407 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2049|2934|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|||2049||2049|2934 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|4251|6086|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|||4251||4251|6086 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|6735|8905|lyfalmen|V0198|8905|00|98|0|98|PortFarma ehf|PortFarma |||5943||5943|8905 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|11151|14192|lyfalmen|V0193|14192|00|98|0|196|PortFarma ehf|PortFarma |||9839||9839|14192 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|4295|6362|lyfalmen|V0197|5712|00|98|0|98|PortFarma ehf|PortFarma |||4069||4069|6362 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2228|3426|lyfalmen|V0507|3426|00|10|0|2|PortFarma ehf|PortFarma |||1905||1905|3426 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|9261|11577|lyfalmen|V0508|11538|00|40|0|7|PortFarma ehf|PortFarma |||7912||7912|11577 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|14225|17953|lyfalmen|V0955|17953|00|100|0|75|PortFarma ehf|PortFarma |||12665||12665|17953 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|27072|32192|lyfalmen|V0956|32192|00|100|0|150|PortFarma ehf|PortFarma |||24102||24102|32192 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma||||||1716 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1|Vistor hf|Orion Pharma|||||| 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 104356|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|30|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||193||193|1102 104372|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|100|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|475|1485|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||475||475|1485 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3527|5627|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|||3527||3527|5627 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2434|4143|lyfalmen|||00|21|0|0|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|||2434||2434|4143 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8898|12915|lyfalmen|||04|28|0|19|Vistor hf|Ferring|||8898||8898|12915 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5163|7847|lyfalmen|||56|700|0|5|Vistor hf|Ferring|||5163||5163|7847 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|6325|9424|lyfalmen|||10|100|0|33|Vistor hf|Ferring|||6325||6325|9424 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||5432||5432|7777 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|3532|5633|lyfalmen|V0084|5633|00|28|0|19|D.A.C. ehf|D.A.C. ehf|||3532||3532|5633 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|6964|10291|lyfalmen|V0086|10291|00|56|0|37|D.A.C. ehf|D.A.C. ehf|||6964||6964|10291 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|12306|17506|lyfalmen|V0087|17506|00|100|0|67|D.A.C. ehf|D.A.C. ehf|||12306||12306|17506 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|16613|22868|lyfalmen|V0089|22868|00|100|0|133|D.A.C. ehf|D.A.C. ehf|||16613||16613|22868 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|18310|24981|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|||18310||18310|24981 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|15106|20992|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|||15106||15106|20992 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|27467|36381|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|||27467||27467|36381 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|7553|11090|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|||7553||7553|11090 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|13733|19283|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|||13733||13733|19283 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|10071|14507|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|||10071||10071|14507 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4418|6836|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4418||4418|6836 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|13705|19248|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||13705||13705|19248 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4418|6836|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4418||4418|6836 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|14596|20357|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||14596||14596|20357 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2072|3652|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2072||2072|3652 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2257|3903|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2257||2257|3903 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3167|5138|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|||3167||3167|5138 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|0|100|0|50|PortFarma ehf|PortFarma|||802||802|1929 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|0|100|0|100|PortFarma ehf|PortFarma|||1153||1153|2405 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|0|100|0|200|PortFarma ehf|PortFarma|||2725||2725|4538 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|16373|22252|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||16373||16373|22252 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|9055|12964|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9055||9055|12964 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|15761|21807|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|||15761||15761|21807 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|13131|18533|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||13131||13131|18533 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|19769|26797|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||19769||19769|26797 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1846|3345|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1846||1846|3345 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|15761|21807|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|||15761||15761|21807 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis hf|||||| 107581|N02BE0106|Parasupp|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.12.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|0|Actavis Group hf|Actavis hf||||||0 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||2535 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1117|2356|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|||1117||1117|2356 108183|N02BE0106|Parasupp|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.12.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|1|Actavis Group hf|Actavis hf||||||0 108209|N02BE0106|Parasupp|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis hf|||||| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2704|4510|lyfalmen|||63|100|0|33|Vistor hf|Bayer HealthCare AG|||2704||2704|4510 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|4151|6473|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||4151||4151|6473 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|11323|16206|lyfalmen|||00|90|0|0|Vistor hf|Novartis Europharm Ltd|||11323||11323|16206 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1061|2094|vetalmen|||27|1200|0|0|Icepharma hf|Kela Laboratoria NV|||1061||1061|2094 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|923|2093|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|||923||923|2093 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1352|2675|lyfalmen|V0965|2607|24|120|0|38|Vistor hf|AstraZeneca A/S DK|||1352||1352|2675 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|203|1116|lyfalmen|V0775|1106|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|||203||203|1116 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|775|1892|lyfalmen|V0780|1874|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|||775||775|1892 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|23035|30864|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||23035||23035|30864 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|18442|25145|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||18442||18442|25145 109462|V01AA0301|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7159|10555|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||7159||7159|10555 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Actavis Group hf|Actavis hf|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|607|1664|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|||607||607|1664 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|677|1759|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|||677||677|1759 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0|Ísaga ehf|AGA AB|||||| 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1461|2823|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|||1461||1461|2823 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4280|6649|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|||4280||4280|6649 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|10995|15761|lyfalmen|V1351|15761|00|8|0|16|D.A.C. ehf|D.A.C. ehf|||||10995|15761 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|711|1805|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|||711||711|1805 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|765|1879|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|||765||765|1879 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1215|2489|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1215||1215|2489 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3368|5411|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|||3368||3368|5411 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|9153|13261|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||9153|13261 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|25195|33553|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||25195|33553 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|9153|13261|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||9153|13261 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3114|5066|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|||3114||3114|5066 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|25195|33553|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||25195|33553 113639|A02AD0105|Novaluzid|tuggutfl|500|mg|100|stk|1|þpakki||A02AD01|01.03.1983|31.01.2009|L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|100|0|10|Vistor hf|BioPhausia AB|||||| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5049|7692|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|||5049||5049|7692 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|33295|43320|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|||33295||33295|43320 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|698694|871742|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|||698694||698694|871742 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|565|1607|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|||565||565|1607 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|825|1960|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|||825||825|1960 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1094|2325|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|||1094||1094|2325 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|694|1782|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||694||694|1782 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|3506|lyfalmen|V0919|3506|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|||1964||1964|3506 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|2556|lyfalmen|V0918|2556|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|||1264||1264|2556 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1489|lyfalmen|V0917|1489|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|||478||478|1489 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2472|4195|lyfalmen|V0989|4127|06|5|0|0|Icepharma hf|M.S.D.|||2472||2472|4195 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|3938|6184|lyfalmen|||0|750|0|0|Vistor hf|Boehringer Ingelheim International|||3938||3938|6184 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1593|3002|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|||1593||1593|3002 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|11804|16859|lyfalmen|||0|2250|0|0|Vistor hf|Boehringer Ingelheim International|||11804||11804|16859 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|23607|31576|lyfalmen|||0|4500|0|0|Vistor hf|Boehringer Ingelheim International|||23607||23607|31576 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|3938|6184|lyfalmen|||0|1100|0|0|Vistor hf|Boehringer Ingelheim International|||3938||3938|6184 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|11804|16859|lyfalmen|||0|3300|0|0|Vistor hf|Boehringer Ingelheim International|||11804||11804|16859 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|23607|31576|lyfalmen|||0|6600|0|0|Vistor hf|Boehringer Ingelheim International|||23607||23607|31576 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|1822|3313|lyfalmen|V1090|3263|06|5|0|17|Icepharma hf|M.S.D.|||1822||1822|3313 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1153|2405|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|||1153||1153|2405 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3204|5188|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3204||3204|5188 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0|Icepharma hf|Norpharma |||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3438|4922|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3438||3438|4922 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1797|2573|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1797||1797|2573 116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|846|1988|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||846||846|1988 116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1870|3378|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||1870||1870|3378 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10|Icepharma hf|Galderma Nordic AB|||||| 116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|846|1988|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||846||846|1988 116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1860|3364|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||1860||1860|3364 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Actavis Group hf|Actavis hf|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|751|1860|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||751||751|1860 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|420|1410|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||420||420|1410 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1016|2219|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||1016||1016|2219 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|17286|23706|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||17286|23706 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|6117|9141|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||6117|9141 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|6498|9658|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||6498|9658 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|19579|26561|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||19579|26561 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|35039|45809|lyfalmen|V1702|45809|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|||35039||35039|45809 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|35039|45809|lyfalmen|V1703|45809|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|||35039||35039|45809 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|8659|16665|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||8659||8659|16665 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|7394|10874|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|||7394||7394|10874 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|5538|8356|lyfalmen|||00|100|0|33|Icepharma hf|Roche|||5538||5538|8356 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|11635|16630|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|||||11635|16630 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|20563|27786|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|||||20563|27786 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2283|3939|lyfalmen|||10|100|0|8|Icepharma hf|Roche|||2283||2283|3939 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|3556|5666|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|||||3556|5666 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|35556|46452|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|||||35556|46452 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|41126|53387|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|||||41126|53387 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|9224|15963|vetorma|||00|250|0|0|Vistor hf|Bayer Animal Health GmbH|||9224||9224|15963 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2478|4203|lyfalmen|||61|28|0|28|Vistor hf|Bayer HealthCare AG|||2478||2478|4203 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|4359|6756|lyfalmen|||61|98|0|98|Vistor hf|Bayer HealthCare AG|||4359||4359|6756 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|10451|15023|lyfalmen|||61|98|0|196|Vistor hf|Bayer HealthCare AG|||10451||10451|15023 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|6049|11694|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||6049||6049|11694 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|10609|20380|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||10609||10609|20380 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|3794|4317|lyfalmen|V0809|4317|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|||2562||2562|4317 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5393|5781|lyfalmen|V0810|5781|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|||3641||3641|5781 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|20914|19761|lyfalmen|V0812|19761|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|||14117||14117|19761 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|15977|15476|lyfalmen|V0815|15476|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|||10785||10785|15476 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1548|2941|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1548||1548|2941 118165|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.05.2008|31.01.2009|R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|||lyfalmen|||00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||3841||| 118176|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.05.2008|31.01.2009|R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|||lyfalmen|||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||18395||| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15|Actavis Group hf|Actavis hf|||||| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|675|1756|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|||675||675|1756 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|6767|10024|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|||6767||6767|10024 118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|846|1988|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||846||846|1988 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|16442|15901|lyfalmen|V0811|15901|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|||11098||11098|15901 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|8723|12678|lyfalmen|||00|50|0|33|Vistor hf|Ferring|||8723||8723|12678 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|25657|34128|lyfalmen|||00|150|0|100|Vistor hf|Ferring|||25657||25657|34128 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3375|5420|lyfalmen|V1401|5420|00|100|0|8|Lyfjaver ehf|Lyfjaver ehf|||||3375|5420 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|9942|14332|lyfalmen|V1400|14135|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|||||9942|14332 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|79748|101154|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|||79748||79748|101154 119305|B05BA0109|Vamin Glukos|irl|0| |1000|ml|6|fl||B05BA01|01.09.1998|31.12.2008|R|A|1.5|0|0|0|1|FRP|0|0|0|100|DKK|21823|29037|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||21823||21823|29037 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|12048|17185|lyfalmen|||00|98|0|98|Icepharma hf|Roche|||12048||12048|17185 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10|PortFarma ehf|PortFarma|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|425888|532416|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||425888|532416 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|425888|532416|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||425888|532416 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|939|2115|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|||939||939|2115 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|44665|57475|lyfsjukr|||00|1|0|0|Icepharma hf|Lilly ICOS Limited|||||44665|57475 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|11526|15460|lyfalmen|V1370|15460|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||10773||10773|15460 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|35469|43488|lyfalmen|V1371|43487|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|||33175||33175|43488 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|DKK|3048|4977|lyfalmen|V0939|4897|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|||3048||3048|4977 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|19405|26344|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|||19405||19405|26344 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|18432|25133|lyfalmen|V1710|25133|00|100|0|25|Lyfjaver ehf|Lyfjaver ehf|||||18432|25133 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|678|1760|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||678||678|1760 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|316|1269|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||316||316|1269 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|357|1325|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|||357||357|1325 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|1901|3420|lyfalmen|V0908|1581|00|100|0|25|Vistor hf|Novartis Healthcare A/S-|||1901||1901|3420 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|2941|4831|lyfalmen|||98|30|0|10|Icepharma hf|Schering Oy|||2941||2941|4831 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|523|1550|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|||523||523|1550 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|816|1948|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|||816||816|1948 123264|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|11484|16425|lyfalmen|V0125|13450|0|28|0|2|Actavis Group hf|Alpharma ApS|||||11484|16425 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|IKR|1755|3222|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||1755||1755|3222 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|22999|30819|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|||||22999|30819 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|12245|17430|lyfalmen|V1080|16894|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||12245||12245|17430 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|284|1226|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||284||284|1226 123596|N02AA5904|Ibukod sterkar|töflur|0| |100|stk|1|glas|30+200 mg|N02AA59|01.10.1998||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|2116|3712|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||2116||2116|3712 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|37548|48932|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|||37548||37548|48932 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|974|2162|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||974||974|2162 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|949|2128|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|||949||949|2128 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|00|100|0|100|Actavis Group hf|Actavis hf|||1153||1153|2405 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|2201|3827|lyfalmen|V0144|3769|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|||2201||2201|3827 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|20518|23669|lyfalmen|V1701|23669|00|28|0|6|D.A.C. ehf|D.A.C. ehf|||17256||17256|23669 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|17071|23438|lyfalmen|V1732|18072|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|||17071||17071|23438 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|15147|21043|lyfalmen|V1730|17906|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|||15147||15147|21043 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|19217|26110|lyfalmen|V1731|26110|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|||19217||19217|26110 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3|Vistor hf|Janssen-Cilag AB|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|99317|125517|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||99317|125517 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|25488|33600|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||25488|33600 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|24078|31845|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|||24078||24078|31845 126561|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|3021|lyfalmen|||00|28|0|14|Gróco ehf|Ranbaxy (UK) Ltd|||1607||1607|3021 126572|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|3045|4973|lyfalmen|||00|56|0|28|Gróco ehf|Ranbaxy (UK) Ltd|||3045||3045|4973 126583|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|3021|lyfalmen|||00|28|0|28|Gróco ehf|Ranbaxy (UK) Ltd|||1607||1607|3021 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|3045|4973|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|||3045||3045|4973 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8026|11491|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|||8026||8026|11491 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1550|2944|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|||1550||1550|2944 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|XEU|3848|6062|lyfalmen|V1951|6062|00|28|0|14|D.A.C. ehf|D.A.C. ehf|||||3848|6062 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 127647|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 127696|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9152|6330|lyfalmen|V0810|5781|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4045||4045|6330 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstil|0||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|5754|11132|vetalmen|||0|30|0|0|Vistor hf|Boehringer Ingelheim Danmark|||||5754|11132 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|435|1431|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||435||435|1431 128280|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 128306|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|2000|0|0|Actavis Group hf|Braun|||||| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1169|2427|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|||1169||1169|2427 128769|V07AB09|Sterilt Vatten Braun|leysir|0| |10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|200|0|0|Actavis Group hf|Braun||||||0 128819|V07AB09|Sterilt Vatten Braun|leysir|0| |20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|400|0|0|Actavis Group hf|Braun||||||0 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4|Vistor hf|McNeil Denmark ApS|||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|||||| 128926|V07AB09|Sterilt Vatten Braun|leysir|0| |50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|1000|0|0|Actavis Group hf|Braun||||||0 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|3767|5393|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|||3767||3767|5393 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|27952|17536|lyfalmen|V0811|15901|00|56|0|42|Icepharma hf|Eli Lilly Nederland -|||12330||12330|17536 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|35540|21714|lyfalmen|V0812|19761|00|56|0|56|Icepharma hf|Eli Lilly Nederland -|||15686||15686|21714 129254|V07AB09|Sterilt Vatten Braun|leysir|0| |100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|2000|0|0|Actavis Group hf|Braun||||||0 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB||||||2580 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4713|7236|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|||4713||4713|7236 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|14555|17999|lyfalmen|V0726|15935|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|||12702||12702|17999 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|23040|27217|lyfalmen|V0727|24594|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|||20106||20106|27217 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|3793|5988|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|||3793||3793|5988 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|10793|15487|lyfalmen|||0|53|0|21|Vistor hf|Pfizer Limited|||||10793|15487 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|370|1342|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|||370||370|1342 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|709|1803|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||709||709|1803 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|776|1893|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||776||776|1893 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|859|2006|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||859||859|2006 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5181|7871|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|||5181||5181|7871 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|||||| 131987|J01AA0203|Doxytab|töflur|100|mg|10|stk|1|glas||J01AA02|01.12.2008|31.12.2008|R|A|4|0|0|0|0|AGP|0|0|1|100|IKR|||lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group PTC ehf|||||| 131995|J01AA0203|Doxytab|töflur|100|mg|30|stk|1|glas||J01AA02|01.04.1987|28.02.2009|R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||||| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|222|1142|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|||222||222|1142 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|293|1238|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|||293||293|1238 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|11710|16731|lyfalmen|V0192|16731|00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|||11710||11710|16731 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|8104|11838|lyfalmen|V0191|11838|00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|||8104||8104|11838 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1364|2691|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|||1364||1364|2691 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6998|10337|lyfalmen|||0|30|0|27|Vistor hf|Janssen-Cilag AB|||||6998|10337 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||23|8|0|8|Icepharma hf|Napp|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1070|2292|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||1070||1070|2292 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3|Vistor hf|Abigo Medical AB|||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|775|1892|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|||775||775|1892 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|76273|96827|lyfsjukr|||02|5|0|4|Vistor hf|Chugai sanofi-aventis|||76273||76273|96827 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|30975|40431|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|||||30975|40431 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|34607|44953|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|||||34607|44953 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|38452|49740|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|||||38452|49740 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|8304|12109|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|||8304||8304|12109 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|104807|132352|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|||104807||104807|132352 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2249|3892|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|||2249||2249|3892 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|156655|196813|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|||156583||156583|196813 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|4051|6338|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4051||4051|6338 135111|H01AC0101|Genotropin|sts|0| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|68324|86931|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||68324||68324|86931 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|862|2010|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|||862||862|2010 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|1966|3508|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1966||1966|3508 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|775|1892|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|||775||775|1892 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|5764|8662|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||5764||5764|8662 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|94657|119715|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|||94657||94657|119715 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|70093|89133|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|||70093||70093|89133 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3|Vistor hf|McNeil Denmark ApS|||||| 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10|Vistor hf|McNeil Denmark ApS|||||| 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1407|2750|lyfalmen|||00|100|0|13|Vistor hf|Schering-Plough|||1407||1407|2750 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|933|2107|lyfalmen|||00|100|0|7|Vistor hf|Schering-Plough|||933||933|2107 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-||||||1494 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-||||||1851 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|148447|186684|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|||148447||148447|186684 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4132|6448|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|||4132||4132|6448 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2033|2911|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|||2033||2033|2911 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2763|3956|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|||2763||2763|3956 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1905|3426|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|||1905||1905|3426 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2023|3586|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|||2023||2023|3586 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|2572|4451|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||2572||2572|4451 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|2828|4678|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|||2828||2828|4678 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|2604|4374|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|||2604||2604|4374 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2379|4069|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|||2379||2379|4069 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1609|3024|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |||1609||1609|3024 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|13339|18475|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||13339||13339|18475 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|601|860|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|||601||601|860 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3|Vistor hf|McNeil Denmark ApS|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1273|2568|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1273||1273|2568 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|2859|4720|lyfalmen|V2002|4720|00|25|0|5|D.A.C. ehf|D.A.C. ehf|||||2859|4720 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1284|2583|lyfalmen|V0451|2583|08|80|0|0|D.A.C. ehf|D.A.C. ehf|||1284||1284|2583 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|8395|12020|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|||8395||8395|12020 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|13406|18875|lyfalmen|V0011|17349|00|25|0|5|D.A.C. ehf|D.A.C. ehf|||13406||13406|18875 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|25445|33547|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|||25445||25445|33547 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3111|5062|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |||3111||3111|5062 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|3815|6018|lyfalmen|||0|84|0|0|Icepharma hf|Bayer AB|||||3815|6018 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2008||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|591|1642|lyfalmen|||00|28|0|7|Actavis Group hf|Actavis UK Ltd.|||||591|1642 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|8599|12510|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|||8599||8599|12510 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|413|1401|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|||413||413|1401 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|530|1560|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||530||530|1560 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|7334|10500|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|||7334||7334|10500 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|918|2086|lyfalmen|V0143|2086|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||918||918|2086 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2254|3899|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|||2254||2254|3899 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|734|1836|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||734||734|1836 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1939|3472|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1939||1939|3472 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4352|6231|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4352||4352|6231 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|689|1775|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|||689||689|1775 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1370|2700|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||1370||1370|2700 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3035|4959|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||3035||3035|4959 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|884|2040|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||884||884|2040 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1648|3077|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1648||1648|3077 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2105|3697|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|||2105||2105|3697 143631|A10BD0701|Janumet|filmhtfl|0||56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|8198|11965|lyfalmen|||0|56|0|0|Icepharma hf|M.S.D.|||||8198|11965 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|10199|5798|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|||3653||3653|5798 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|870|2021|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||870||870|2021 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1136|2382|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|||1136||1136|2382 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2634|4415|lyfalmen|V0429|4381|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2634||2634|4415 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|3986|5707|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3986||3986|5707 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|7661|10969|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7661||7661|10969 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|3566|5680|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|||3566||3566|5680 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4492|6936|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||4492||4492|6936 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|14009|19309|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14009||14009|19309 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|90628|114699|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|||90628||90628|114699 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28|Actavis Group hf|Actavis Group hf|||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|56903|72712|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|||56903||56903|72712 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|36998|47930|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|||36998||36998|47930 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|850|1994|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||850||850|1994 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|395|1376|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|||395||395|1376 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|682|1766|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|||682||682|1766 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3007|4921|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3007||3007|4921 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|4661|7166|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||4661||4661|7166 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0|Vistor hf|Recip AB|||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0|Vistor hf|Recip AB|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0|Vistor hf|Recip AB|||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|19783|26815|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||19783||19783|26815 146207|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|9824|14066|lyfsjukr|||0|2|0|0|Icepharma hf|Mayne Pharma Plc|||||9824|14066 146218|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|23272|30841|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|||||23272|30841 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|718|1815|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|||718||718|1815 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4562|6532|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|||||4562|6532 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|3849|5511|lyfsjukr|||0|10|0|0|Icepharma hf|Mayne Pharma Plc|||||3849|5511 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981||R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1201|2470|lyfalmen|||00|50|0|50|Vistor hf|LEO Pharma A/S|||1201||1201|2470 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|11480|16160|lyfsjukr|||00|6000|0|6|Vistor haf|Meda AB|||11480||11480|16160 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|18352|24716|lyfsjukr|||00|6000|0|6|Vistor haf|Meda AB|||18352||18352|24716 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|38339|49600|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|||38339||38339|49600 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|115948|146540|lyfalmen|||00|750|0|30|Icepharma hf|Roche as|||115948||115948|146540 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1002|2200|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|||1002||1002|2200 148650|G03AA0703|Neogynon|töflur|0| |63|stk|1|þpakki||G03AA07|01.12.1974|31.12.2008|R|A|5|0|0|0|0|SAG|0|0|0|100|SEK|1105|2340|lyfalmen|||23|63|0|84|Icepharma hf|Schering AG|||1105||1105|2340 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|14795|18147|lyfalmen|V2001|18147|00|120|0|120|D.A.C. ehf|D.A.C. ehf|||12821||12821|18147 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|14341|20040|lyfalmen|V0192|16731|00|98|0|196|D.A.C. ehf|D.A.C. ehf|||||14341|20040 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3437|6718|vetalmen|||27|25|0|0|Vistor hf|Bayer Animal Health GmbH|||3437||3437|6718 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1719|3173|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1719||1719|3173 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|12850|18183|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|||12850||12850|18183 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3187|5165|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3187|5165 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|6785|10048|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||6785||6785|10048 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|968|2154|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|||968||968|2154 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|15088|20970|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|||||15088|20970 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|46589|60188|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|||||46589|60188 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|5709|8588|lyfalmen|V0437|8588|00|90|0|90|Actavis Group PTC ehf|Mylan AB|||||5709|8588 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1521|2904|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1521||1521|2904 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1049|2264|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1049||1049|2264 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|661|946|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|||661||661|946 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3562|5674|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|||3562||3562|5674 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5513|8322|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|||5513||5513|8322 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|8900|12918|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|||8900||8900|12918 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1499|2875|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|||1499||1499|2875 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1606|3020|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1606||1606|3020 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1816|3305|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||1816||1816|3305 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1451|2809|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||1451||1451|2809 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|3845|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2214||2214|3845 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GSC|0|0|0|100|DKK|350744|438544|lyfsjukr|||00|10|0|14|Swedish Orphan International AB|Gilead Science International (S) |||350744||350744|438544 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|5022|7655|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|||5022||5022|7655 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|6478|9631|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|||6478||6478|9631 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5253|7969|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|||5253||5253|7969 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1277|2573|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1277||1277|2573 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4998|7623|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4998||4998|7623 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|11127|15940|lyfalmen|||00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|||11127||11127|15940 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1122|2363|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1122||1122|2363 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1594|3004|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|||1594||1594|3004 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|494|1511|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|||494||494|1511 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|9502|13735|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|||9502||9502|13735 155903|J05AF0101|Retrovir|mixtúra|10|mg/ml|200|ml|1|glas||J05AF01|01.07.1995|31.12.2008|R|A|2|0|1|0|1|GSK|0|0|0|100|GBP|6472|9266|lyfsjukr|||63|200|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6472||6472|9266 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|5994|8975|lyfalmen|||00|42|0|14|Icepharma hf|Roche|||5994||5994|8975 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|8769|12740|lyfalmen|||00|84|0|28|Icepharma hf|Roche|||||8769|12740 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|306|1256|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|||306||306|1256 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|6911|11960|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||6911||6911|11960 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|554|1592|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||554||554|1592 157909|D07XC0101|Diprosalic|áburður|0| |100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3193|5173|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||3193||3193|5173 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|954|2135|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|||954||954|2135 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|50148|64302|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||50148|64302 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|78982|100200|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||78982|100200 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1062|2282|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|||1062||1062|2282 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|808|1937|lyfalmen|V0608|1937|10|100|0|50|Actavis Group PTC ehf|Mylan AB|||||808|1937 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|1906|3427|lyfalmen|V2003|3427|00|98|0|31|D.A.C. ehf|D.A.C. ehf|||||1906|3427 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3332|5362|lyfalmen|V1050|5362|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|||||3332|5362 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|6415|9546|lyfalmen|V1051|9546|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|||||6415|9546 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|8977|13023|lyfalmen|V1052|13023|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|||||8977|13023 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10792|15486|lyfalmen|V1053|15486|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|||||10792|15486 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6159|4308|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||2555||2555|4308 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|24385|32544|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||24385||24385|32544 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|12607|11541|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|||7885||7885|11541 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1783|2405|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|||1153||1153|2405 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|3086|3400|lyfalmen|V0923|2562|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||1886||1886|3400 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6359|4542|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||2728||2728|4542 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|161097|202433|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|||161097||161097|202433 159806|QG51BE0001|Streptoc. m/sulfadim., vet.|legstil|0| |50|stk|50|stilar||QG51BE00|01.11.1979||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|9605|18467|vetalmen|||00|2500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||9605||9605|18467 160051|C07AA0701|Sotacor|töflur|160|mg|100|stk|1|þpakki||C07AA07|01.05.1983|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||2395||| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2155|3085|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|||2155||2155|3085 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|819|1952|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|||819||819|1952 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2245|3887|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|||2245||2245|3887 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|305|1254|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|||||305|1254 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|319|1273|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|||319||319|1273 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|71335|90680|lyfsjukr|||0|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||||71335|90680 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|727|1827|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||727||727|1827 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1700|2434|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1700||1700|2434 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|2915|4174|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2915||2915|4174 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|666|1744|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||666||666|1744 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4612|7099|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|||4612||4612|7099 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|63766|81574|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||63766||63766|81574 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|SEK|2669|3821|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|||2669||2669|3821 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|SEK|5454|7809|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|||5454||5454|7809 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|SEK|14583|20023|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|||14583||14583|20023 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2246|3888|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2246||2246|3888 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|1966|3508|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1966||1966|3508 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1131|2375|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|||||1131|2375 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1580|2985|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|||1580||1580|2985 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|193|1102|lyfalmen|||0|20|0|20|Actavis hf|Asctavis EAD|||||193|1102 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2619|4394|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2619||2619|4394 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|6575|9763|lyfalmen|||00|454|1|0|Parlogis hf|Parlogis - óskráð lyf|||6575||6575|9763 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2472|4195|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2472||2472|4195 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|5760|8657|lyfalmen|V0299|8657|98|60|0|20|Icepharma hf|Schering Oy|||5760||5760|8657 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS|||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS|||||| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4571|7043|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|||4571||4571|7043 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3990|6255|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|||3990||3990|6255 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2575|4335|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|||2575||2575|4335 165589|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|5|hgl||QH02AB06|01.12.1972||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|6535|12619|vetalmen|||58|250|0|0|Icepharma hf|Intervet International B.V.|||6535||6535|12619 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|13702|19244|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||13702||13702|19244 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|812|1942|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||812||812|1942 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|288|1231|lyfalmen|||00|25|0|12|Vistor hf|U.C.B|||288||288|1231 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCB|0|0|1|100|IKR|||lyflausa|||00|10|0|5|Vistor hf|U.C.B|||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|||227395||227395|284974 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2352|4032|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|||2352||2352|4032 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|842|1983|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|||842||842|1983 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2173|3789|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|||2173||2173|3789 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|15512|21497|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15512||15512|21497 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|23797|31495|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|||23797||23797|31495 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|47593|61121|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|||47593||47593|61121 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1089|2318|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|||1089||1089|2318 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3543|5648|lyfalmen|V0789|5623|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|||3543||3543|5648 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1140|2387|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|||1140||1140|2387 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6621|9825|lyfalmen|V0713|9559|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|||6621||6621|9825 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|42871|55242|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|||42871||42871|55242 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|194715|244288|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|||194715||194715|244288 169524|J01AA0203|Doxytab|töflur|100|mg|14|stk|1|glas||J01AA02|01.07.1993|31.12.2008|R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|14|0|14|Actavis Group hf|Actavis hf|||720||| 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2876|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1500||1500|2876 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|23062|30580|lyfsjukr|||00|5|0|5|Icepharma hf|Roche as|||23062||23062|30580 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|4895|7483|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4895||4895|7483 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2860|4722|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2860||2860|4722 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3072|5009|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||3072||3072|5009 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|4482|6923|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||4482||4482|6923 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|4647|7147|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|||4647||4647|7147 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|8534|12421|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|||8534||8534|12421 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1310|2618|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1310||1310|2618 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|V0125|14411|10|30|0|2|Icepharma hf|NordMedica A/S|||10000||10000|14411 170845|A07AA0901|Vancocin|hylki|250|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988|31.12.2008|R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|||lyfalmen|||10|30|0|4|Icepharma hf|NordMedica A/S|||20000||| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2881|4750|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||2881||2881|4750 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3104|5053|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3104||3104|5053 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|732|1834|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||732||732|1834 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3517|5613|lyfalmen|V0709|5613|00|60|0|5|Vistor hf|Janssen-Cilag AB|||3517||3517|5613 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5790|8698|lyfalmen|V0710|8698|00|60|0|10|Vistor hf|Janssen-Cilag AB|||5790||5790|8698 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|43025|55434|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|||43025||43025|55434 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|36960|47883|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|||36960||36960|47883 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|10455|15028|lyfalmen|V0711|14745|00|60|0|20|Vistor hf|Janssen-Cilag AB|||10455||10455|15028 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|21443|28882|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|||21443||21443|28882 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|64236|81841|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|||64236||64236|81841 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|2497|4229|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2497||2497|4229 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|11709|16730|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|||11709||11709|16730 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6316|9412|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |||6316||6316|9412 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|12055|17193|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |||12055||12055|17193 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|20050|27147|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |||20050||20050|27147 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2180|3799|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2180||2180|3799 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2180|3799|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2180||2180|3799 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3105|5054|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||3105||3105|5054 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|798|1923|lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB|||798||798|1923 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|23017|30841|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |||23017||23017|30841 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|744|1850|lyfalmen|V0901|1831|00|50|0|50|Icepharma hf|Valeant Pharmaceuticals B.V.|||744||744|1850 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2269|3920|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2269||2269|3920 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS||||||3288 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|4843|7413|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||4843||4843|7413 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|870|2021|lyfalmen|||00|10|0|10|Vistor hf|Meda AS|||870||870|2021 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|278|1218|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|||278||278|1218 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Parlogis hf|Parlogis - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Parlogis hf|Parlogis - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1309|1874|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|||1309||1309|1874 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|531|1561|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|||531||531|1561 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|543|1577|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|||543||543|1577 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|205|1119|lyfalmen|V0886|1119|00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||205||205|1119 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2227|3426|lyfalmen|V0507|3426|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1905||1905|3426 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|6604|4701|lyfalmen|V0809|4317|00|28|0|7|Icepharma hf|Eli Lilly Nederland -|||2845||2845|4701 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|3851|6066|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|||3851||3851|6066 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|673|1754|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|||673||673|1754 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A|||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|602|1188|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||602||602|1188 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|696|1785|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|||696||696|1785 177741|D07CB0102|Kenalog Comp med Mycostatin|smyrsli|0| |15|g|1|túpa||D07CB01|01.12.1972|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|1|100|DKK|533|1564|lyfalmen|||00|15|0|15|Vistor hf|Bristol-Myers Squibb|||533||533|1564 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|557|1596|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|||557||557|1596 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10016|14337|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|||10016||10016|14337 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|5472|8266|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|||5472||5472|8266 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|14586|20345|lyfalmen|||00|98|0|98|Vistor hf|Bristol-Myers Squibb|||14586||14586|20345 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|828|1964|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||828||828|1964 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|702|1793|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|||702||702|1793 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||23|50|0|5|Vistor hf|Bayer A/S|||||| 181396|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|glas||M01AE01|01.01.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||345||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|7085|13667|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||7085||7085|13667 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|SEK|29518|38617|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|||29518||29518|38617 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|SEK|40232|51956|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|||40232||40232|51956 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|SPA|0|0|0|100|DKK|4641|9012|vetalmen|||16|100|0|0|Vistor hf|Schering-Plough A/S|||4641||4641|9012 183293|D08AG0201|Betadine|smyrsli|100|mg/g|40|g|1|túpa||D08AG02|01.07.1988|31.12.2008|L|A|3|0|0|0|0|NAP|0|0|0|100|CHF|||lyflausa|||00|40|0|40|Icepharma hf|Napp|||||| 183319|D08AG0201|Betadine|smyrsli|100|mg/g|80|g|1|túpa||D08AG02|01.07.1988|31.12.2008|L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|80|0|80|Icepharma hf|Napp||||||0 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5129|9941|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||5129||5129|9941 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1131|2375|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||1131||1131|2375 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|788|1910|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|||788||788|1910 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1455|2815|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|||1455||1455|2815 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|3996|6263|lyfalmen|||98|700|0|5|Icepharma hf|Schering Oy|||3996||3996|6263 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|22179|29798|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||22179||22179|29798 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|58587|75126|lyfalmen|V0563|75126|00|100|0|100|Vistor hf|Novartis Healthcare A/S-|||||58587|75126 184309|R03DA0404|Theo-Dur|forðatfl|200|mg|100|stk|1|glas||R03DA04|01.11.1981|31.01.2009|R|A|3|0|0|B|0|BIP|0|0|0|100|SEK|1527|2913|lyfalmen|||10|100|0|50|Vistor hf|BioPhausia AB|||1527||1527|2913 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4382|6787|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|||4382||4382|6787 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A|3|0|0|B|0|MNA|0|1|0|100|SEK|941|2117|lyfalmen|V1140|2117|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|||941||941|2117 186742|R03DA0404|Theo-Dur|forðatfl|300|mg|100|stk|1|glas||R03DA04|01.11.1981|31.01.2009|R|A|3|0|0|B|0|BIP|0|0|0|100|SEK|2166|3780|lyfalmen|||10|100|0|75|Vistor hf|BioPhausia AB|||2166||2166|3780 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|3601|5727|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||3601||3601|5727 188532|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|50|sk|1|stauk||R03BA02|01.10.1993|31.12.2008|R|A|2|0|0|0|1|AZD|0|0|0|100|IKR|2824|4043|lyfsjukr|||23|50|0|25|Vistor hf|AstraZeneca A/S DK|||2824||2824|4043 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2788|4624|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|||2788||2788|4624 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|1936|3468|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|||1936||1936|3468 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|45835|54685|lyfalmen|V0561|50450|00|30|0|90|Vistor hf|AstraZeneca UK Ltd|||42169||42169|54685 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|9903|14179|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|||9903||9903|14179 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2890|4762|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2890||2890|4762 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1236|2518|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1236||1236|2518 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|647|1718|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||647||647|1718 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|767|1881|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|||767||767|1881 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|416|1405|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|||416||416|1405 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1687|3130|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|||1687||1687|3130 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4253|6089|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4253||4253|6089 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4338|6211|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4338||4338|6211 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|5601|8019|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||5601||5601|8019 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|5|Vistor hf|AstraZeneca A/S DK|||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|472|1481|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||472||472|1481 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1529|2915|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|||1529||1529|2915 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|426|1418|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|||426||426|1418 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|641|1710|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|||641||641|1710 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S||||||2085 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1071|2294|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|||1071||1071|2294 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|SEK|1160|1661|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|||1160||1160|1661 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1956|3495|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|||1956||1956|3495 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|471|1480|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|||471||471|1480 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||639||639|1708 194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|41191|53150|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Healthcare A/S-|||41191||41191|53150 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1676|3115|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer HealthCare AG|||1676||1676|3115 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|3635|5773|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer HealthCare AG|||3635||3635|5773 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|3560|5671|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer HealthCare AG|||3560||3560|5671 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|6905|10211|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer HealthCare AG|||6905||6905|10211 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3003|4916|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|||3003||3003|4916 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|748|1855|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|||748||748|1855 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|819|1952|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|||819||819|1952 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|20639|27881|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|||20639||20639|27881 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|632|1698|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|||632||632|1698 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|305|1254|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|||305||305|1254 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|721|1819|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|||721||721|1819 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1149|2400|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||1149||1149|2400 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2432|4799|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2432||2432|4799 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|11579|22227|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||11579||11579|22227 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS||||||5646 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|724|1823|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|||724||724|1823 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|V0705|5347|00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|810|1940|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||810||810|1940 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3836|6046|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3836||3836|6046 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2246|3888|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||2246||2246|3888 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1516|lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf|||498||498|1516 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1508|2887|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1508||1508|2887 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|9658|13828|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9658||9658|13828 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|395|566|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|||395||395|566 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|35251|46072|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||35251||35251|46072 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||17114||17114|23174 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|838|1978|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||838||838|1978 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7289|10732|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7289||7289|10732 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|53578|68572|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|||53578||53578|68572 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4982|7601|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||4982||4982|7601 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|3959|6213|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||3959||3959|6213 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|542|776|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|||542||542|776 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|16625|22566|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|||16625||16625|22566 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|544|779|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|||544||544|779 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S|||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S|||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S||||||7835 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5|Actavis Group hf|Actavis hf|||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|2638|4420|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|||2638||2638|4420 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|7397|10878|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|||7397||7397|10878 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3912|6149|lyfalmen|||00|100|0|17|Icepharma hf|Roche|||3912||3912|6149 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Vistor hf|McNeil Denmark ApS|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Vistor hf|McNeil Denmark ApS|||||| 372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|17769|24307|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|||17769||17769|24307 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|8819|12808|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||8819||8819|12808 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|113747|143483|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||113747||113747|143483 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|227127|284641|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||227127||227127|284641 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|522485|652361|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||522485||522485|652361 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2372|4059|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|||2372||2372|4059 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|23385|31299|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|||23385||23385|31299 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|3823|6028|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3823||3823|6028 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|5972|8945|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||5972|8945 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|7815|11446|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||7815|11446 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2767|4595|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2767||2767|4595 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|743|1849|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|||743||743|1849 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|4696|7213|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|||4696||4696|7213 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|10041|14467|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10041||10041|14467 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|2|Vistor hf|Janssen-Cilag AB|||||| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|17715|24240|lyfalmen|V0560|19803|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|||17715||17715|24240 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2380|4070|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|||2380||2380|4070 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6838|10120|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|||6838||6838|10120 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7604|11159|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|||7604||7604|11159 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|10365|14906|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|||10365||10365|14906 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4248|6605|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|||4248||4248|6605 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|34753|45452|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|||34753||34753|45452 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|9725|12115|lyfalmen|V0508|12115|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8308||8308|12115 379669|H01CB0202|Sandostatin Lar|sts|5|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|149165|187578|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|||149165||149165|187578 379677|H01CB0202|Sandostatin Lar|sts|10|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|166494|209153|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|||166494||166494|209153 379685|H01CB0202|Sandostatin Lar|sts|15|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|208980|262048|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|||208980||208980|262048 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1428|2778|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|||1428||1428|2778 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1765|3236|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|||1765||1765|3236 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|24913|32884|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|||24913||24913|32884 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|100032|126407|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|||100032||100032|126407 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5679|8547|lyfalmen|||17|15|0|38|Icepharma hf|Eli Lilly Nederland -|||5679||5679|8547 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5580|8413|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|||5580||5580|8413 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|14374|11210|lyfalmen|V0367|3035|00|98|0|261|Icepharma hf|M.S.D.|||7641||7641|11210 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5504|8310|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|||5504||5504|8310 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1620 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|7328|12681|vetorma|||00|20|0|0|Vistor hf|Bayer Animal Health GmbH|||7328||7328|12681 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Actavis Group hf|Actavis hf|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120|Actavis Group hf|Actavis hf|||||| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|48037|61991|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|||48037||48037|61991 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|693|1368|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||693||693|1368 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|212363|266259|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|||212363||212363|266259 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2917|4799|lyfalmen|V2002|4720|00|25|0|5|Vistor hf|AstraZeneca A/S DK|||2917||2917|4799 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3290|5305|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|||3290||3290|5305 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|6140|9173|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|||6140||6140|9173 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2251|3895|lyfalmen|V0388|3895|23|84|0|84|Vistor hf|BioPhausia AB|||2251||2251|3895 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2057|3632|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|||2057||2057|3632 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|849|1993|lyfalmen|V0408|1993|00|84|0|84|Vistor hf|BioPhausia AB|||849||849|1993 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|604|1660|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|||604||604|1660 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|291249|364473|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|||291249||291249|364473 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|920|2089|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|||920||920|2089 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|11324|16208|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|||11324||11324|16208 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2239|3879|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|||2239||2239|3879 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3208|5194|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|||3208||3208|5194 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7106|10484|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7106||7106|10484 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|2850|4708|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2850||2850|4708 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|13393|18859|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||13393||13393|18859 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2657|4446|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|||2657||2657|4446 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|4763|9244|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||4763||4763|9244 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|||||| 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|880|2035|lyfalmen|||00|30|0|30|Icepharma hf|Galderma Nordic AB|||880||880|2035 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|168753|211965|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|||168753||168753|211965 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|10195|14560|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|||10195||10195|14560 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|59102|75449|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|||59102||59102|75449 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|V0706|8873|00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|10274|14783|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10274||10274|14783 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1468|2833|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|||1468||1468|2833 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0|Actavis Group hf|Actavis hf|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5288|8016|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5288||5288|8016 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|344|1307|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||344||344|1307 400275|N05BA0402|Sobril|töflur|15|mg|250|stk|1|glas||N05BA04|01.01.1985|31.12.2008|R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2577|4337|lyfalmen|||00|250|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2577||2577|4337 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|560|1600|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||560||560|1600 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|244|1171|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||244||244|1171 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8|Vistor hf|McNeil Denmark ApS|||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|720|1817|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|||720||720|1817 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1153|2405|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||1153||1153|2405 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|620|1682|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Biologicals B.V.|||620||620|1682 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1511|2982|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1511||1511|2982 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|4880|9467|vetalmen|||27|20|0|0|Vistor hf|Schering-Plough A/S|||4880||4880|9467 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6648|9862|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|||6648||6648|9862 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1173|2432|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|||1173||1173|2432 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy||||||1668 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|94033|118939|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|||94033||94033|118939 404640|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996|28.02.2009|R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|||lyfalmen|||00|28|0|2|Actavis Group hf|Alpharma ApS|||12952||| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|595|852|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|||595||595|852 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1563|2961|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1563||1563|2961 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|19289|26200|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||19289||19289|26200 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|19581|26563|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|||19581||19581|26563 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|19581|26563|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||19581||19581|26563 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|19581|26563|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|||19581||19581|26563 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|19777|26807|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|||19777||19777|26807 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|59623|76416|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|||59623||59623|76416 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|64668|82697|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||64668||64668|82697 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|69713|88978|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|||69713||69713|88978 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|6608|9808|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|||6608||6608|9808 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|544|1579|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|||544||544|1579 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1795|3276|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||1795||1795|3276 407403|A01AB0402|Fungizone|sogtfl|10|mg|60|stk|1|þpakki||A01AB04|01.04.1993|31.12.2008|R|A|1,5|0|0|E|0|BRS|0|0|1|100|DKK|1214|2488|lyfalmen|||00|60|0|15|Vistor hf|Bristol-Myers Squibb|||1214||1214|2488 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|232|1155|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||232||232|1155 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|652|1725|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||652||652|1725 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1008|2208|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||1008||1008|2208 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|4625|7117|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||4625||4625|7117 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1008|2208|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||1008||1008|2208 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2754|4578|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||2754||2754|4578 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|4952|7560|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4952||4952|7560 409193|N02BE0101|Panodil|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.07.1975|31.12.2008|L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|20|0|3|Icepharma hf|GlaxoSmithKline CH A/S||||||0 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3657|5803|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||3657||3657|5803 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|3495|5583|lyfalmen|V0966|5490|23|200|0|100|Vistor hf|AstraZeneca A/S DK|||3495||3495|5583 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|11814|16873|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||11814||11814|16873 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|2882|4751|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||2882||2882|4751 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|10054|19323|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||10054||10054|19323 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1621|lyfalmen|V0290|1621|00|100|0|33|Actavis Group hf|Actavis hf|||575||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|9573|13831|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||9573||9573|13831 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1043|2256|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|||1043||1043|2256 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|611|1670|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|||611||611|1670 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|534|1565|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|||534||534|1565 411157|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.01.1990|31.01.2009|R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|||lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||1324||| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|6946|9945|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|||6946||6946|9945 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|22149|29443|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||22149||22149|29443 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1767|3238|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|||1767||1767|3238 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6929|10243|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6929||6929|10243 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|19864|26916|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|||19864||19864|26916 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3039|4351|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|||3039||3039|4351 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|9505|18277|vetalmen|||02|100|0|0|Vistor hf|Merial|||9505||9505|18277 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1771|3244|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1771||1771|3244 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1131|2375|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||1131||1131|2375 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|99490|125733|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|||99490||99490|125733 413369|S01AX1201|Noroxin|augndr|3|mg/ml|5|ml|1|glas||S01AX12|01.04.1992||R|A|3|0|0|E|0|LBO|0|0|1|100|XEU|615|1675|lyfalmen|||06|5|0|0|Laboratories THEA|Laboratories THEA|||615||615|1675 413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|31274|40804|lyfsjukr|||00|4|0|1|Vistor hf|Novartis Healthcare A/S-|||31274||31274|40804 413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|31274|40804|lyfsjukr|||00|2|0|1|Vistor hf|Novartis Healthcare A/S-|||31274||31274|40804 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|2026|3590|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2026||2026|3590 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4312|6692|lyfalmen|||00|90|0|54|Icepharma hf|Servier|||4312||4312|6692 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1378|2710|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|||1378||1378|2710 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki|+stjaka|G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1943|3477|lyfalmen|V0418|3424|05|15|0|15|Vistor hf|Novo-Nordisk|||1943||1943|3477 415687|V08BA0101|E-Z-HD|mixtduft|0| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988||R|A|4|0|0|0|1|EZE|0|0|0|100|USD|16440|22335|lyfsjukr|||08|288|0|0|Icepharma hf|E-Z-Em|||16440||16440|22335 415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|46222|59414|lyfsjukr|||00|384|0|0|Icepharma hf|E-Z-Em|||46222||46222|59414 415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|57779|73802|lyfsjukr|||00|480|0|0|Icepharma hf|E-Z-Em|||57779||57779|73802 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|3401|5456|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||3401||3401|5456 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|9072|8905|lyfalmen|V0198|8905|00|98|0|98|Icepharma hf|M.S.D.|||5943||5943|8905 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3849|6064|lyfalmen|||00|300|1|15|Parlogis hf|Parlogis - óskráð lyf|||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|2746|4567|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|||2746||2746|4567 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|23094|30937|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|||23094||23094|30937 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|968|2154|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|||968||968|2154 417030|A02AD0104|Balancid Novum|tuggutfl|0| |30|stk|1|þpakki||A02AD01|01.10.1992|31.01.2009|L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|30|0|3|Vistor hf|BioPhausia AB|||||| 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|502|991|vetalmen|||00|10|0|0|Vistor hf|Merial|||502||502|991 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|36252|47001|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||36252||36252|47001 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|3987|6251|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|||3987||3987|6251 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1653|3084|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||1653||1653|3084 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|8110|11846|lyfalmen|V0299|8657|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|||8110||8110|11846 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|1850|3651|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1850||1850|3651 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2401|4738|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2401||2401|4738 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3877|6102|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|||3877||3877|6102 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9156|13266|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|||9156||9156|13266 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|63429|80837|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|||63429||63429|80837 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|52634|67397|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|||52634||52634|67397 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|44462|57223|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|||44462||44462|57223 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|732|1834|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||732||732|1834 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|11450|16379|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11450||11450|16379 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|11470|16148|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11470||11470|16148 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4987|7608|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4987||4987|7608 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7241|10667|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7241||7241|10667 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|2202|3829|lyfalmen|V0144|3769|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||2202||2202|3829 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2934|4822|lyfalmen|||43|98|0|62|Vistor hf|AstraZeneca A/S DK|||2934||2934|4822 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5778|8681|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|||5778||5778|8681 422402|G03FB0505|Estracomb|forðapl|0| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2436|4146|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|||2436||2436|4146 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|7509|11030|lyfalmen|||49|100|0|50|Vistor hf|Meda AS|||7509||7509|11030 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||1924 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|839|1979|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||839||839|1979 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|26056|34625|lyfalmen|||52|100|0|25|Vistor hf|Meda AS|||26056||26056|34625 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3248|5248|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3248||3248|5248 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|531|1561|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|||531||531|1561 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|693|1781|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|||693||693|1781 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5|Vistor hf|McNeil Denmark ApS|||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10|Vistor hf|McNeil Denmark ApS|||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15|Vistor hf|McNeil Denmark ApS|||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International ||||||2541 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|944|2121|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|||944||944|2121 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|937|2112|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|||937||937|2112 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|27383|35959|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer HealthCare AG|||27383||27383|35959 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|42883|55257|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer HealthCare AG|||42883||42883|55257 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|477|1488|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|||477||477|1488 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|786|1907|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|||786||786|1907 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5278|8003|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||5278||5278|8003 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|39479|51336|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||39479||39479|51336 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|5444|8228|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5444||5444|8228 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1552|2222|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|||1552||1552|2222 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1852|2652|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|||1852||1852|2652 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|3634|7093|vetalmen|||27|100|0|0|Vistor hf|Schering-Plough A/S|||3634||3634|7093 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2413|4115|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2413||2413|4115 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|723|1822|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|||723||723|1822 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1074|2298|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|||1074||1074|2298 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|||||| 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|||785||785|1906 432336|J01GB0701|Netilyn|stl/irþ|10|mg/ml|1,5|ml|10|lykjur||J01GB07|01.01.1986|30.11.2008|R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|||lyfsjukr|||02|15|0|0|Vistor hf|Schering-Plough|||||| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|||952||952|2132 432971|J01DC0201|Cefuroxim Scand Pharm|sts|750|mg/hgl|750|mg|1|hgl||J01DC02|01.01.1996|31.12.2008|R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|230|329|lyfsjukr|||00|750|0|0|NM Pharma ehf|Generics|||230||230|329 432989|J01DC0201|Cefuroxim Scand Pharm|sts/irs|1,5|g/hgl|1,5|g|1|hgl||J01DC02|01.01.1996|31.12.2008|R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|459|657|lyfsjukr|||00|2|0|0|NM Pharma ehf|Generics|||459||459|657 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11742|16775|lyfalmen|V0729|16456|00|100|0|20|Vistor hf|Orion Corporation|||11742||11742|16775 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2355|4036|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2355||2355|4036 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4320|6703|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4320||4320|6703 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5777|8680|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5777||5777|8680 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|7232|10655|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7232||7232|10655 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8332|12147|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8332||8332|12147 433359|N02AA0106|Contalgin Uno|forðahlk|200|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|11250|16107|lyfalmen|||00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11250||11250|16107 433722|J01EE0104|Primazol sterkar|töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1500|lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf|||486||486|1500 433730|J01EE0104|Primazol sterkar|töflur|960|mg|20|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|929|2101|lyfalmen|||00|20|0|10|Actavis Group hf|Actavis hf|||929||929|2101 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1223 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1303|2609|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|||1303||1303|2609 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|6868|10161|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|||6868||6868|10161 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|6868|10161|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|||6868||6868|10161 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|10238|14734|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|||10238||10238|14734 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5283|8010|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|||5283||5283|8010 435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|2258|3905|lyfalmen|||00|3|0|3|Vistor hf|AstraZeneca UK Ltd|||2258||2258|3905 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4411|6826|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|||4411||4411|6826 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6519|8558|lyfalmen|V0725|7451|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|||5687||5687|8558 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2499|4232|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|||2499||2499|4232 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3534|5636|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||3534||3534|5636 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10128|14585|lyfalmen|V0191|11838|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||10128||10128|14585 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|5308|8044|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5308||5308|8044 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|893|2052|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||893||893|2052 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|||||| 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|5842|8768|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5842||5842|8768 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|10591|15213|lyfalmen|V0728|14909|00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10591||10591|15213 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|22514|30215|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||22514||22514|30215 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|704|1796|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|||704||704|1796 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1748|3212|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1748||1748|3212 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|700|1790|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|||700||700|1790 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2892|4765|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|||2892||2892|4765 436808|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3308|5329|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|||3308||3308|5329 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|814|1945|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|||814||814|1945 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|2854|4713|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|||2854||2854|4713 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|SEK|17481|23949|lyfalmen|V0955|17953|00|100|0|75|Icepharma hf|Wyeth AB|||17481||17481|23949 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|SEK|8893|12909|lyfalmen|||00|28|0|42|Icepharma hf|Wyeth AB|||||8893|12909 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|498|1516|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||498||498|1516 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1183|2446|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|||1183||1183|2446 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|SEK|4689|7204|lyfalmen|||00|28|0|21|Icepharma hf|Wyeth AB|||4689||4689|7204 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|SEK|16151|22293|lyfalmen|V0955|17594|00|98|0|74|Icepharma hf|Wyeth AB|||16151||16151|22293 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|SEK|30522|40185|lyfalmen|V0956|31548|00|98|0|147|Icepharma hf|Wyeth AB|||30522||30522|40185 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|SEK|33003|43274|lyfalmen|V0956|32192|00|100|0|150|Icepharma hf|Wyeth AB|||33003||33003|43274 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|1862|3367|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough|||1862||1862|3367 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|5623|8471|lyfalmen|V0984|3662|00|100|0|100|Vistor hf|Schering-Plough|||5623||5623|8471 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2013|3572|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2013||2013|3572 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9138|13241|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||9138||9138|13241 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1066||1066|2287 440123|S01BA0401|Ultracortenol|augndr|5|mg/ml|5|ml|1|glas||S01BA04|01.12.1972|31.01.2009|R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|774|1891|lyfalmen|||29|5|0|0|Vistor hf|Novartis Healthcare A/S-|||774||774|1891 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1406|2013|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|||1406||1406|2013 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2219|3177|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|||2219||2219|3177 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1374|2705|lyfalmen|V0221|2694|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1374||1374|2705 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1208|2480|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|||1208||1208|2480 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0|Aco Hud Nordic AB|ACO Hud AB|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|785|1906|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|||785||785|1906 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|26651|35048|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||26651||26651|35048 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3481|5564|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|||3481||3481|5564 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|30113|39676|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||30113||30113|39676 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|42847|55212|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|||42847||42847|55212 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|43459|55974|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|||43459||43459|55974 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|3076|5015|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|||3076||3076|5015 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2709|4517|lyfalmen|||00|100|0|8|Icepharma hf|Roche|||2709||2709|4517 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|17237|23328|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||17237||17237|23328 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1710|3161|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|||1710||1710|3161 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|11636|5449|lyfalmen|V0411|5126|10|98|0|98|Icepharma hf|M.S.D.|||3396||3396|5449 445965|H01AC0104|Saizen|sts|0| |1,33|mg|1|hgl|+ leysir|H01AC01|01.07.1992|31.12.2008|R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|5733|8208|lyfsjukr|||02|1|0|2|Gróco ehf|Serono Nordic|||5733||5733|8208 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1373|2709|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1373||1373|2709 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3837|6047|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3837||3837|6047 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1635|3059|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1635||1635|3059 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10696|15355|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10696||10696|15355 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6102|9121|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6102||6102|9121 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7474|10983|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7474||7474|10983 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8975|13020|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8975||8975|13020 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|V0352|1798|00|100|0|25|Actavis Group hf|Actavis hf|||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|497|1515|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|||497||497|1515 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|971|2158|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|||971||971|2158 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6496|9656|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||6496||6496|9656 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2238|3877|lyfalmen|V0712|2431|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|||2238||2238|3877 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|747|1854|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|||||747|1854 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991|28.02.2009|R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|98|0|131|Actavis Group PTC ehf|Merck NM AB|||1224||| 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5263|7535|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|||5263||5263|7535 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2233|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1024|1651|lyfalmen|V0902|1522|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|||597||597|1651 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3230|4575|lyfalmen|V0903|4040|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||2752||2752|4575 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|5434|7476|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|||4890||4890|7476 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|18026|23833|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|||17388||17388|23833 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|15750|21794|lyfalmen|V0552|10534|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15750||15750|21794 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1103|2337|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|||1103||1103|2337 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|52749|67857|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||52749||52749|67857 452482|V07AB09|Sterilt Vatten Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|12164|17329|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|||12164||12164|17329 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||L|A|3|0|0|0|0|LCF|0|0|0|100|IKR|||lyflausa|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.|||||| 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2427|4134|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |||2427||2427|4134 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7986|11678|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |||7986||7986|11678 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2306|3970|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2306||2306|3970 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4583|7060|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |||4583||4583|7060 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2425 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|14509|20249|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |||14509||14509|20249 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9232|13369|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |||9232||9232|13369 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24910|33198|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|||24910||24910|33198 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|3428|4908|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3428||3428|4908 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2184|3804|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2184||2184|3804 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|9652|7752|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|||5093||5093|7752 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14595|20356|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14595||14595|20356 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|45124|58364|lyfalmen|V0375|58364|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||45124||45124|58364 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16467|22686|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16467||16467|22686 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|48823|62970|lyfalmen|V0376|62970|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||48823||48823|62970 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|46711|60023|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||46711||46711|60023 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1039|2050|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1039||1039|2050 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|801|1927|lyfalmen|||00|30|0|5|Vistor hf|Bayer HealthCare AG|||801||801|1927 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|2878|4746|lyfalmen|||00|120|0|20|Vistor hf|Bayer HealthCare AG|||2878||2878|4746 455428|B03XA0103|NeoRecormon|sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|60737|77485|lyfsjukr|||00|3|0|30|Icepharma hf|Roche|||60737||60737|77485 455527|B03XA0103|NeoRecormon|sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|120763|152217|lyfsjukr|||00|3|0|60|Icepharma hf|Roche|||120763||120763|152217 455576|B03XA0103|NeoRecormon|sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|197593|247871|lyfsjukr|||00|5|0|10|Icepharma hf|Roche|||197593||197593|247871 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|20825|28112|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|||20825||20825|28112 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Icepharma hf|Doetsch Grether|||||| 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|Doetsch Grether|||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|948|2127|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group hf|||948||948|2127 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1034|2244|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis Group hf|||1034||1034|2244 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2265|3914|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis Group hf|||2265||2265|3914 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3849|5511|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||3849||3849|5511 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|3849|5511|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||3849||3849|5511 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4202|6016|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4202||4202|6016 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4202|6016|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4202||4202|6016 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|6291|9007|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||6291||6291|9007 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|6291|9007|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||6291||6291|9007 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|6291|9007|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||6291||6291|9007 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7875|11275|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7875||7875|11275 457127|N05BA1202|Paxal|töflur|0,25|mg|20|stk|1|glas||N05BA12|01.04.1990|28.02.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|||117||| 457135|N05BA1202|Paxal|töflur|0,25|mg|50|stk|1|glas||N05BA12|01.04.1990|31.01.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|50|0|12|Actavis Group hf|Actavis hf|||246||| 457143|N05BA1202|Paxal|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.04.1990|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf|||461||| 457150|N05BA1202|Paxal|töflur|0,5|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|199|1110|lyfalmen|V0856|1110|00|20|0|10|Actavis Group hf|Actavis hf|||199||199|1110 457192|N05BA1202|Paxal|töflur|0,5|mg|50|stk|1|glas||N05BA12|01.04.1990|28.02.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|50|0|25|Actavis Group hf|Actavis hf|||440||| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7677|10992|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7677||7677|10992 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10206|14574|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10206||10206|14574 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|924|2094|lyfalmen|||00|25|0|5|Vistor hf|Astra|||924||924|2094 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1520|2903|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|||1520||1520|2903 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2280|3934|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|||2280||2280|3934 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8297|12100|lyfalmen|V0456|12100|00|100|0|33|Vistor hf|LEO Pharma A/S|||8297||8297|12100 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10287|14675|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10287||10287|14675 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10287|14675|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10287||10287|14675 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10287|14675|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10287||10287|14675 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|12239|17105|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||12239||12239|17105 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1351|1934|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1351||1351|1934 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|81114|102854|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||81114||81114|102854 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1657|2372|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1657||1657|2372 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1920|3446|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|||1920||1920|3446 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2105|3697|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|||2105||2105|3697 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2100|3690|lyfalmen|||00|30|0|8|Vistor hf|Meda AS|||2100||2100|3690 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4271|6636|lyfalmen|||00|60|0|15|Vistor hf|Meda AS|||4271||4271|6636 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|956|2138|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|||956||956|2138 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4033|6313|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||4033||4033|6313 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1430|2781|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|||1430||1430|2781 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2601|4370|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|||2601||2601|4370 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|17197|23278|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|||17197||17197|23278 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120|Vistor hf|Janssen-Cilag AB|||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|5770|8671|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Biologicals B.V.|||5770||5770|8671 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|68783|87502|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|||68783||68783|87502 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|84091|106561|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|||84091||84091|106561 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|181501|227836|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|||181501||181501|227836 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|585|1634|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||585||585|1634 462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2302|3964|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2302||2302|3964 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|585|1634|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||585||585|1634 462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2302|3964|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2302||2302|3964 462143|B05AA0703|Hemohes 10%|irl|100|mg/ml|500|ml|10|fl||B05AA07|01.11.1999|28.02.2009|R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|||lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|||||| 462226|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|10|fl||B05AA07|01.11.1999|28.02.2009|R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|||lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|||||| 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6758|10011|lyfalmen|V0297|9827|56|7|0|7|Vistor hf|AstraZeneca A/S DK|||6758||6758|10011 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|6368|12301|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||6368||6368|12301 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5080|9848|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5080||5080|9848 463778|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|glas||M01AE01|01.01.1989|31.12.2008|L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|||||| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1681|3122|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Ovation Healthcare International Ltd.|||1681||1681|3122 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|S|3|0|0|0|0|INI|0|0|0|100|DKK|1128|2226|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1128||1128|2226 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1066|2104|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1066||1066|2104 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1142|2254|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1142||1142|2254 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|602|1188|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||602||602|1188 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|713|1808|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||713||713|1808 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2501|4234|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2501||2501|4234 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1516|2898|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1516||1516|2898 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6085|9098|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6085||6085|9098 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2915|4796|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2915||2915|4796 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8134|11879|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|||8134||8134|11879 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4666|7172|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4666||4666|7172 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4684|7197|lyfalmen|||64|100|0|50|Vistor hf|Meda AS|||4684||4684|7197 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|15070|20630|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|||15070||15070|20630 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|23618|31272|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|||23618||23618|31272 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|25573|33706|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|||25573||25573|33706 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|41654|53727|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|||41654||41654|53727 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|SEK|36864|48081|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|||36864||36864|48081 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|15769|21817|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|||15769||15769|21817 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|85266|108024|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|||85266||85266|108024 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|29847|39344|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|||29847||29847|39344 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|658|942|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|||658||658|942 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6087|6194|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||3945||3945|6194 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|383|548|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|||383||383|548 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|10620|5899|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||3728||3728|5899 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|22394|11957|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|||8192||8192|11957 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|9654|13941|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9654||9654|13941 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2757|4582|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|||2757||2757|4582 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|11236|16088|lyfalmen|V0738|12740|00|100|0|67|Icepharma hf|Grunenthal|||11236||11236|16088 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2155|3765|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|||2155||2155|3765 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|8532|12419|lyfalmen|V0736|8592|00|100|0|50|Icepharma hf|Grunenthal|||8532||8532|12419 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1465|2828|lyfalmen|V0733|2345|00|20|0|7|Icepharma hf|Grunenthal|||1465||1465|2828 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|5828|8749|lyfalmen|V0734|6730|00|100|0|33|Icepharma hf|Grunenthal|||5828||5828|8749 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4725|7252|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4725||4725|7252 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|||6223||6223|8910 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||7625||7625|10917 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||9018||9018|12912 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||9600||9600|13745 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1891|3407|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1891||1891|3407 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2220 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2021|3583|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|||2021||2021|3583 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|4522|8785|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||4522||4522|8785 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1945|3480|lyfalmen|V2003|3427|43|98|0|31|Vistor hf|AstraZeneca A/S DK|||1945||1945|3480 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2188|3810|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2188||2188|3810 473348|A03AA0402|Spasmerin|töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|957|2139|lyfalmen|||00|50|0|22|Actavis Group hf|Actavis hf|||957||957|2139 473371|A03AA0402|Spasmerin|töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1680|3120|lyfalmen|||00|100|0|45|Actavis Group hf|Actavis hf|||1680||1680|3120 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|12199|17055|lyfsjukr|||00|400|0|0|Vistor haf|Meda AB|||12199||12199|17055 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|875|2028|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|||875||875|2028 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|39573|51136|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |||39573||39573|51136 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1832|3326|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|||1832||1832|3326 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|1|Actavis Group hf|Actavis Group hf|||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3560|5671|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|||3560||3560|5671 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|196|1106|lyfalmen|V0775|1106|00|20|0|7|Actavis Group hf|Actavis hf|||196||196|1106 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|272|1209|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||272||272|1209 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|762|1874|lyfalmen|V0780|1874|00|100|0|33|Actavis Group hf|Actavis hf|||762||762|1874 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|5924|8880|lyfalmen|||00|98|0|98|Icepharma hf|Roche|||5924||5924|8880 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2910|4789|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|||2910||2910|4789 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3893|6123|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|||3893||3893|6123 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|11360|16256|lyfalmen|||00|98|0|196|Icepharma hf|Roche|||11360||11360|16256 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5583|8417|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|||5583||5583|8417 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|4500|6947|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|||4500||4500|6947 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1010|2211|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1010||1010|2211 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|5937|8897|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|||5937||5937|8897 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|9022|13084|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|||9022||9022|13084 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|3964|6220|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3964||3964|6220 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|8711|12662|lyfalmen|||00|98|0|131|Vistor hf|Meda AS|||8711||8711|12662 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|18689|25453|lyfalmen|||00|98|0|261|Vistor hf|Meda AS|||18689||18689|25453 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|IKR|3183|5160|lyfalmen|||00|28|0|28|Icepharma hf|Daiichi Sankyo Europe GmbH|||3183||3183|5160 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|IKR|9486|13713|lyfalmen|||00|84|0|84|Icepharma hf|Daiichi Sankyo Europe GmbH|||||9486|13713 481168|N06AX1201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|6638|9848|lyfalmen|||00|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||6638|9848 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|10244|14742|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10244||10244|14742 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|37647|48738|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||37647||37647|48738 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|58956|75585|lyfalmen|V0557|33109|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||58956||58956|75585 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3418|4894|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3418||3418|4894 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5180|7416|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5180||5180|7416 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|78162|99179|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|||78162||78162|99179 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|6355|9464|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||6355||6355|9464 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1149|2400|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|||1149||1149|2400 484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004||R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||543||543|777 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|655|1729|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|||655||655|1729 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|645|1716|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|||645||645|1716 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2364|4048|lyfalmen|||00|30|0|15|Icepharma hf|Servier|||2364||2364|4048 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|3450|5522|lyfalmen|||00|30|0|30|Icepharma hf|Servier|||3450||3450|5522 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|697|1786|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|||697||697|1786 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis Group hf|||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|749|1857|lyfalmen|||00|20|0|10|Vistor haf|Meda AB|||749||749|1857 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2232|3869|lyfalmen|||00|60|0|30|Vistor haf|Meda AB|||2232||2232|3869 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis Group hf|||||| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|9247|13389|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|||9247||9247|13389 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|16692|22967|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|||16692||16692|22967 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|960|1474|lyfalmen|V0609|1436|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2097|3686|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|||2097||2097|3686 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2458|4176|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|||2458||2458|4176 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|8147|11896|lyfalmen|||00|5|0|2|Icepharma hf|Roche as|||8147||8147|11896 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4482|6923|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4482||4482|6923 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10282|9888|lyfalmen|V0337|6756|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6667||6667|9888 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|6956|10280|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6956||6956|10280 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|14591|13434|lyfalmen|V0338|9234|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9280||9280|13434 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10797|15492|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10797||10797|15492 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|18558|16727|lyfalmen|V0339|11516|00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11707||11707|16727 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|20935|28249|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|||20935||20935|28249 491753|C10AC0102|Questran Loc|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1992|31.12.2008|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|2922|4806|lyfalmen|||00|50|0|14|Vistor hf|Bristol-Myers Squibb|||2922||2922|4806 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|45970|59100|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|||45970||45970|59100 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3223|5214|lyfalmen|||10|100|0|17|Icepharma hf|Roche|||3223||3223|5214 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7069|10433|lyfalmen|V1800|9735|00|100|0|50|Vistor hf|AstraZeneca A/S DK|||7069||7069|10433 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1233|2514|lyfalmen|V1140|2352|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||1233||1233|2514 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4068|6361|lyfalmen|||00|28|0|28|Vistor hf|Bristol-Myers Squibb|||4068||4068|6361 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1395|2733|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|||1395||1395|2733 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3730|5902|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|||3730||3730|5902 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|82978|105175|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|||82978||82978|105175 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|207446|260138|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|||207446||207446|260138 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2154|3763|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2154||2154|3763 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2457|4175|lyfalmen|V0408|1993|23|84|0|84|Vistor hf|Novo-Nordisk|||2457||2457|4175 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3117|5070|lyfalmen|V0388|3895|23|84|0|84|Vistor hf|Novo-Nordisk|||3117||3117|5070 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3002|4914|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |||3002||3002|4914 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||| 495267|A04AA0101|Zofran|töflur|4|mg|100|stk|1|glas||A04AA01|01.01.1991|31.12.2008|R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|95283|120812|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||95283||95283|120812 495275|A04AA0101|Zofran|töflur|8|mg|100|stk|1|glas||A04AA01|01.01.1991|31.12.2008|R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|134227|169298|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||134227||134227|169298 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|16267|22437|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||16267||16267|22437 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6327|9426|lyfalmen|V1088|7729|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6327||6327|9426 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|9039|13107|lyfalmen|V1089|12111|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9039||9039|13107 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|16299|22477|lyfalmen|||00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16299||16299|22477 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|27475|36391|lyfalmen|||00|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||27475||27475|36391 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2482|4209|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2482||2482|4209 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4013|7815|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||4013|7815 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3585|5705|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3585||3585|5705 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|905|2069|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||905||905|2069 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|2840|4694|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2840||2840|4694 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|530|1560|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||530||530|1560 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|805|1933|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||805||805|1933 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3065|5000|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3065||3065|5000 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|00|100|0|50|Actavis Group hf|Actavis hf|||802||802|1929 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|00|100|0|200|Actavis Group hf|Actavis hf|||2725||2725|4538 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|693|1781|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|||693||693|1781 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1292|2594|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|||1292||1292|2594 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|17389|23834|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17389||17389|23834 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|18746|25524|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18746||18746|25524 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|25366|33766|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||25366||25366|33766 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|29149|38475|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||29149||29149|38475 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|693|1781|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|||693||693|1781 500751|M01AB0101|Confortid|hylki|50|mg|30|stk|1|plglas||M01AB01|01.01.1977|31.12.2008|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1068|2290|lyfalmen|||10|30|0|15|Actavis Group hf|Actavis Group hf|||1068||1068|2290 500769|M01AB0101|Confortid|hylki|50|mg|100|stk|1|glas||M01AB01|01.01.1977|31.12.2008|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis Group hf||2323|2323|2323|| 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3364|5405|lyfalmen|||10|100|0|17|Icepharma hf|Roche|||3364||3364|5405 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2001|3556|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2001||2001|3556 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|2833|4685|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|||2833||2833|4685 502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|4128|6442|lyfalmen|||00|100|0|53|Vistor hf|Schering-Plough|||4128||4128|6442 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|29325|38377|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|||29325||29325|38377 503722|A01AC0102|Kenalog|munnh.pa|1|mg/g|10|g|1|túpa||A01AC01|01.05.1998|31.12.2008|R|A|5|0|0|E|0|BRS|0|0|1|100|DKK|1267|2558|lyfalmen|||20|10|0|0|Vistor hf|Bristol-Myers Squibb|||1267||1266|2558 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|1945|3480|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|||1945||1945|3480 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2109|3702|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|||2109||2109|3702 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1229|2508|lyfalmen|||10|50|0|50|Vistor hf|Schering-Plough|||1229||1229|2508 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007||R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|573|1618|lyfalmen|||00|50|0|0|Vistor hf|Schering-Plough|||573||573|1618 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1213|2486|lyfalmen|||00|100|0|30|Icepharma hf|Roche|||1213||1213|2486 505644|A01AA0104|Fluorette|tyggigúm|0,25|mg|90|stk|1|stk||A01AA01|01.01.1996|31.12.2008|L|A|1,5|0|0|0|0|FET|0|0|1|100|DKK|||lyfalmen|||00|90|0|20|Icepharma hf|Fertin A/S||||||0 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|7795|11419|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|||7795||7795|11419 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3138|4493|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3138||3138|4493 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|6108|8745|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6108||6108|8745 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|10838|15361|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10838||10838|15361 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|2966|4247|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|||2966||2966|4247 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|27503|36109|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|||27503||27503|36109 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2326|3997|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2326||2326|3997 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12|Vistor hf|Orion Pharma|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|380|1356|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|||380||380|1356 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1083 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||4602 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|8630|14935|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||8630||8630|14935 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|2387|4710|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||2387||2387|4710 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|5070|7721|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|||5070||5070|7721 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4852|9414|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||||4852|9414 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|3891|7583|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||3891||3891|7583 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|12038|23102|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||12038||12038|23102 508952|G03FB0902|Nuvelle|töflur|0| |84|stk|1|þpakki||G03FB09|01.08.1997||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2869|4734|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||2869||2869|4734 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|9476|13700|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|||9476||9476|13700 509091|J01CF0101|Diclocil|hylki|500|mg|100|stk|1|þpakki||J01CF01|01.09.1977|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|10473|15051|lyfalmen|||10|100|0|25|Vistor hf|Bristol-Myers Squibb|||10473||10472|15051 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon||||||2575 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|390|1370|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||390||390|1370 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|440|1437|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||440||440|1437 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|322|1277|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||322||322|1277 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|390|1370|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||390||390|1370 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|42072|54247|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||42072||42072|54247 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|12477|17401|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|||12477||12477|17401 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|24955|32936|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|||24955||24955|32936 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|36430|47223|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|||36430||36430|47223 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|61534|78477|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|||61534||61534|78477 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|102110|128994|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|||102110||102110|128994 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|233357|292397|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|||233357||233357|292397 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|3958|5126|lyfalmen|V0411|5126|00|98|0|98|Actavis Group hf|Actavis hf|||3158||3158|5126 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|2707|4514|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |||2707||2707|4514 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2556|4309|lyfalmen|V0385|4224|23|84|0|84|Vistor hf|Novo-Nordisk|||2556||2556|4309 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|18352|24716|lyfsjukr|||00|6000|0|6|Vistor haf|Meda AB|||18352||18352|24716 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|11480|16160|lyfsjukr|||00|6000|0|6|Vistor haf|Meda AB|||11480||11480|16160 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9028|12926|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||9028||9028|12926 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0|Vistor hf|AstraZeneca A/S DK|||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1723|3179|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|||1723||1723|3179 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|1993|3545|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1993||1993|3545 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|4781|7328|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4781||4781|7328 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|1374|2705|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|||1374||1374|2705 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3743|5920|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|||3743||3743|5920 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4393|6802|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|||4393||4393|6802 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|5403|8173|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|||5403||5403|8173 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|871|2022|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|||871||871|2022 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|4142|6461|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|||4142||4142|6461 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1979|3526|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|||1979||1979|3526 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|869|2020|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|||869||869|2020 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|7855|11500|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|||7855||7855|11500 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|4570|7042|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4570||4570|7042 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5160|7843|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5160||5160|7843 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|15649|21668|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15649||15649|21668 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5538|8356|lyfalmen|||00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5538||5538|8356 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|16570|22815|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16570||16570|22815 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1623|3043|lyfalmen|V0308|3043|00|100|0|100|Actavis Group hf|Actavis hf|||1623||1623|3043 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2644|4428|lyfalmen|V0310|4428|00|100|0|200|Actavis Group hf|Actavis hf|||2644||2644|4428 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|351|1317|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|||351||351|1317 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|32070|42112|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|||32070||32070|42112 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|7584|14618|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||7584||7584|14618 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3,5|0|0|0|0|SPM|0|0|0|100|XEU|3157|5125|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3157||3157|5125 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|252190|315844|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|||252190||252190|315844 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|383|1360|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|||383||383|1360 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1583|2989|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|||1583||1583|2989 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|9243|13384|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|||9243||9243|13384 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|817|1949|lyfalmen|V0732|1949|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|||817||817|1949 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|8437|12290|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|||8437||8437|12290 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|348|1313|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|||348||348|1313 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann||||||1253 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1062|2282|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||1062||1062|2282 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|22654|30389|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|||22654||22654|30389 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|882|2037|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|||882||882|2037 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2210|3839|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|||2210||2210|3839 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf||||||1112 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf||||||1093 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|962|2146|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|||962||962|2146 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|959|2142|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|||959||959|2142 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|10455|15028|lyfalmen|||00|30|0|10|Vistor hf|Cephalon France (V)|||10455||10455|15028 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vatten Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|6923|10235|lyfalmen|||00|100|0|33|Icepharma hf|Roche|||6923||6923|10235 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4367|6767|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|||4367||4367|6767 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|SPA|0|0|0|100|DKK|6325|12219|vetalmen|||16|188|0|0|Vistor hf|Schering-Plough A/S|||6325||6325|12219 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3874|6098|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|||3874||3874|6098 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|12756|17749|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|||12756||12756|17749 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1194|2461|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1194||1194|2461 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|1820|2606|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|||1820||1820|2606 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4059|7903|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4059||4059|7903 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3496|6831|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||3496||3496|6831 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|4655|6665|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|||4655||4655|6665 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|75860|96313|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||75860||75860|96313 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|9172|13132|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|||9172||9172|13132 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|24872|32833|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|||24872||24872|32833 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|49745|63800|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|||49745||49745|63800 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3276|5286|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|||3276||3276|5286 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2346|4024|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|||2346||2346|4024 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|8598|12310|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |||8598||8598|12310 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|298|1245|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|||298||298|1245 532739|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Actavis Group hf|Braun|||||| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1584|2990|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|||1584||1584|2990 534537|J01EE0103|Primazol|töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1486|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|||476||476|1486 534552|J01EE0103|Primazol|töflur|480|mg|100|stk|1|glas|80+400 mg|J01EE01|01.10.1995|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf||2062|2062|2062|| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|Bioglan Pharma AB|||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5372|8130|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|||5372||5372|8130 536029|S01EB0105|Isopto Carpine|augndr|10|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|347|1311|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||347||347|1311 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|421|1412|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||421||421|1412 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|537|1569|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||537||537|1569 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|13512|19007|lyfalmen|||52|100|0|12|Vistor hf|Meda AS|||13512||13512|19007 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||595 537720|L01CB0101|Vepesid|hylki|100|mg|10|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13691|18913|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|||13691||13691|18913 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon||||||2188 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2|Icepharma hf|Bayer AB|||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|5|Icepharma hf|Bayer AB|||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|10|Icepharma hf|Bayer AB|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|118229|149063|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|||118229||118229|149063 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|9683|13981|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|||9683||9683|13981 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|166|1066|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|||166||166|1066 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|362|1332|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|||362||362|1332 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Janssen-Cilag AB|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2414|4116|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2414||2414|4116 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2645|4430|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|||2645||2645|4430 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|7415|10903|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|||7415||7415|10903 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1620|3039|lyfalmen|V0987|3028|23|200|0|50|Vistor hf|AstraZeneca A/S DK|||1620||1620|3039 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|9023|13085|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|||9023||9023|13085 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|14616|20382|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|||14616||14616|20382 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1420|2767|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|||1420||1420|2767 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4176|6507|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|||4176||4176|6507 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Actavis Group hf|Actavis hf|||||| 543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|SEK|24062|31825|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||24062||24062|31825 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|22|Vistor hf|Recip AB|||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|9|Vistor hf|AstraZeneca A/S DK|||||| 543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|SEK|47683|61233|lyfsjukr|||00|1|0|1|Icepharma hf|Wyeth Europe|||47683||47683|61233 543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|SEK|94722|119796|lyfsjukr|||00|1|0|2|Icepharma hf|Wyeth Europe|||94722||94722|119796 543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004||R|K|2|0|0|0|1|WTE|0|0|0|100|SEK|172221|216283|lyfsjukr|||00|1|0|4|Icepharma hf|Wyeth Europe|||172221||172221|216283 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|||||| 544049|C01DA1402|Monit-L|forðahlk|60|mg|100|stk|1|glas||C01DA14|01.10.1992|31.12.2008|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2489|4218|lyfalmen|||10|100|0|150|Actavis Group hf|Actavis hf|||2489||2489|4218 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|21878|29423|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|||21878||21878|29423 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|644|1714|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||644||644|1714 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1130|2374|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|||1130||1130|2374 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3002|4914|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||3002||3002|4914 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|28680|37892|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||28680||28680|37892 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|23123|30973|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||23123||23123|30973 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|28849|38102|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||28849||28849|38102 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|24509|32699|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||24509||24509|32699 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5|Actavis Group hf|Actavis hf|||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6004|8988|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||6004||6004|8988 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyflausa|||23|60|0|15|Vistor hf|Orion Corporation|||||| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|8984|12863|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||8984||8984|12863 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|2961|4239|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||2961||2961|4239 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|8134|11879|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|||8134||8134|11879 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|50572|65147|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|||50572||50572|65147 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4178|6510|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|||4178||4178|6510 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|20335|27502|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|||20335||20335|27502 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|16313|22495|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|||16313||16313|22495 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|16313|22495|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|||16313||16313|22495 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|1992|2852|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|||1992||1992|2852 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5027|7662|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||5027||5027|7662 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|13723|19270|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||13723||13723|19270 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|35176|45979|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||35176||35176|45979 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|98438|124423|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|||98438||98438|124423 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|7464|10969|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|||7464||7464|10969 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|141139|177586|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|||141139||141139|177586 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1876|3386|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1876||1876|3386 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S|||||| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S|||||| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S|||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|8632|12554|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|||8632||8632|12554 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1438|2792|lyfalmen|||03|1|0|3|Vistor haf|Meda AB|||1438||1438|2792 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3280|5291|lyfalmen|||00|100|0|50|Vistor haf|Meda AB|||3280||3280|5291 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2417|4120|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|||2417||2417|4120 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|3931|6175|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||3931||3931|6175 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2140|3744|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|||2140||2140|3744 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|3740|5916|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|||3740||3740|5916 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|7485|10998|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|||7485||7485|10998 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3382|5430|lyfalmen|||63|100|0|67|Vistor hf|Bayer HealthCare AG|||3382||3382|5430 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|569|1613|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|||569||569|1613 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|3958|6212|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|||3958||3958|6212 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3316|5340|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|||3316||3316|5340 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3291|5306|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|||3291||3291|5306 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2260|3907|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2260||2260|3907 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4368|6768|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4368||4368|6768 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|6875|13267|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||6875||6875|13267 555607|N06AB0601|Zoloft|mixtúra|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|4633|7128|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4633||4633|7128 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2996|4290|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||2996||2996|4290 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|5764|8253|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||5764||5764|8253 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4888|6998|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|||4888||4888|6998 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3601|5156|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||3601||3601|5156 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3348|4793|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||3348||3348|4793 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5215|7917|lyfalmen|||00|100|0|30|Vistor hf|Novartis Healthcare A/S-|||5215||5215|7917 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6383|9502|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|||6383||6383|9502 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|11361|16258|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|||11361||11361|16258 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1516|2898|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|||1516||1516|2898 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|143470|180488|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|||143470||143470|180488 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|929|2101|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|||929||929|2101 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2082|3666|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|||2082||2082|3666 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|992|2187|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|||992||992|2187 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|556|1595|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|||556||556|1595 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1553|2948|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|||1553||1553|2948 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|893|2052|lyfalmen|V0732|1949|02|10|0|2|Icepharma hf|Grunenthal|||893||893|2052 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2302|3964|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|||2302||2302|3964 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6730|9973|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6730||6730|9973 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2488|4217|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|||2488||2488|4217 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2748|4570|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|||2748||2748|4570 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|9416|13481|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|||9416||9416|13481 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann||||||1257 560193|C09AA0101|Capoten|töflur|12,5|mg|100|stk|1|þpakki||C09AA01|01.07.1990|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|2182|3800|lyfalmen|||00|100|0|25|Vistor hf|Bristol-Myers Squibb|||2182||2181|3800 560235|C09AA0101|Capoten|töflur|25|mg|100|stk|1|þpakki||C09AA01|01.04.1995|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|50|Vistor hf|Bristol-Myers Squibb|||3166||| 560250|C09AA0101|Capoten|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.04.1995|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||5286||| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|2677|4473|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2677||2677|4473 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|10539|15142|lyfalmen|||00|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||10539||10539|15142 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1526|2911|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1526||1526|2911 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5101|7763|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5101||5101|7763 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5532|8348|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5532||5532|8348 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|102719|129753|lyfsjukr|||00|5|0|1|Vistor hf|Abbott Scandinavia AB|||102719||102719|129753 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|541401|508653|lyfsjukr|||00|20|0|5|Vistor hf|Abbott Scandinavia AB|||407057||407057|508653 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2307|3971|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|||2307||2307|3971 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|31603|41531|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|||31603||31603|41531 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|23617|31588|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|||23617||23617|31588 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|36356|47448|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|||36356||36356|47448 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|595|1648|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||595||595|1648 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1848|3348|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1848||1848|3348 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|595|1648|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||595||595|1648 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1848|3348|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1848||1848|3348 563494|N02AA0101|Contalgin|forðatfl|5|mg|25|stk|1|þpakki||N02AA01|01.10.1993|31.12.2008|R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|613|1672|lyfalmen|||10|25|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||613||613|1672 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1538|2928|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1538||1538|2928 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|195306|245341|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|||195306||195306|245341 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|4505|6954|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||4505||4505|6954 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|4745|7280|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||4745||4745|7280 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|8378|12210|lyfalmen|||00|98|0|49|Vistor hf|Novartis Healthcare A/S-|||8378||8378|12210 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|10608|15236|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||10608||10608|15236 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|144028|181182|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|||144028||144028|181182 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6003|8987|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||6003||6003|8987 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|9009|13066|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||9009||9009|13066 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1593|3002|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1593||1593|3002 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|10959|15712|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||10959||10959|15712 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1333|2649|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|||1333||1333|2649 566661|L04AB0101|Enbrel|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|SEK|101185|127843|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|||101185||101185|127843 566984|A10BG0201|Avandia|töflur|4|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000|31.12.2008|R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|5178|7866|lyfalmen|||00|28|0|19|GlaxoSmithKline ehf|SmithKline Beecham PLC|||5178||5177|7866 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|5485|8284|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5485||5485|8284 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1386|2721|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|||1386||1386|2721 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6990|10326|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|||||6990|10326 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|5535|8352|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|||5535||5535|8352 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|5356|8109|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|||5356||5356|8109 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|11792|16843|lyfalmen|V0793|8270|00|60|0|24|Vistor hf|Janssen-Cilag AB|||11792||11792|16843 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|19598|26584|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|||19598||19598|26584 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|25968|34515|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|||25968||25968|34515 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12|Vistor hf|Janssen-Cilag AB|||||| 567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|19654|26654|lyfalmen|||00|98|0|196|Vistor hf|Bristol-Myers Squibb|||19654||19654|26654 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|0|Icepharma hf|GE Healthcare AS|||14023||14023|19326 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||27452||27452|36045 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||5568||5568|7972 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||28937||28937|37894 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|15289|21220|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|||15289||15289|21220 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1911|3434|lyfalmen|||00|100|0|27|Vistor hf|Schering-Plough|||1911||1911|3434 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|957|2139|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||957||957|2139 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|16873|22874|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|||16873||16873|22874 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|16873|22874|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|||16873||16873|22874 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2180|3799|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2180||2180|3799 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3105|5054|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||3105||3105|5054 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|117150|147719|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|||117150||117150|147719 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|153343|192780|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|||153343||153343|192780 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|288476|361020|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|||288476||288476|361020 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3186|5164|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|||3186||3186|5164 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|96914|122525|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|||96914||96914|122525 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|24831|32782|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|||24831||24831|32782 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|48599|62373|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|||48599||48599|62373 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|3412|3267|lyfalmen|V0931|2428|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1788||1788|3267 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|11287|8768|lyfalmen|V0933|6361|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5842||5842|8768 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|5852|4913|lyfalmen|V0935|3559|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3001||3001|4913 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|18410|14243|lyfalmen|V0937|10351|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9876||9876|14243 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0|Icepharma hf|Norpharma |||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|5362|7677|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|||5362||5362|7677 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|89928|113828|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|||89928||89928|113828 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|6053|9055|lyfalmen|||00|28|0|14|Sofus Consulting AB|Procter & Gamble-|||6053||6053|9055 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2647|4432|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||2647||2647|4432 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1031|2239|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|||1031||1031|2239 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|SEK|813|1944|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|||813||813|1944 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|29136|38142|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|||29136||29136|38142 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|58010|74090|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|||58010||58010|74090 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|116279|146635|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|||116279||116279|146635 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|2|Vistor hf|AstraZeneca A/S DK|||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|4712|8154|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||4712||4712|8154 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|17757|30729|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||17757||17757|30729 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||39554||39554|51112 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||70812||70812|90028 582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|465|1471|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|||465||465|1471 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|642|1712|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|||642||642|1712 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||27452||27452|36045 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|||53298||53298|68224 583443|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|934|2108|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||934||934|2108 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||82356||82356|104401 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||28937||28937|37894 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|||61388||61388|78296 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||92841||92841|117455 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3607|5164|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|||3607||3607|5164 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1879|2690|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||1879||1879|2690 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|6937|9932|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|||6937||6937|9932 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5691|8148|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|||5691||5691|8148 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2764|3957|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||2764||2764|3957 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7901|11312|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|||7901||7901|11312 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3126|4476|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||3126||3126|4476 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3726|5335|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|||3726||3726|5335 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2107|3017|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||2107||2107|3017 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0|Icepharma hf|Fresenius Kabi|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|3217|5206|lyfalmen|||64|30|0|30|Vistor hf|Meda AS|||3217||3217|5206 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9433|13506|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|||9433||9433|13506 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3436|4919|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|||3436||3436|4919 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|33778|43921|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|||33778||33778|43921 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3176|5150|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3176||3176|5150 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|32714|42914|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|||32714||32714|42914 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2489|4218|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2489||2489|4218 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2928|4192|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||2928||2928|4192 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1289|2590|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|||1289||1289|2590 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2075|3656|lyfalmen|V0426|3598|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2075||2075|3656 588590|B01AC0501|Ticlid|töflur|250|mg|30|stk|1|þpakki||B01AC05|01.04.1995|31.01.2009|R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3786|5978|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||3786||3786|5978 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|11377|16280|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|||11377||11377|16280 588723|B03AA0702|Ferlen-R|forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|60|0|30|Actavis Group hf|Actavis hf|||||| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|8303|12108|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|||8303||8303|12108 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|5761|9970|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||5761||5761|9970 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2233|3864|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2233||2233|3864 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|5558|9618|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||5558||5558|9618 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3002|5195|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3002||3002|5195 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3118|5396|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3118||3118|5396 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2415|4179|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2415||2415|4179 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|129369|162932|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|||129369||129369|162932 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|81183|102940|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|||81183||81183|102940 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|20|Vistor hf|Bayer A/S|||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|25071|33398|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|||25071||25071|33398 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|184889|232054|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|||184889||184889|232054 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|||31979||31979|41681 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|||36833||36833|47725 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3076|4404|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|||3076||3076|4404 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|5934|8893|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|||5934||5934|8893 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|2|Actavis Group hf|Actavis hf|||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|613|1672|lyfalmen|||00|50|0|3|Icepharma hf|Roche|||613||613|1672 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|957|2139|lyfalmen|||00|150|0|9|Icepharma hf|Roche|||957||957|2139 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1626|3047|lyfalmen|||00|100|0|25|Icepharma hf|Roche|||1626||1626|3047 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|16862|23178|lyfalmen|||03|12|0|32|Vistor haf|Meda AB|||16862||16862|23178 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||554 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||4602 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2699|3864|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|||2699||2699|3864 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|968|1910|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||968||968|1910 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|8238|11795|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|||8238||8238|11795 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|541|1575|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||541||541|1575 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3675|5828|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3675||3675|5828 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|||||| 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991||L|A|5|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|858|2005|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|||858||858|2005 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1218|2493|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1218||1218|2493 907024|A04AD0501|Vogalene|eþ-stil|5|mg|10|stk|1|pakki||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|1597|3008|lyfalmen|||00|10|1|3|Distica|Distica - óskráð lyf|||1597||1597|3008 908048|J07AM5201|Immunoglob. mot tetanus|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|9865|14228|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||9865||9865|14228 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4276|6643|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4276||4276|6643 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2314||2314|3981 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3294|4716|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3294||3294|4716 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1461|2092|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||1461||1461|2092 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12013|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||8233||8233|12013 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3242|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||1770||1770|3242 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2510|4247|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||2510||2510|4247 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2993|4902|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||2993||2993|4902 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|10884|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|||7401||7401|10884 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|11596|16577|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||11596||11596|16577 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Parlogis hf|Parlogis - óskráð lyf|||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Parlogis hf|Parlogis - óskráð lyf|||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Parlogis hf|Parlogis - óskráð lyf|||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Distica|Distica - óskráð lyf|||1837||1837|3333 942468|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|3163|5133|lyfalmen|||00|20|1|20|Distica|Distica - óskráð lyf|||3163||3163|5133 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Distica|Distica - óskráð lyf|||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||10030||10030|14355 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1202|2472|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1202||1202|2472 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|3952|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|||2293||2293|3952 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947690|C01CA2403|Adrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA24|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1301|2606|lyfalmen|||00|10|1|20|Parlogis hf|Parlogis - óskráð lyf|||1301||1301|2606 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3266|5273|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3266||3266|5273 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3651|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3651 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1307||1307|1871 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|755|1865|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||755||755|1865 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4952|7090|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||4952||4952|7090 952251|J01CA0101|Ampicillin|sts|0| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952798|A03BA0101|Atropin|stl|1|mg/ml|1|ml|10|lykjur||A03BA01|01.07.2004||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1315|2625|lyfalmen|||00|10|1|7|Parlogis hf|Parlogis - óskráð lyf|||1315||1315|2625 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|||3127||3127|5084 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1890|3405|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1890||1890|3405 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|647|1718|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||647||647|1718 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|16941|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|16941 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|9780|14003|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||9780||9780|14003 961286|H02AB0905|Hydrocortisone|töflur|20|mg|30|stk|1|glas|0|H02AB09|01.10.2008|31.12.2008|R|A|0|0|0|E|0|LDR|0|0|1|100|IKR|4836|7403|lyfalmen|||00|30|1|20|Parlogis hf|Parlogis - óskráð lyf|||4836||4836|7403 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2108|3701|lyfalmen|||00|20|1|20|Parlogis hf|Parlogis - óskráð lyf|||||2108|3701 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4400|6811|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|||4400||4400|6811